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Visions and values 
Our contribution to a sustainable world
Bayer has been committed to envi-
ronmental protection and social responsibility around
the world for more than a century. In line with the princi-
ples of sustainable development, our future-oriented
strategy pays equal attention to economic, ecological
and social requirements. 
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Bayer is a global enterprise with core competen-
cies in the fields of health care, nutrition and high-
tech materials. Our products and services are
designed to benefit people and improve their
quality of life.
In reorganizing the Bayer Group and continuing
to streamline our portfolio, we have set out to cre-
ate a new Bayer – focused on its strengths, its
potential, its customers and the markets of the
future.
To speed innovation and growth, we are carrying
out a strategic realignment and concentrating our
future activities in three subgroups: HealthCare,
CropScience and MaterialScience, supported by
three service companies. Our employees are eager
to actively participate on the basis of common val-
ues, using their knowledge and their innovative
skills.
Building on a proud history as an inventor compa-
ny, we plan to continue setting trends in research-
intensive areas. For us, innovation is a major fac-
tor in improving existing products and discover-
ing new ones. It lays the foundation for competi-
tiveness, growth and economic success.
We believe our technical and commercial exper-
tise entails a duty to contribute to sustainable
development – a principle we wholeheartedly
endorse, mindful of its social, ethical and environ-
mental elements. In awareness of our responsibil-
ities as a corporate citizen, we define economy,
ecology and social commitment as values of equal
rank.
We seek to retain society’s confidence through
performance, flexibility and open communi-
cation as we work in pursuit of our overriding cor-
porate goals: to steadily create corporate value
and generate a high value added for the benefit of
our stockholders, our employees and the commu-
nity in every country in which we operate.
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The new Bayer Group
The Bayer Group has been reorganized – faster
and more sustainably than ever before. The new Bayer Group is flexible,
competent and focused on its core businesses and particularly on
research, paving the way for long-term growth and a sustained increase
in corporate value. The new corporate structure comprises a holding com-
pany (Bayer AG), three subgroups and three service companies. Bayer
Chemicals (with the exception of H.C. Starck and Wolff Walsrode) and
some areas of the MaterialScience business area are being transferred to
a new company called Lanxess, which is to be listed on the stock exchange
by the start of 2005.
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Bayer AG
Bayer AG is the management holding company for the Bayer Group. It is headed by a four-member Board of 
Management, which is supported by the Corporate Center. Global coordination of the subgroups and service groups
is carried out through Community Management, a Group-wide network of teams and working groups with defined
assignments, responsibilities and procedures. Their role is to share experience, discuss and decide on a wide range of
tasks and issues and implement policies and directives adopted for the entire Bayer Group.
Bayer CropScience
Bayer CropScience AG, which is based in
Monheim, Germany, is one of the world’s
leading innovative plant science companies.
Its activities cover crop protection, seed
treatment, plant biotechnology and non-
agricultural pest control. Bayer CropScience
aims to become the world’s top crop science
company through the expertise of its staff,
its innovative products, its unique research
platform and its customer focus. Offices
and agencies in more than 120 countries
ensure that it is always close to its cus-
tomers.
Bayer MaterialScience
Bayer MaterialScience AG is a leading man-
ufacturer of high-quality polymers. A large
proportion of sales is generated by prod-
ucts that occupy leading positions on the
world market. The main success factors of
the company are its efficiency, closeness to
the customer and expertise in innovative
system solutions. Its portfolio includes
polycarbonates, polyurethanes, coatings
and adhesive raw materials, thermoplastic
polyurethanes and inorganic basic chemi-
cals. Bayer MaterialScience includes the
Wolff Walsrode and H.C. Starck sub-
sidiaries, which have an excellent position
in specialist niche markets and contribute
valuable additions to the portfolio. It has
facilities at 40 sites worldwide.
Bayer Industry Services 
As operator of the largest German chemical
park network, which spans the sites in Lev-
erkusen, Dormagen, Krefeld-Uerdingen and
Brunsbüttel, Bayer Industry Services sup-
ports efficient manufacturing operations. It
provides a custom-tailored portfolio of core
infrastructure, safety, utility, waste man-
agement and analytical services. More than
35 companies at the chemical park sites,
including Bayer’s subgroups, use its exten-
sive range of services.
Bayer Technology Services 
Bayer Technology Services provides tech-
nology services and innovations for all
major Bayer sites around the world and
other companies at Bayer’s chemical park
sites. It specializes in the development,
planning and construction of production
facilities and optimization of established
products and processes for Bayer’s sub-
groups and other companies. 
Bayer Business Services
Bayer Business Services (BBS) is the Bayer
Group’s IT-based competence center pro-
viding business, administrative and scien-
tific services. Its offering ranges from tech-
nical consultancy to the performance of
business processes in the areas of procure-
ment, human resources, logistics, IT opera-
tions and accounting. The company also
groups together a number of subsidiaries
providing hosting, travel and media 
services. 
Bayer HealthCare
Bayer HealthCare AG, which is headquar-
tered in Leverkusen, Germany, operates
worldwide in the following divisions: Ani-
mal Health, Biological Products, Consumer
Care, Pharmaceuticals and Diagnostics
(Self-Testing Systems and Professional Test-
ing Systems). It is one of the world’s largest
suppliers of pharmaceuticals, diagnostics
and other medical products to prevent,
diagnose and treat diseases in people and
animals. Together with its German sub-
sidiaries Bayer Vital and KVP Kieler Pharma
+ Veterinärprodukte GmbH and a large
number of foreign affiliates, Bayer Health-
Care does business in more than one hun-
dred countries.
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Foreword
Werner Wenning
We want to shape a sustainable
world for future generations! 
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With its realignment, Bayer has
taken on a new shape over the
past couple of years. Having 
successfully adopted a holding
structure with subgroups re-
sponsible for the operating busi-
ness, supported by three inde-
pendent service companies, we
have now decided to transfer the
majority of our chemicals busi-
ness and some areas of our poly-
mers operations to a new com-
pany – Lanxess – which is to be
listed on the stock market as an
independent organization. The
future Bayer Group will therefore
be able to focus entirely on its
core competencies in the areas
of health care, nutrition and
high-tech materials. Our ulti-
mate goal is to offer products and
technologies that help make life
healthier and more pleasant.
That objective is clearly ex-
pressed by our new corporate
slogan: Bayer – Science For A 
Better Life.
Much has changed at Bayer, but
we have remained true to our
fundamental principles, includ-
ing our commitment to sustain-
able development, the vision
generated by the community of
nations of how to reconcile eco-
nomic progress with a sustain-
able future. Alongside economic
and ecological requirements, the
concept of sustainable develop-
ment embraces a commitment
to society. We are proud to rank
among the leaders in industry as
a whole – not just the leaders in
the chemical industry – in all
three areas. 
In summer 2000, when UN Sec-
retary-General Kofi Annan
approached selected interna-
tional companies with the idea
of a global pact to promote
respect for human rights and
environmental responsibility,
Bayer did not hesitate to endorse
the idea. The principles of corpo-
rate social responsibility form an
integral part of our corporate
philosophy because we believe
they are inseparable from sus-
tainable development. 
Bayer was among the founding
members of the UN Global Com-
pact, comprising eight German
companies and about 50 compa-
nies worldwide. We are aware of
our responsibility to society and
play an active role in preventing
child labor, eliminating discrimi-
nation and promoting health,
nature and the environment in
many parts of the world. These
are the standards that shape our
present and future decisions.
Sustainable development also
involves a responsibility to en-
sure that products are manufac-
tured in a way that is safe and
environmentally compatible and
saves resources. We have been
committed to these goals for
decades.
We have also set standards in the
field of social and societal
responsibility. In the early twen-
tieth century, Bayer set up Ger-
many’s first training workshop,
pioneering cultural facilities and
a wide range of clubs and soci-
eties for employees to use out-
side of work. Our commitment to
society has long extended
beyond the factory gate. These
days we organize, fund and sup-
port several hundred social proj-
ects throughout the world. 
Accordingly, our Sustainable
Development Report does not
simply focus on environmental
data. We want to show you what
Bayer is doing to balance eco-
nomic, ecological, social and soci-
etal requirements. We believe it
is important to publish our sus-
tainable development objectives
as a yardstick against which our
performance can be measured.
We regard that as an important
part of our dialog with the 
general public. 
The following pages show how
young people in many countries
see the future. Bayer aims to
combine expertise with respon-
sibility to help turn their visions
into reality.
Sincerely, 
Werner Wenning
Dear readers,
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Management
Practical sustainability is a team function 
Sustainability is a priority issue in our company, but its defi-
nition is also exposed to a constant tide of change in public
opinion. We have to respond to the public debate and take
up the standard interpretation, yet at the same time devel-
op and define our own specific procedures. For Bayer, sus-
tainable development means finding a balance between
economic, ecological and social requirements. We have
identified five elements as a basis for this: quality, partner-
ship, commitment, a systematic approach and global scope.
Sustainability Excellence
Bayer Values & Principles
Quality Partnership Commitment SystematicApproach
Global
Scope
Social
Responsibility Economy Ecology
Our endeavors in all these areas
are geared to sustainability
excellence, in other words, a con-
tinuous process of improvement
in our sustainability profile. 
Sustainability excellence is
achieved by integrating compa-
ny-specific demands and
requirements in order to create
value. That means that the
demands made at various levels
must be linked together. Build-
ing on our values and principles,
we aim to foster sustainability
excellence by concentrating on
quality, partnership, commit-
ment, a systematic approach
and global scope. 
Organizational integration
of sustainability
As a strategic task with long-
term implications, sustainability
management is a governance
task. As such, it can only be car-
ried out in conjunction with the
subgroups. Accordingly, a Corpo-
rate Sustainability Board forms
the heart of the sustainability
management structure for the
Bayer Group. The Corporate Sus-
tainability Board is chaired by
the member of the Group Man-
agement Board who is responsi-
ble for Innovation, Technology &
Environment. It is responsible
for making decisions on objec-
tives, strategy and major initia-
tives and for communicating 
the issue of sustainable develop-
ment (SD), and our activities and
initiatives in the area of corpo-
rate social responsibility (CSR), in-
ternally and externally. The work
of the Corporate Sustainability
Board is supported by the SD
Planning Group, whose task is to
make sure the strategies and ini-
tiatives are put into practice. The
SD Planning Group is an inter-
disciplinary team comprising the
heads of relevant functions at
the subgroups and staff from
various Corporate Center depart-
ments.
Components of sustainability
excellence in the Bayer Group
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The main elements of practical
sustainable development at
Bayer are discussed at an annual
SD Conference which is also
attended by the Group’s Respon-
sible Care officers.
Responsible Care is a global
chemical industry initiative ded-
icated to achieving continuous
improvement in environmental
protection, health and safety. It
is voluntary and, in some areas,
its goals exceed statutory re-
quirements. Bayer has been
committed to this voluntary ini-
tiative since it was introduced. 
Elements for implementing 
sustainability excellence
Sustainable development is sup-
ported by various programs and
initiatives, each of which has to
be driven individually, but all of
which interact. Management 
of these interfaces is important
because the multi-facetted
nature of sustainable develop-
Corporate Sustainability Board
SD Planning Group
Chair: Head of Governmental & Product Affairs
SD Vision 
and Goals SD Strategy
Management
of Attainment
of Goals
Agreement
on SD
Programs
Chair
Group Management Board member responsible for Innovation, 
Technology & Environment
Members
Members of the Management Boards of the subgroups responsible 
for research & technology, Head of International Human Resources, 
Head of Communications, Head of Governmental & Product Affairs
ment requires transparent inter-
nal and external integration.
This is achieved through the
organizational structure shown
below. The most important acti-
vities and programs embedded
in our sustainable development
strategies are as follows:
Responsible Care, the world-
wide initiative of the chemical
industry, plays an important role
by involving the employees in
the process. 
The Bayer Eco-Check is an
evaluation method developed by
Bayer to examine products with
a view to the key aspects of sus-
tainability. This tool is thus an
extended form of product stew-
ardship.
Corporate social responsibili-
ty brings all the threads of our
social commitment together: 
As a globally operative company,
we are part of society in all coun-
tries where we operate – as 
an employer, neighbor and busi-
ness partner. We take our
responsibilities seriously, in-
corporate them into our busi-
ness decisions, take part in 
many community projects and
support a wide range of initia-
tives. 
Support of the capacity-build-
ing activities of the International
Council of Chemical Associa-
tions (ICCA): Capacity building
means passing on information
and know-how on sustainable
production and the safe hand-
ling of chemicals, especially to
newly industrializing and devel-
oping countries.
At Group level, HSE (health,
safety, environmental protec-
tion) management directs the
main elements of implementa-
tion, e.g. the management sys-
tems and audits and the provi-
sion of information on sub-
stances and sites. 
Ensuring transparency within
the company and for outsiders
requires clear reporting of the
main information required by
our stakeholders. Systematic
recording and tracking of such
data are the most important
steps in this assignment. We set
ourselves concrete objectives
which we publish and against
which we allow ourselves to be
measured. 
Organization of sustainability 
in the Bayer Group
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For a global corporation, acting responsibly
means keeping a close eye on changing markets to make sure that the
right decisions are made at the right time. Bayer regularly reviews and
actively adapts its organizational structure in response to changing mar-
ket requirements. In 2002 we embarked on the most far-reaching reor-
ganization in our history to create “The New Bayer” – a future-oriented
group, initially comprising four subgroups and three service companies
managed in line with the principles of good corporate governance. As a
logical continuation of this process, we decided in the fall of 2003 to con-
centrate in future on our core businesses in health care, nutrition and
high-tech materials. The chemicals operations and some parts of the
MaterialScience business area that are no longer core businesses are to
be transferred to a separate company called Lanxess, which is to 
be floated on the stock market as an independent company by the start
of 2005.
Estefania Ortega, Colombia, aged 3
➔ More on the children´s pictures
“My wish is for a future 
with lots of children who are
friends with one another,
together with many animals,
mountains and a house on a
small lake.”
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Klaus Kühn
Sustainability strengthens our company
Economic responsibility means,
among other things, reviewing
the company’s competitive posi-
tion at regular intervals as a
basis for any necessary action.
One example is the extensive
reorganization of the Bayer
Group. This reflects the fact that
there is no permanent patent
recipe for dealing with the
increasing pace of change in the
modern world. In order to be suc-
cessful, we have to align our cor-
porate structures to the
dynamism of the global market,
changing customer needs,
mounting international compet-
itive pressure, the need for sus-
tainable development and a
large number of other factors. In
the initial restructuring phase,
which took just seven months,
we created an organization of
which we were proud: “The New
Bayer.”
As a logical continuation of the
reorganization we shall now
transfer our chemicals opera-
tions and parts of the polymers
business to a new independent
company, which is to be floated
on the stock market, so that in
future we can concentrate on our
innovation-based core business.
Our objective is continued inno-
vation and increased growth.
Ecological achievements 
honored
The restructuring of the Bayer
Group has naturally given priori-
ty to ensuring that we continue
to apply the principles of
Responsible Care and sustain-
able development as effectively
as in the past. We have long
ranked among the world leaders
in these fields, a fact confirmed
by many experts and institu-
tions. However, since nothing is
ever so good that it cannot be
improved, our aim is to enhance
our performance in these areas
still further.
In the future, these areas will be
increasingly important determi-
nants of the success of the com-
pany. 
Companies like Bayer that ac-
tively implement the principles 
of sustainable development
through social as well as ecologi-
cal responsibility are investing in
sustainable growth in corporate
value – in the interests of their
stockholders, employees and
society as a whole. 
We have received many awards
for our pioneering ecological
achievements, including the
renowned Presidential Green
Chemistry Challenge Award in
the United States on several
occasions. Our social and socie-
tal commitment is evidenced by
the fact that we were one of the
50 or so founding members of
the Global Compact initiative
introduced by UN Secretary-
General Kofi Annan.
Milestones in 
corporate development
1863
The businessman
Friedrich Bayer 
and dyer Johann
Weskott found
“Friedr. Bayer 
et comp.” in
Wuppertal,
Germany on
August 1. 
1870
Bayer opens its
first foreign 
agencies in
Austria, France
and the UK.
1875
Bayer starts to
conquer the U.S.
market. A year
later it opens its
first foreign 
production plant
in Moscow.
1881
“Farbenfabriken
vorm. Friedr. Bayer
& Co.,” a joint
stock company
with equity capital
of 5.4 million
marks, is estab-
lished on July 1.
1891
Bayer buys the
ultramarine 
factory Dr. Carl
Leverkus & Söhne
and further sites
on the banks of
the Rhine in
Wiesdorf (now
Leverkusen). 
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This ethical focus has been
acknowledged by the capital
market for many years. A report
by the Oekom Institute of
Munich, Germany, ranks Bayer
third among the world’s leading
pharmaceutical companies for
social and ecological commit-
ment and Bayer was included in
the Dow Jones Sustainability
World Index in 2003 for the fifth
consecutive year. This index
tracks companies with a pro-
active sustainability-driven poli-
cy. Bayer stock is also included in
a number of well-known sus-
tainable investment funds. 
Bayer commands trust in 
the United States too
Our commitment to sustainable
development enhances the
standing of our company, a fact
shown, for example, by a survey
of 850 opinion leaders in the
United States and Europe re-
garding the credibility of organi-
zations and companies. Accord-
ing to this survey, Bayer com-
mands more confidence in the
United States than any other
non-American company. The
only companies that obtained a
better rating were Microsoft,
Coca Cola and McDonalds. In
Europe Bayer was ranked sixth.
That was the best score by a
European company: The first
three places went to non-gov-
ernmental organizations (NGOs)
such as Amnesty International.
This survey shows that we are on
the right track. Our goal now is
to continue this excellent track-
record. 
Klaus Kühn has been Bayer AG’s 
CFO since May 2002.  
Guidelines for legal compliance and corporate responsibility at Bayer
Bayer is committed to lawful and ethical conduct. Already in July 1999 it introduced guide-
lines for legal compliance and corporate responsibility. Among other aspects, this code of
conduct, which was recently updated, sets out basic principles for dealings with col-
leagues, customers, suppliers, other companies and authorities. 
1900
Bayer’s sites have
800 managers
(known at the time
as clerical staff), 145
chemists, 35 engi-
neers and 4,400
laborers. Bayer is
thus the second
largest German
chemical company.  
1904
On January 6, the
Bayer cross is 
registered as a
trademark with
the Imperial
Patents Office.
1912
Leverkusen
becomes the 
company’s 
headquarters.
1925
Farbenfabriken
vorm. Friedr. 
Bayer & Co ceases
to exist. It is 
integrated into
I.G. Farben’s Lower
Rhine operating
consortium.
1945
I.G. Farben is 
dissolved by the
Allies immediately
after the Second
World War.
1947
On July 1, the 
facilities belong-
ing to the Lower
Rhine operating
consortium are
renamed “Farben-
fabriken Bayer.”
1951
Bayer is “founded”
for the second
time in its history:
On December 19 
it is entered in 
the commercial
register as
“Farbenfabriken
Bayer Aktien-
gesellschaft.”
1953
Bayer stock is 
re-listed on the
stock exchange.
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Corporate governance 
A tradition of transparency
Corporate governance means responsible corporate management and supervision. Bayer
has always been committed to these principles in the interests of long-term value 
management. This commitment long predates the introduction of the German Corporate 
Governance Code.
To raise the confidence of
national and international
investors, customers, employees
and the general public in the
management and supervision of
public companies in Germany,
the German government has
drawn up a Corporate Gover-
nance Code. Bayer has tradition-
ally placed great value on
responsible corporate policy
geared to increasing the value of
the company. We therefore wel-
come the adoption of the Ger-
man Corporate Governance
Code because it can raise trans-
parency, especially international-
ly. We will be following most of
the recommendations made by
the code and therefore issued a
“Declaration of Conformance” in
December 2002. 
Bayer applied the same 
principles in the past
The German Corporate Gover-
nance Code encompasses statu-
tory requirements and recog-
nized national and international
standards on responsible man-
agement and supervision of list-
ed companies. Specifically, it de-
tails the rights of stockholders
and the tasks and responsibilities
of the Board of Management and
Supervisory Board. It also con-
tains rules on corporate trans-
parency, accounting and auditing. 
Bayer complied with many of the
standards and rules set out in
the code well before it was intro-
duced so it has not triggered any
1958
Bayer’s annual
sales exceed 
DM 2 billion.
Exports account
for 42 percent.
1963 
Bayer celebrates
its centenary. The
122-meter high
administrative
block by the River
Rhine is opened.
1971
First reorganiza-
tion of the com-
pany creates 
nine divisions
operating as
independent 
profit centers 
and nine central
service units. 
1972
The company
changes its 
name from
“Farbenfabriken
Bayer AG” to
“Bayer AG.” 
1979
Bayer’s annual
sales exceed 
DM 25 billion. 
1984
Bayer groups its
operations in six
sectors comprising
25 business groups,
a corporate ad-
ministration center
and five central
service divisions. 
1991
The sector struc-
ture is dissolved.
The heads of the
business groups
now report 
directly to the
Board of
Management. 
1994
In September,
Bayer regains the
right to use its
name and logo in
the United States
and Canada. 
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major changes in our corporate
structure and processes. 
Since Bayer AG is headquartered
in Leverkusen, Germany, it is
required to comply with the Ger-
man law on which the Corporate
Governance Code is based. This
stipulates a dual management
structure. The Board of Manage-
ment and Supervisory Board
each have their own indepen-
dent role to play. This contrasts
with the common international
system where the management
and supervision of companies is
in the hands of a single manage-
rial body, the board of directors. 
As a global company, Bayer AG is
listed on many foreign stock
exchanges. Since January 2002 it
has also been listed on the New
York Stock Exchange. That
means it has to comply with spe-
cific U.S. regulations, especially
the Sarbanes-Oxley Act, which
was passed in July 2002 to pre-
vent accounting fraud. This leg-
islation also impacts corporate
governance. Where necessary,
we will adapt our corporate gov-
ernance procedures to make
sure that we also comply with
American legislation. 
Ensuring maximum 
transparency
To maximize transparency, we
provide regular information for
stockholders, financial analysts,
stockholders’ associations, the
media and the general public on
the company’s performance and
major business trends. In line
with the principle of “fair disclo-
sure,” we provide the same infor-
mation for all stockholders and
key target groups. All significant
new facts are disclosed immedi-
ately. Stockholders also have
timely access to information
that Bayer publishes in foreign
countries to comply with local
stock market regulations. 
In addition to our regular report-
ing through our Annual Report,
Stockholders’ Newsletter and
the internet, we issue news re-
leases and ad-hoc statements on
developments that may affect
our net worth, financial position
or general business performance
and could thus materially affect
the price of Bayer stock. 
Bayer is one of the first compa-
nies in Germany to publish de-
tails of the remuneration of
members of its Board of Man-
agement and Supervisory Board.
This information is published as
an annex to the financial state-
ments in our Annual Report.
Improvements at 
EU level welcomed 
On May 21, 2003 the European
Commission published an action
plan on “Modernizing Company
Law and Enhancing Corporate
Governance.” Since Bayer has
affiliated companies in nearly all
countries in the European Union,
we welcome this initiative to
harmonize national corporate
governance rules and will be
examining the practicability of
the recommendations.
Further information on corporate governance can be
found in Bayer’s Annual Report and on our website:
www.bayer.com 
1999
To celebrate the
centenary of
Aspirin®, Bayer’s
administrative
high-rise in
Leverkusen is
turned into the
largest Aspirin®
pack in the 
world. 
2000
Bayer acquires 
the polyols busi-
ness of Lyondell
Chemical Com-
pany, making it
the world’s 
leading producer
of polyurethane
raw materials.
2001
Bayer acquires
Aventis Crop-
Science for 
€7.25 billion and
becomes a world
leader in crop 
protection. 
2002
Bayer is listed on
the New York
Stock Exchange.
2003
In April, the Annual
Stockholders’
Meeting approves
the reorganization
of the Bayer Group
into a holding 
company, four sub-
groups and three
service companies. 
2003
In November, the
Supervisory 
Board approves
the Board of
Management’s
plans to split off
Bayer Chemicals
(except H.C. 
Starck and Wolff
Walsrode) and
some parts of the
MaterialScience
business area 
into a separate
company.
2004
The new company
for the chemicals
business and
parts of the poly-
mers operations 
is named Lanxess.
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The history of environmental protection at Bayer
began on November 5, 1901. That was the date on which the newly 
founded Wastewater Commission at the Leverkusen dyeworks first 
convened. Since then Bayer has consistently stuck to its principle of more
environmental protection, health protection and safety. Today, the com-
pany’s achievements in these fields are acknowledged throughout the
world and documented with numerous awards. 
Valentina Laborde, Ecuador, aged 8 
“I imagine a future 
with lots of technology 
and with me developing
computer games. 
But there must still also 
be large forests.”
➔ More on the children´s pictures
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Dr. Udo Oels
Product-integrated environmental 
protection is an everyday matter for us
In June 2002, in the presence of
the Federal German Chancellor,
Gerhard Schröder, the Federa-
tion of German Industries (BDI)
awarded Bayer its Environmental
Prize for the development of Bay-
pure®, an environment-friendly
dispersion agent based on
polyaspartic acid that combats
limescale. Previously, Bayer’s U.S.
subsidiary, Bayer Corporation,
was twice presented with the
prestigious Presidential Green
Chemistry Challenge Award set
up by the former U.S. President,
Bill Clinton. This Environmental
Protection Agency (EPA) award,
also made in recognition of the
development of environment-
friendly products, is regarded 
as the American “environment
Oscar.“  
Environmental protection 
concerns top management
Two things stand out here. First-
ly, environmental protection has
evidently become a political
matter for top management in
many industrial countries. Sec-
ondly, awards are not being pre-
sented for environmental pro-
tection facilities and processes,
but for endeavors made by com-
panies to develop products that
have no impact on the environ-
ment and, in ideal circum-
stances, also protect it from any
adverse effects. 
Both of these apply to us. At
Bayer, environmental protection
is a matter for the top echelons
of management. Having said
that, every individual employee
is – as stated in our Guidelines
for Responsible Care, Health Pro-
tection and Safety – also com-
mitted to act in line with corpo-
rate objectives in this field. 
For Bayer, environmental protec-
tion has been taken for granted
for many decades. In fact, we
have gone a good deal further
than that. We have moved for-
ward from so-called ‘end-of-
pipe’ environmental protection
to ‘in-process’ environmental
protection, which means that
environmental protection is
more or less built into our pres-
ent-day production facilities
through process optimization, so
that pollutant emissions are
substantially reduced or avoided
completely. End-of-pipe environ-
mental protection is becoming
increasingly superfluous.
Now, Bayer is pushing on with
third-generation environmental
protection – so-called product-
integrated environmental pro-
tection – which also covers prod-
uct-integrated safety. Our prod-
ucts must not affect, let alone
endanger, humans, animals or
the environment during their
production and use or during
their disposal. Above all, they
must also comply with the prin-
Milestones in 
ecological responsibility
1898
Establishment
and official recog-
nition of Bayer’s
own monitoring
and control
department 
1903
First accident 
statistics 
published
1913
“Committee for
Clean Factory Air“
in Leverkusen 
1934
Department 
for accident 
prevention
1901
Wastewater
Commission of
the Leverkusen
Dyeworks
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ciple of sustainability; in other
words they must be manufac-
tured in a way that ensures max-
imum conservation of resources
and energy, and also be largely
recyclable or allow problem-free
disposal. We are thus one of the
pioneers in this field. Through
our Responsible Care and prod-
uct stewardship programs we
were practicing “integrated
product policy“ long before it
was first called for by the Euro-
pean Commission.
Proud of U.S. 
Responsible Care award
The fact that we are one of the
leading companies in the world
in matters of Responsible Care 
is also documented by a prize
that makes us particularly proud:
The American Chemistry Council
(ACC) has presented our sub-
sidiary Bayer Corporation with
the Responsible Care Leadership
Award – which is the most
important recognition in the
United States for outstanding
achievements in the field of
environmental protection and
safety that a chemical company
can receive. 
The level of acceptance of our
efforts was also illustrated by a
recent survey in Germany in
which more than 2,000 of those
questioned named Bayer as the
second most environment-
friendly company among major
enterprizes. 
For us, such recognition is an
encouragement not to let up in
our endeavors to constantly
develop and further enhance our
performance in the fields 
of environmental protection,
health and safety. 
Another important objective is
the further reduction of our
Dr. Udo Oels, since 1996 
member of the Bayer Board 
of Management responsible 
for Innovation, Technology &
Environment
environmental impact through
eco-efficient products and man-
ufacturing technologies. Among
our approaches in this regard
has been the introduction of 
the Eco-Check, a tool by means
of which we can examine im-
portant products with respect 
to ecology and sustainability. 
We are also constantly optimiz-
ing our use of finite resources
and improving eco-efficiency. 
As a result, we have already
today achieved the officially
specified targets for 2010 and
have even exceeded them in
some areas.
1936
First appointment
of an officer to
monitor air at the
Leverkusen site
1954
Wastewater and
emission control
laboratory in
Leverkusen
1959
Laboratory for
aquatic biology 
to examine the
toxicity and
biodegradability
of chemicals
1963
First Bayer air
measurement
network to moni-
tor sulfur dioxide
emissions
1966
Leverkusen waste
management 
center with
wastewater 
treatment plant,
incinerator and
landfill
1974
Bayer AG’s 
first safety 
competition
1979
Technical intro-
duction of Bayer
Tower Biology®
1986
Guidelines for
environmental
protection and
safety 
Guidelines for Responsible Care in Environmental Protection, Health Protection and Safety
In 1986, we published our first “Bayer Guidelines for Responsible Care in Environmental Protection
and Safety,“ which are binding for all employees. Following the establishment of the international
Responsible Care initiative by the chemical industry, Bayer has integrated the principles of the ini-
tiative into its guidelines and regularly adapts them to new developments. The idea is that all
employees should act in line with corporate environmental protection and safety objectives, adopt
them in their personal areas of work, and implement innovative solutions to ensure constant
improvements in health protection, safety and environmental protection.
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Responsible Care in 
our day-to-day work 
Designing products that take into account environmental protection, health protection and 
safety, and responsibly accompanying them over their entire life cycle – from their initial 
development and production to their use and final disposal – is nothing new for Bayer. Product
stewardship traditionally covers a whole spectrum of measures, extending from the specific
development of improved products and the testing of new ones, to responsible product 
management and the carrying out of research activities aimed at acquiring knowledge of the
long-term effects of substances on humankind and the environment. 
1987
First international
press forum to
present Bayer’s
perspective on 
the environment;
launch of a 
DM 3 billion pro-
gram to improve
environmental
protection 
1989
Guidelines on
quality and 
quality assurance
1993
Bayer AG’s first
Environmental
Report
1994
Guidelines for
Responsible Care
in Environmental
Protection and
Safety in line 
with the global
Responsible Care
initiative
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1995
Guidelines 
for Quality
Management 
at Bayer
1995
Second Environ-
mental Report
(Group-wide for
the first time) 
1997
Third Environ-
mental Report
with updating of
targets so that 
the public can
monitor if the 
targets are being
achieved
1999
Bayer Site Infor-
mation System
(BAYSIS TM) Group;
Responsible Care
Report 
2000
Media forum 
on environmental
protection and
safety: “Bayer’s
Perspective on
Ecology 2000“;
introduction 
of the Bayer 
Eco-Check
2001
First Sustainable
Development
Report with
account of 
sustainable 
development 
targets
2002
Dr. Udo Oels,
Bayer Board of
Management
member responsi-
ble for Innovation,
Technology &
Environment,
opens the German
Business Day at
the World Summit
in Johannesburg,
South Africa, and
presents Bayer’s
achievements 
in sustainable 
development. 
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Consumers today often make
demands on products that
extend well beyond the tradi-
tional definition of quality. The
focus is no longer merely on a
product’s use and its safety in
application. 
Nowadays, it is also important
that a product meets ecological
and health requirements and
that it is accepted by society, in
other words by customers, con-
sumers, the authorities and also,
for example, by groups with spe-
cific interests. Its chances of
market success are being increas-
ingly dictated by such criteria. 
That is why, when Bayer has a
new idea for a product, it makes
a thorough examination of
which criteria it satisfies: The
product must have a high bene-
fit for the user and it must be
accepted by society. It must not
constitute any appreciable risk
for humankind, the animal world
or the environment throughout
its life. Its production should
consume as few resources as
possible and cause a minimum
of emissions. It should be largely
recyclable, or at least be readily
disposable. And, of course, it
should be relatively economical
to manufacture and yield a maxi-
mum return. 
Although such a product seldom
materializes in its entirety, by
continuously developing prod-
ucts it is possible to come ever
closer to this ideal. In order to
systematically evaluate present
and future products against
these criteria, Bayer has intro-
duced what it calls the “Bayer
Eco-Check.“
Key products 
under scrutiny
For Bayer, product stewardship
means also monitoring products
already on the market for their
environmental compatibility,
safety, health protection and
resource efficiency, especially if
they are regarded critically by
the general public, so that, if nec-
essary, appropriate countermea-
sures can then be taken. 
For this purpose, Bayer uses the
Bayer Eco-Check, which was
described in detail in the 2001
Sustainable Development Re-
port. The evaluation is made on
the basis of six core criteria: eco-
nomy, health, environment, life
cycle, technology and public
value. Specialists from all parts
of the company analyze the
results and draw up recommen-
dations for the product manage-
ment teams. 
The Bayer Eco-Check provides a
comprehensive analysis of a
product by linking up the techni-
cal (application) angle, the
health aspect and the economic
evaluation to the stakeholders’
viewpoints – i.e. the views of the
customers, the consumers and
society generally. 
To present the results in graphic
form, we use a diamond-shaped
diagram in which the six criteria
making up the Eco-Check are
mapped on a uniform evaluation
scale. A rating in the green sec-
tor indicates an excellent per-
formance, while yellow indicates
that the performance is “state-
of-the-art.“ Generally speaking,
an evaluation in the red area
indicates that there is need for
action. 
The diagram on the right shows
the result for Teldor®. This crop
protection agent is used to com-
bat fungal diseases on wine,
fruit and vegetables. (The results
of the project are explained in
detail on pages 25 – 26.)
On the health axis, our experts
assess the safety of the product
(and possibly also of its inter-
mediate products) for our em-
ployees, users and consumers.
The environment axis contains
an evaluation of the environ-
mental compatibility, both dur-
ing production and during the
service life of the product. 
The life cycle axis looks at the use
of resources and the resultant
ecological effects. Finally, the
technology axis evaluates plant
safety and includes aspects such
as the availability of technology
and the state of development of
the process. 
The Bayer Eco-Check
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The six quality criteria of
the Bayer Eco-Check 
Through the Eco-Check each
product is analyzed and eval-
uated against six relevant cri-
teria. These comprise:
1. Health – the safety of the
product for the consumer,
processor, customer and em-
ployee;  
2. Environment – an examina-
tion of the product’s environ-
mental compatibility; 
3. Life cycle – a consideration
of all possible effects of
extensive emissions on the
environment and the dwin-
dling supply of natural
resources throughout the
entire product life cycle (eco-
balance);  
4. Technology – safety of the
production processes and
availability of the raw materi-
als;
5. Public value – a look at the
acceptance of the product in
the overall corporate environ-
ment and its value for society;
6. Economy – the economic
opportunities and risks. 
This overall picture is then com-
pleted by an economic evalua-
tion and an assessment of the
public value. The public value
covers evaluations that were not
drawn up by our experts but
were submitted or requested by
other parties such as our cus-
tomers, the consumers, the
authorities or politicians and
affect the relevant product.
These evaluations allow conclu-
sions to be drawn about the level
of acceptance of the product
among these groups – an essen-
tial factor for the sustained suc-
cess of the product on the mar-
ket.
In the case of Teldor®, the Eco-
Check confirmed its sustainable
value for customers and for
Bayer. Through the use of Tel-
dor®, consumers can now enjoy
even higher-quality foodstuffs.    
Economy
Life cycle
Environment
Teldor®
HealthPublic value
Technology
An example of
an evaluation
using the Eco-
Check: In all six
areas, the crop
protection
agent Teldor® 
is in the green
sector, an 
excellent rating
that reflects 
the sustainable
value of the
product for the
customer and
for Bayer.
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In a declaration made in Febru-
ary 2003, Bayer HealthCare AG
committed itself to support the
aims of Responsible Care in all
sectors of the company, extend-
ing from research and produc-
tion to the storage, use and dis-
posal of its products. 
The following examples show
how Bayer HealthCare honors
this commitment across all divi-
sions.
Animal experiments 
reduced considerably
In our search for innovative and
effective drugs, we regard it as
part of our product stewardship
responsibility to first test poten-
tial development candidates for
their safety and effectiveness in
animal experiments before they
are tested on humans. In any
case, it is a moral obligation to
make safe and effective products
available. In this connection, it
would be unethical not to use
the most telling method to
achieve this. Moreover, animal
experiments are also indispens-
able when it comes to developing
medication for animals because
it means that millions of other
animals can be successfully treat-
ed as a result. In doing this, we
are also acting in line with the
legal requirements, and we strict-
ly observe the regulations gov-
erning the protection of animals.
Although alternative and sup-
plementary methods may help
reduce the use of animal tests,
they cannot and will not be able
to completely replace animal
experiments in the foreseeable
future. From a scientific point of
view, animal tests are in many
cases the only way to assess and
ensure the safety and efficacy of
drugs. This is why animal testing
will continue to be an important
part of biomedical research and
development for the foreseeable
future. Nevertheless, it is Bayer's
declared aim to minimize the
use of animal experiments and
to opt for alternative and supple-
mentary methods wherever this
is possible. We now use some 60
percent fewer animals than we
did ten years ago.
Bayer HealthCare Effective drugs
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International committee advises Bayer on ethical matters
The Biological Products Division at Bayer HealthCare AG set up an independent international commit-
tee in 2003 to advise Bayer on all ethical issues that could arise in connection with blood plasma prod-
ucts. It is called the “Bayer International Bioethics Advisory Council” (BIBAC). It has nine members from
six countries, including medical experts, lawyers, philosophers and a theologian, all experts with a
worldwide reputation. BIBAC is completed by two Bayer representatives, whose job it is to advise the
council on technical matters. BIBAC has already begun work and has advised the World Bank, which
intends to set up a similar initiative.
“Bayer HealthCare wants the
products it has developed to
be of the greatest benefit to
humans and animals. Product
stewardship in the sense 
of sustainable development
therefore has a very special
meaning for us. Products
which do not meet our expec-
tations are not developed 
further. Products which are 
already authorized for sale,
which, despite scrupulous
testing, cause unexpected se-
rious side effects, are removed
from the market, regardless of
any financial aspects.”
Rolf Classon, Chairman of the
Executive Committee of Bayer
HealthCare
Baytril®: Combating the 
development of resistance
The Bayer veterinary medicinal
product Baytril® has now been
licensed for over 15 years in
numerous countries throughout
the world for the treatment of
many common infectious dis-
eases in cattle, pigs and poultry
as well as in dogs and cats. As it
is particularly effective against
the main bacterial pathogens,
this anti-infective agent, which
belongs to the fluoroquinolone
group of substances (active
ingredient: enrofloxacin), is now
regarded as the “gold standard”
among treatments. Around
3,000 scientific publications
make Baytril® currently the 
best-documented anti-infective
agent in veterinary medicine. 
Like all antibiotics, the fluoro-
quinolones have the disadvan-
tage that bacterial resistance
can develop if they are used
inappropriately. In order to pre-
vent this, Baytril® is only avail-
able for the treatment of infec-
tions on a veterinary prescrip-
tion. It is not licensed as a
growth promoter – Bayer is also
very much against this. The
Baytril® active ingredient, en-
rofloxacin, has one advantage
over many of the anti-infective
agents developed in the past: 
It prevents the genes which 
are responsible for resistance
from being transferred from 
one species of bacterium to
another. 
In order to find out more about
the problem of resistance, Bayer
started building up a resistance
monitoring program in several
European countries in 1992. The
monitoring network has now
been further strengthened. To-
gether with ten other pharma-
ceutical companies and the
European Animal Health Study
Center (CEESA), Bayer has set up
the EASSA Program (European
Antimicrobial Susceptibility Sur-
veillance in Animals). The EASSA
experts in eight European coun-
tries collect and analyze samples
– another important step in
coming to grips with the forma-
tion of resistance. 
In addition, the continuous fur-
ther development and optimiza-
tion of formulations and admin-
istration regimens helps to
reduce the risk of resistance
development. Bayer has issued
special guidelines to ensure 
the correct and responsible use
of Baytril® by veterinarians
throughout the world (Prudent
Use Guidelines).
In keeping with its commitment to product stewardship, Bayer has also set up an 
international initiative to combat the increasing danger of resistance formation from
human anti-infectives: LIBRA. You can find out more about this initiative on the internet
at www.librainitiative.com or in the 2001 Sustainable Development Report, p. 19.
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Bayer CropScience
encouraging good agricultural
practice, e.g. the expansion of
integrated agriculture and
ecosystem management. This
involves the responsible and effi-
cient use of agricultural tech-
nologies, the careful manage-
ment of water and energy
resources, and biodiversity (see
also pages 57 – 58).
Teldor® – a crop protection
agent under scrutiny
Products not only have to meet
the demands of customers, they
also have to be environmentally
compatible and meet the expec-
tations of our society. The crop
protection agent Teldor® (active
ingredient: fenhexamid) was
evaluated with the aid of the
Bayer Eco-Check (see also pages
21 – 22) as a model product
against competitors’ products.
All these products are used in
wine-growing to combat the
fungus botrytis. The excellent
action of such products against
fungi improves the quality of the
grapes, raises the wine yield per
hectare, and, as a result, brings
considerable cost savings and
higher profits for the vintner. In
each of the Eco-Check cate-
gories, all the products investi-
gated received a ‘very favorable’
rating – a reflection of the strin-
Sustainable agriculture must
ensure an efficient equilibrium
between economic success, eco-
logical responsibility and social
acceptance. Bayer CropScience
(BCS) provides agricultural tech-
nologies and solutions that help
to safeguard harvests, reduce
harvest losses, improve the qual-
ity of products, and optimize the
use of natural resources. In this
way, BCS makes an important
contribution towards meeting
the global demand for food and
animal feedstuffs. 
Strategy for sustainable 
agriculture
In 2003, together with a British
non-governmental organization
called the “Stakeholder Forum
for Our Common Future,” BCS
developed a strategy for sustain-
able agriculture that focuses on
three core areas in which BCS
can contribute to the setting up
of sustainable agriculture:
making significant R & D
investment in innovative, eco-
nomical technologies and solu-
tions;
providing consulting and
other services throughout the
entire life cycle of products with
the aim of responsibly shaping
their development, manufacture
and use;
Safeguarding harvests
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A responsible approach to genetic engineering
Bayer believes that responsibility for its products begins as early as the research and development
stage. This also applies to products created or enhanced by genetic engineering techniques, which are
monitored and investigated rigorously.
The science known as “red biotechnology” is generally accepted throughout the world as a key tech-
nology in the treatment of diseases. Although it harbors an enormous development potential and
could help many patients, Bayer rejects certain types of projects for ethical reasons, including those
which involve genetic manipulation of the human germ line.
“Green biotechnology,” on the other hand, is still struggling for broad acceptance in some countries. In
2003, seven million farmers in 18 countries successfully planted genetically enhanced plants. Bayer
believes that plant biotechnology is a vital technology which can usefully supplement classical plant
breeding efforts. The company scrutinizes all developments in the light of its clear commitment to
product safety for people and the environment.
Bayer is convinced that crop protection, conventionally bred seed and genetically enhanced seed are
three areas that will increasingly work together and reinforce each other, helping to safeguard food
production for people today and future generations.
quently given preferential treat-
ment by the authorities in what
is otherwise a highly time-con-
suming licensing procedure. This
move by the U.S. authorities is
intended to encourage the
development of outstanding
new products.
Disposal of obsolete 
pesticides
How seriously Bayer takes prod-
uct stewardship is shown by the
example of the disposal of obso-
lete pesticides from developing
countries. This issue is relevant
mainly in countries with planned
economies in which procure-
ment was organized by central
authorities without the actual
needs of farmers being taken
into account. In many cases
there were donations in the form
of development aid. BCS has
already participated in several
“As one of the world’s lead-
ing plant science companies,
we strongly support sustain-
able agriculture. We fully 
realize that we must meet our
economic targets but, at the
same time, must also fulfill
our social and ecological re-
sponsibilities.”
32 26
Prof. Dr. Friedrich Berschauer,
Chairman of the Board of
Management of Bayer Crop-
Science AG
gency of the licensing require-
ments for crop protection agents
generally. But Teldor® scored a
number of additional points: In
the Environment category, for
example, it received (along with
one other product) a particularly
good rating because of its excel-
lent overall properties. Teldor®
can even be applied very shortly
before harvesting without affect-
ing the color or taste of the 
fruit. The new mode of action of
Teldor® also helps to prevent the
fungus from becoming resistant
when used in a spraying se-
quence with other products. An
examination of the toxicological
properties resulted in Teldor®
coming out best with regard to
the potential health risk for
users and consumers. Because of
its positive properties, Teldor®
has been classified as a “reduced
risk” active ingredient in the
United States and is conse-
disposal projects involving prod-
ucts from Bayer, for example in
Brazil, Mozambique, Namibia,
Pakistan, South Africa and Swazi-
land. Other cooperation projects
are currently under way in
Ethiopia and Senegal. Help has
also been offered with a disposal
project in Nepal. 
In August 2003, the world crop
protection product association
CropLife International pledged
to contribute 30 million U.S. dol-
lars to the Africa Stockpiles Pro-
gram. The aim of this multi-
stakeholder project, which is also
supported by BCS, is to remove
obsolete crop protection prod-
ucts from Africa in the next 
15 years.
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Bayer MaterialScience 
The core competency of Bayer
MaterialScience is the develop-
ment of innovative products,
applications and processes. For
us, ongoing improvements in
health protection, safety and
environmental protection are
just as important as optimum
quality and maximum econom-
ic efficiency. Here are a few ex-
amples of how Bayer Material-
Science implements the concept
of sustainable development. 
Reduction in energy 
consumption 
Ecological responsibility means,
among other things, handling
natural resources responsibly.
This, of course, includes efforts
to save energy during produc-
tion. Bayer has succeeded in
doing this with the production
of chlorine. By recently convert-
ing the chlor-alkali electrolysis
units at its German sites in Lev-
erkusen and Dormagen – and
partly also in Krefeld-Uerdingen
–  from the amalgam (mercury
cell) process predominantly used
in Europe to the modern mem-
brane technology, Bayer has been
one of the European pioneers in
this field. This has cut the con-
sumption of electrical energy in
chlorine production by up to 
30 percent. It has also brought
about a significant reduction in
the emission of the greenhouse
gas carbon dioxide (CO2) during
electricity production (of approx.
400,000 tons of CO2 equivalents
a year). At the Bayer site in Bay-
town (Texas, U.S.A.), a new chlor-
alkali membrane electrolysis
plant went on stream back in
1999. Consequently, Bayer now
produces 90 percent of its chlo-
rine worldwide by the energy-
saving membrane process. 
In cooperation with various part-
ner companies, Bayer is currently
developing the so-called oxygen-
depolarized cathode technology.
Once the process has reached
industrial maturity, it should be
possible to cut energy consump-
tion by up to 30 percent. 
Rigid foam for 
thermal insulation
Efficient thermal insulation in
buildings can play a significant
part in conserving resources and
preventing emissions. This is an
area where considerable savings
can be made over the entire
service life of a building. In terms
Innovative products 
and processes
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Ecological responsibility
For us, ecological responsibility means responsibility for people's
health and for the protection and preservation of the natural
resources that form the basis for life. It relates to our efforts and
achievements in matters of environmental protection, health pro-
tection and safety with regard to our products and production
processes.   
costly treatment of the solvent
contained in conventional dis-
persions. Dispercoll® products
are used in the production of
shoes and furniture, the con-
struction industry, automotive
engineering and, last but not
least, the DIY sector.
New coating technique 
saves costs and energy
The paintwork on a modern-day
car needs to be really tough. It
must be resistant to intense sun-
light and hot sand, and must not
be damaged by flying stones or
the like. To comply with such
stringent specifications, car
manufacturers apply a final clear
coat that acts like a protective
shell. It not only gives the car its
desired high gloss, it also pro-
tects the layers underneath – the
colored paintwork, surfacer, anti-
corrosion primer and steel. For
such applications, use is nowa-
days frequently made of high-
grade polyurethane clear coats
based on raw materials from
Bayer MaterialScience.
The innovative “Dual Cure” tech-
nology, which Bayer Material-
Science is currently developing
together with the paint and
34 28
of insulation efficiency, rigid
foam insulating boards made
from specially-formulated poly-
urethane raw materials supplied
by Bayer MaterialScience outper-
form all other insulating materi-
als currently in widespread use.
This means that a much higher
insulation performance can be
obtained with the same thick-
ness of external insulation. Alter-
natively, high-performance poly-
urethane insulating materials
provide the same insulation
effect with considerably thinner
walls than is possible when con-
ventional insulating materials
are used.
Solvent-free adhesive 
raw materials
Dispersions for the production of
high-quality adhesives can now
also be formulated without sol-
vents, as is shown by the Disper-
coll® line of products. The bene-
fits of solvent-free adhesives are
obvious: They are safer to use
and make much less of an
impact on the environment than
their solvent-based counter-
parts, and they also have an eco-
nomic advantage, because there
is no longer any need for the
“In our capacity as a global
player we want to be an
attractive partner to our cus-
tomers – the partner of
choice, offering genuine value
added worldwide and earning
the trust of our customers.
We want to grow and enjoy
success together with our
customers.”
Dr. Hagen Noerenberg,
Chairman of the Board of
Management of Bayer 
MaterialScience 
automotive industries, is likely to
set new quality standards in
future. The resulting coatings
combine the advantages of heat
curing with those of efficient
radiation curing. The resultant
polyurethane network has even
higher brilliance and better
scratch resistance than conven-
tional coatings. The coatings
cure with the aid of ultraviolet
radiation in just fractions of a
second. The subsequent heat
curing process cures any areas in
complex three-dimensional geo-
metries that are not normally
accessible for UV radiation. This
extends the field of application
for UV-curing coating systems 
to complex three-dimensional
parts, and, for the first time,
opens the door for this modern
technology to enter the field of
automotive finishing. The Dual
Cure systems are regarded as a
clean technology: They contain
very little solvent and the rapid
curing under UV light consumes
comparatively little energy.
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Responsibility to society
Bayer Sustainable Development Report 2004
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“I agree with Henry Ford that if we industrialists
do not contribute toward solving social problems, we have left our fore-
most duty undone.” These were the words of Carl Duisberg, who made
Bayer a pioneer in corporate social responsibility at the beginning of the
20th century. This tradition has remained strong at Bayer to this day: Cor-
porate social responsibility and corporate citizenship are now more than
ever being rigorously applied in our company.
Neeva Young, United States, aged 3
“I hope that the sun 
always shines so that 
the trees and bushes 
can grow nicely!”
➔ More on the children´s pictures
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Dr. Richard Pott
Success through common values
The goals are ambitious: We
want to achieve a top perfor-
mance in all areas of our enter-
prise and safeguard long-term
success at our approximately
350 companies worldwide. We
aim to create sustained value
An active commitment to
common values
Common basic values provide a
framework for action in specific
situations and serve as a work-
able basis for open, honest and
trusting cooperation both with-
in and outside the Bayer Group.
Traditional Bayer values include
Responsible Care, a gentle
approach to resources and the
environment, an emphasis on
product quality and safety, and a
commitment to reliability, fair-
ness and transparency.
Our commitment to social
responsibility is an integral part
of Bayer’s active corporate cul-
ture worldwide. We take our val-
ues seriously and work to imple-
ment them. We maintain ambi-
tious social programs at numer-
ous locations that contribute to
solving such diverse societal
problems as human rights abus-
es, child labor, discrimination,
hunger, disease and environ-
and improve quality of life with
our ideas, products and services.
At the same time, however, we
want to take into account the
different views and cultural
backgrounds existing through-
out the world and treat all peo-
ple with respect.
The Bayer Group can only be suc-
cessful in its new organizational
structure if all employees adopt
the company’s goals as their
own. For this reason, we require
and support employees who
think and act entrepreneurially.
In other words: Committed,
highly motivated and qualified
employees are our most impor-
tant capital. Essential criteria in
this respect are a commitment
to lifelong learning and a willing-
ness to develop self-initiative,
work independently and assume
responsibility – with the courage
to take risks. As part of our cor-
porate mission, we undertake to
safeguard the future – for Bayer
and for coming generations.
Milestones in 
corporate social responsibility
1877
The “Factory
Workers’ Relief
Fund” of Friedrich
Bayer & Co. is offi-
cially recognized
as a registered
relief fund.
1885
The Bayer “Relief
Fund” becomes a
corporate health
insurance fund.
1887
Bayer joins the
local organization
“Bergischer Verein
für Gemeinwohl”
which builds
houses for work-
ers.
1889
A medical dispen-
sary is established
in Elberfeld.
1890
Two funds – one
for wage earners
and the other for
salaried staff – are
set up to support
employees in
emergencies.
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Dr. Richard Pott joined the Board
of Management of Bayer AG on
May 1, 2002. He is responsible for
Strategy and Human Resources
and also serves as the company’s
Labor Director.
Bringing values to life
We aim to align our employees’ actions to Bayer’s corporate values and assess them accordingly.
This is reflected in the following aspects of human resource policy among others:
Management principles based on Bayer’s values let our employees know what we expect of them.
Performance management demands, supports and honors commercial success and the imple-
mentation of our values.
Lifelong learning and human resources development allow us to recognize, evaluate and sup-
port the potential of our employees through seminars, job rotations and feedback.
mental destruction. This is one
reason why Bayer was a found-
ing member of the Global Com-
pact initiative set up by U.N. Sec-
retary-General Kofi Annan. The
2004 Sustainable Development
Report contains many examples
of how Bayer acts as a global pio-
neer in the area of social respon-
sibility – which is also consistent-
ly supported and practiced with-
in the Bayer Group (see inset).
It is up to all of us to serve as an
example and contribute to a bet-
ter quality of life through our
own actions.
1895
Preferential 
shopping oppor-
tunities are 
established for
employees.
1899
A savings bank 
for workers is
founded.
1900
A medical dispen-
sary is established
in Leverkusen.
1900
The Bayer 
orchestral society
is established.
1901
To meet the
demand for highly
skilled labor, Bayer
establishes a
training school
and workshop in
Leverkusen.
1902
Bayer establishes
a library, a home
for women who
have recently
given birth and 
a housekeeping
school.
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The workforce 
as a guarantor of success
Bayer is successful in more than 150 countries around the world. This can only remain so if we
continue to address rapidly changing market conditions and the related challenges. Here, flexi-
bility, speed and an adjustment of our structures are required to safeguard our existence in the
future. Bayer is relying on its employees’ abilities, motivation and willingness to commit to life-
long learning and accept change.
set up at the 
company’s offices
to advise on 
hirings and 
dismissals and
serve as an
appeals body 
for complaints.
1905
Bayer establishes
a preschool.
1907
A group of Bayer
employees sets 
up a continuing 
education center
for Bayer workers
and craftsmen on
August 18.
1907
The Cultural
Affairs Depart-
ment is estab-
lished and its 
program steadily
expanded.
1904
The first Bayer
athletics club (TuS
04) is established.
1904
The company’s
various care 
units are inte-
grated into a 
single welfare
department. An
“Employee Affairs
Committee” is 
1908
The “Erholungs-
haus” performing
arts center is
inaugurated in
Leverkusen-Wies-
dorf on Septem-
ber 13.
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1909
Expenditures for
voluntary welfare
facilities total 
1.6 million marks 
– 18 times the
statutory mini-
mum at that 
time.
1909
The eight-hour
shift is introduced.
1910
Bayer becomes
the first German
company to
employ a “social
secretary” whose
job it is to medi-
ate in disputes
between workers
and supervisors.
1912
The “Böttinger
Home” is built in
the Bergisches
Land region near
Leverkusen for
employees requir-
ing recuperation
or care. 
1920
A society of long-
serving employees
is founded on
November 28,
with a member-
ship of 627. Today
it has more than
28,000 members.
1922
For the first time,
students are hired
at Bayer to fill in
for employees on
vacation.
1926
An annual bonus
is introduced for
all employees.
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Bayer places tremendous value
on the outstanding qualifica-
tions and high motivation of its
employees – and thus also on
appropriate remuneration. An
important tool for employee
motivation is a remuneration
concept that includes both a
competitive fixed income and
variable income components
that allow employees to partici-
pate in the company’s business
success. The concept also com-
prises appropriate pension bene-
fits.
Innovative incentives 
for employees
Another aspect of Bayer’s remu-
neration system involves further
innovative incentives for all
employees such as Bayer AG’s
stock participation program,
which has since also been intro-
duced in Belgium, the Nether-
lands, France, the United King-
dom, Ireland, Spain and Greece.
As Bayer shares have been listed
on the New York Stock Exchange
since 2002, we have also estab-
lished share purchase programs
for employees of our U.S. sub-
sidiaries.
Bayer’s stock programs are very
popular. More than 60 percent of
those eligible take advantage of
the offer each year. At the end of
2003, approximately 55,000
employees around the world
held more than 15 million Bayer
shares in all – 2.1 percent of the
company’s capital stock. Nearly
half of all Bayer employees own
stock in the company. 
Provisions for secure 
pension benefits
A further key fringe benefit is
Bayer’s company pension sys-
tem, which is of particular
importance in countries where
the social security systems are
only now being established.
Bayer provides for the period fol-
lowing retirement either directly
or by making payments into pri-
vate funds. The company’s bene-
fits vary according to the legal,
tax and economic conditions
existing in the individual coun-
tries and are generally based 
on the employee’s salary and
duration of employment.
In 2003 Bayer paid €747 million
into all forms of pension plans
for its employees – nearly 40 per-
cent of the company’s total
expenditures of approximately
€1.9 billion for social benefits
and support.
Individual and flexible 
work schedules
Wherever it is possible and com-
patible with the circumstances
existing in individual countries,
Bayer is a proponent of flexible
work schedules that meet both
corporate and individual needs.
For example, about 16,000 non-
managerial employees of Bayer
AG for many years have enjoyed
the benefits of flexible working
hours. In 2001 Bayer introduced
annual worktime accounts for a
further 13,000 employees in Ger-
many with fixed working hours.
This allows staff to be deployed
flexibly, according to production
requirements.
Since the beginning of 2003, we
have increasingly made employ-
ees at many of our sites around
the world aware of the possibili-
ty of individually shaping their
Remuneration concepts and social benefits
1926
Carl Duisberg
decides to consider-
ably expand the
Japanese Garden
first established in
1913 near his villa
next to the Lever-
kusen site. The re-
sult is an attractive
garden landscape in
the Japanese style.
1943
The Social Depart-
ment sets up a
special industrial
safety unit. A ser-
vice is also estab-
lished to assist
employees whose
homes have been
destroyed by
bombing during
World War II.
1952
Bayer-Wohnungen
GmbH is estab-
lished. Cons-
truction of new
housing for
employees begins
for the first time
since the war.
1953
Bayer shares are
listed once again
on the stock 
market. The first
employee stock
ownership
scheme is
launched.
1957
Introduction of
the 43.75-hour
working week. The
collective bargain-
ing agreement
still provides for a
45-hour working
week.
1959
An agreement is
concluded govern-
ing cooperation
between manage-
ment and the
works councils of
Bayer AG. It great-
ly expands on the
first Industrial
Constitution Act
of the Federal
Republic of
Germany enacted
in 1952, already
introducing ele-
ments of the 1972
Act.
1965
Groups are estab-
lished to support
non-German
employees. A wide
range of language
courses is offered.
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working hours, while taking
account of the requirements of
business operations. They can
choose from numerous flexible
part-time models, including two
different part-time working
arrangements in Germany for
older employees winding down
their careers. Options also
include sabbaticals lasting a
longer period of time for person-
al or educational reasons. These
practices are already gaining
increased acceptance in many
countries and companies. Fur-
thermore, we are open to tele-
working options, allowing
employees to work from home
with the help of modern com-
munication and information
technology.
Balancing family 
and career
For a number of years now, the
company’s social benefits have
also included a commitment to
balancing family and career. At
Bayer’s headquarters in Lever-
kusen, this commitment is evi-
dent in part through the support
of pre-schools operated by the
German Red Cross. Bayer also
supports certain parental initia-
tives and assists employees in
finding daycare options for their
children.
The company also offers a num-
ber of other services to help
young parents balance their
family and career responsibili-
ties, such as extended maternity
or paternity leaves lasting up to
seven years. Our part-time
employment, job-sharing and
teleworking practices also serve
this purpose.
Other Bayer companies help to
locate pre-school openings for
the children of their employees
or find suitable daycare centers,
as is the case at Bayer Corpora-
tion in the United States. There,
the company assumes part of
the costs for these services.
Bayer Corporation is also active
in finding care takers for elderly
family members requiring care.
In this case, too, the company
helps defray the cost of these
services.
1970
The Kurt Hansen
Foundation is
established for
the training of 
science teachers.
1977
Introduction of 
the “Learning by
Doing” program
for young people
without a school
diploma.
1981
The Herbert
Grünewald
Foundation is
established to
promote sports
for the disabled.
1982
Following the
death of Professor
Dr. Otto Bayer 
on August 1, the
“Otto Bayer
Foundation for
the Recognition
and Support of
Scientific
Researchers” is
established. 
1986
Bayer AG estab-
lishes an endow-
ment to finance a
teaching position
for industrial
chemistry in the
Mathematics and
Science Faculty of
the University of
Cologne.
1987
The “Family and
Career” agreement
takes effect. It
allows mothers or
fathers with young
children to take up
to seven years’
leave of absence
with a guarantee
that they will be
reinstated at the
end of this period.
Such employees
are, however, obli-
gated to continue
their professional
education during
this absence so
they retain their
skills.
Bayer offers its employees a number of modern flexible work-
time options: Men also take advantage of part-time employment
opportunities, although the percentage of women using these
models is higher. The ratio is approximately two to one.
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Employee advancement inde-
pendent of gender is a matter of
course at Bayer. The focus is on
supporting men and women in
planning their careers and pri-
vate lives and giving them equal
opportunities for individual
development in the company.
This is achieved at the compa-
ny’s German sites in part
through the “Equal Opportunity”
task force, a joint body of the
management and Works Council
that was established more than
a decade ago. The result: Over
the past ten years, the propor-
tion of female managerial
employees at the company’s
locations in Germany has more
than doubled, and the number
continues to grow. Women
account for one in every five
newly employed university grad-
uates at Bayer. These are excel-
lent figures for the German
chemicals sector, since most
graduates in scientific and tech-
nical fields are still men. In Ger-
many, Bayer AG received the
“Total E-Quality” award from the
association of the same name in
May 2003 for the third time in
honor of its commitment to
equal opportunity. Nearly 20 per-
cent of all Bayer AG employees
are women. The proportion of
female trainees at Bayer is
almost 25 percent.
Strengthening the role of 
women at the workplace
In the United States, Bayer Corpo-
ration was named a 2002 recipi-
ent of the Catalyst Award for its
role in promoting the advance-
ment of women with the initia-
tive “Bayer Women: Leaders for
the Global Marketplace.” Catalyst
is a non-profit research and advi-
sory organization working to
advance women in business and
the professions, with offices in
New York and Toronto. The award
is given to companies imple-
menting new and creative solu-
tions for ensuring women’s
advancement in the workplace of
the 21st century. The initiative
“Leaders for the Global Market-
place” focuses on preparing
women of all colors for wide-
ranging tasks in a global compa-
ny.
Cultural diversity – 
multicultural interaction
The company’s efforts to fight
racism and anti-foreigner senti-
ment throughout the world are
every bit as intensive as its com-
mitment to the advancement of
women. As a multinational com-
pany, equal opportunity for all
our employees is a guiding prin-
ciple of our corporate policy.
Therefore, we support the sixth
principle of the United Nations
Global Compact initiative: “In-
dustry should work to eliminate
discrimination in respect of
employment and occupation.”
(Read more about Bayer’s partic-
ipation in the “Global Compact
initiative” on pages 48–49.)
Bayer employs people from a
wide range of cultural back-
grounds. This is not only the case
at Bayer’s German sites – where
foreign workers have been
employed for decades, currently
accounting for about 5.8 percent
of the company’s total workforce
– but also around the world,
where people of different
nationalities and ethnicities are
employed at Bayer sites. For the
Group as a whole this figure is
around five percent.
We see this cultural diversity as
a tremendous opportunity for
our company. That’s why our
human resources development
programs encourage assign-
ments in foreign countries to
prepare our employees for glob-
al responsibilities and sensitize
them to cultural differences.
Employee advancement
1988
The Hermann
Strenger Foun-
dation is estab-
lished for the 
promotion of
international
employment
experience.
1991
The Bayer
Communication
Center – or
“BayKomm” 
for short – is 
inaugurated 
in Leverkusen.
1992
The “Bayer
Foundation for
German and
International
Labor and
Commercial Law”
is established
jointly with the
University of
Cologne.
1993
The integrated
community pro-
gram “Bayer goes
to the community”
is launched in
Belford Roxo, Brazil.
Through March
2003, 400,000
people from the
community sur-
rounding Bayer’s
site north of Rio de
Janeiro have partic-
ipated in programs
providing health
education, training,
school lunches 
and many other
services.
1993
First environmental
report for Bayer AG.
1994
The first produc-
tion facility comes
on stream at
Bayer’s new site in
Bitterfeld, eastern
Germany. Bayer’s
choice of this 
location was a
social policy deci-
sion made in the
context of German
reunification.
1996
The Agrovida pro-
gram is intro-
duced in Brazil to
improve living and
working condi-
tions for farm
laborers. Specially
developed educa-
tion models are
employed to teach
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In the 1990s our U.S. subsidiary
Bayer Corporation set up the
“Bayer Diversity Advisory Coun-
cil.” The goal of this body is to
promote the unprejudiced coex-
istence of different cultures
within the company. This is
achieved partly through a men-
toring program for the integra-
tion of new colleagues. The pro-
gram is also aimed at investigat-
ing and putting a stop to any
potential discrimination due to
ethnicity, skin color or other
physical characteristics. Nearly
all of our U.S. managerial staff –
and many other employees –
have since visited a seminar
aimed at breaking down stereo-
types and misconceptions about
other nations and races.
Increased opportunities 
for the disadvantaged
The principle of equal opportuni-
ty naturally also applies to disad-
vantaged people in our society.
These include young people
without a high school diploma.
As their career opportunities are
initially very poor, we believe we
have a special social obligation to
help such young people com-
plete a vocational training
course. To help achieve this, we
maintain a program at our Ger-
man sites of Leverkusen, Dorma-
gen and Krefeld-Uerdingen, that
gives youngsters without a high
school diploma the opportunity
to prepare over a 12-month peri-
od for a vocational training
course in a scientific field.
We also support external initia-
tives, such as the campaign at
our headquarters site entitled “A
Ship for Leverkusen.” The two-
year job creation program of the
employment office run by the
educational organization Kolping
Bildungswerk and financed by a
number of sponsors involved the
construction by ten educational-
ly challenged young people of a
vessel able to navigate on the
open sea. Under the direction of
a master shipbuilder, the partici-
pants gained expertise in wood-
and metal-working, painting and
varnishing, and electrical, gas
and water installation – key qual-
ifications that open up chances
to them in the job market.
Support outside of 
the workplace
Many Bayer companies support
their employees outside of the
workplace too. With an exten-
sive “quality of life” program, for
example, Bayer Corporation
helps its employees to overcome
difficulties in their private lives.
The company provides financial
support to employees who
adopt a child. Bayer Corporation
also makes arrangements and
defrays costs for employees
requiring care for their children
or other family members
dependent on assistance. In
addition, the Employee Assis-
tance Program provides free
assistance in a number of areas
affecting employees’ private
lives, including drug counseling.
The company even helps
employees to find legal advice
for a wide range of everyday
problems, as well as professional
debt management services for
those in financial need.
In Germany too, employees with
questions and problems linked
to addiction and dependence
can find professional assistance
in the company.
the laborers about
the safe, economi-
cal and ecological-
ly compatible use
of crop protection
products. About
25,000 families
take part.
1997
Bayer becomes 
a member of the
World Business
Council for
Sustainable
Development.
1998
Bayer launches
extensive projects
in India to assist
street children,
orphans and chil-
dren of migrant
workers.
2000
Bayer becomes a
founding member
of the United
Nations Global
Compact 
initiative.
2000
U.S. President Bill
Clinton honors
Bayer Corporation
with the
President’s Service
Award – the high-
est accolade for
corporate social
responsibility in
the United States
– for the compa-
ny’s “Making
Science Make
Sense” program.
2000
Bayer launches
the global Libra
initiative to 
combat the
spread of anti-
biotic resistance.
2001
Bayer supplies
WHO free of
charge with its
drug products
Germanin® 
and Lampit® to 
combat African 
sleeping sickness.
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In a time of ever more rapidly
developing technologies, chang-
ing tasks and evolving markets,
the key factor for success is not
just acquired knowledge, but
rather the topicality of that
knowledge. This is essential both
for the company, to establish
itself at the top in the interna-
tional arena, and for the career
development of each employee.
Lifelong learning is therefore
both an opportunity and an obli-
gation for our employees. For
this reason, we offer an exten-
sive continuing education pro-
gram worldwide.
Each year more than 20,000
employees at Bayer AG alone
take the opportunity to update
their knowledge in about 4,000
daytime courses and 200
evening courses. This corre-
sponds to more than a million
course hours a year. The compa-
ny invests more than €100 mil-
lion yearly in vocational training
and continuing education.
There is also rising demand for
the management training pro-
grams offered by Bayer’s Asian
and Australian subsidiaries.
Nearly 200 seminars have been
held since they were introduced
in 1992, and the programs were
recently extended to Bayer’s
companies in Belgium and Swe-
den.
An important contribution
to social policy
Continuing education builds on
vocational training. More than
100 years ago, Farbenfabriken
Bayer was one of the first Ger-
man companies to hire appren-
tices, who were familiarized with
their future occupation in a spe-
cial workshop. The training
workshop of yesteryear has
developed into a full-scale corpo-
rate vocational training program
completed by some 5,000 young
people in 20 countries every year.
About half are trained at the
German sites of Bayer AG, while
a further 600 receive training at
the company’s German sub-
sidiaries.
In the fall of 2003, 788 high
school graduates were accepted
into vocational training pro-
grams at the five sites of Bayer
AG. This is about 300 more than
the company is likely to need.
Bayer is thus also making an
important social contribution at
a time when vocational training
openings are rare.
Science-based careers 
particularly popular
More than 20 vocations are
taught at Bayer. About 43 per-
cent of the trainees who entered
the program in the fall of 2003
aim to pursue a scientific career.
A clerical training course was
chosen by 30 percent of the 
participants, while 27 percent
chose technical training. Bayer’s
main site in Leverkusen accepted
the lion’s share of trainees in
2003, with 434 young people. 
At Bayer’s German sites, trainees
account for 6.7 percent of 
the workforce, which is well
above the chemical industry
average.
Continuing education and vocational training
2001
An agreement
reached between
the management
and the Works
Council to help
safeguard the
future of Bayer
AG's German sites
rules out dis-
missals for eco-
nomic reasons
through 2004.
2002
Bayer reaches an
agreement with
WHO subsidiary
“Medicines for
Malaria Venture”
to develop a new
malaria drug to
aid developing
countries.
2003 
Bayer becomes
one of the first
major foreign
sponsors of
Brazil’s “Zero
Hunger Program”
aimed at combat-
ing poverty.
2004
Bayer’s continues
its collaboration
with the Brazilian
government on 
its Zero Hunger
Program.
2004
A third agreement
is reached
between the 
management and
the Works Council
to help safeguard
the future of
Bayer AG’s Ger-
man sites: There
will be no 
dismissals for 
economic reasons
through the end 
of 2007, and the
planned number
of jobs to be
shelved is reduced
by 1,000. 
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Supporting training where 
it’s most needed
Outside of Germany, more than
200 young people in about 20
countries are currently taking
part in dual training programs
based on the German system.
We make an effort to bring qual-
ified young people into our
workforce in other countries as
well – and particularly those
with a completely different voca-
tional training system than in
Germany. Here are just two
examples:
Mexico. Here, Bayer’s training
programs are a good example of
how the company’s social
responsibility and its need for a
well-trained workforce go hand
in hand. Bayer has run the “Centro
de Capacitación para la Industria
Químicia A. C.” (CECIQ) – a modern
vocational training center – in
this Central American country
since 1986. At CECIQ young Mexi-
cans receive a three-year special-
ized training in various occupa-
tional branches according to the
standards of the German Cham-
ber of Industry and Commerce.
Bayer places great importance on
German standards not just in
safety and environmental protec-
tion, but also in the training level
of its employees. For a number of
years now, numerous leading
international companies – and
not just from the chemical indus-
try – have also been taking
advantage of Bayer’s training and
continuing education programs
for the qualification of their
employees, who receive intensive
instruction from staff at the
Bayer school.
As a training provider, Bayer also
participates in the vocational
training programs of the “Institu-
to Superior Mexicano-Aleman de
Capacitación” (ISMAC). ISMAC is
an institute of the German school
in Mexico City that provides
training particularly for office
administrators and industrial
clerks, who complete internships
at Bayer Mexico during their time
at the school.
China. In June 2002 Bayer
signed an agreement with
Shanghai Petrochemical Acade-
my (SPA) concerning cooperation
in the training of chemical pro-
duction technicians. In February
2004, the “Bayer Training Plant”
got under way with three “SPA
Bayer Classes.” The 132 students
receive specialist qualifications
and practical training. Bayer has
provided a sum of €1 million for
the construction of a laboratory,
a pilot plant and a pipe assembly
workshop. The goal of the collab-
oration is to work with the
renowned Chinese training cen-
ter for chemical vocations in
training potential employees for
our new production site in Cao-
jing.
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In the area of education and
research, our goal is to promote
the talents and abilities of young
people and thus help secure the
flow of new  and qualified talent
into the company and industry.
Bayer has a good image in Ger-
many particularly among talent-
ed young scientists. Evidence of
this is supplied by the Absolven-
tenbarometer 2003 – a study
carried out by the Trendence
Institute in Berlin in cooperation
with the Young Chemists’ Forum
of the Society of German
Chemists (GDCh). At 39 universi-
ties throughout Germany, some
700 prospective chemists –
undergraduate, graduate and
doctoral students alike – were
asked to choose their favorite
potential employer out of a list
of 100 companies, primarily from
the chemical, automotive and IT
industries. Bayer and BASF fin-
ished tied for first place by a
wide margin in the survey of the
most popular potential employ-
ers, each garnering 28 percent of
the votes.
Support for up-and-coming
university-level scientists
Bayer is also active in promoting
highly qualified young scientists.
For this reason, we have long
cooperated with universities and
award scholarships to particular-
ly gifted students. The commit-
tees of the various Bayer founda-
tions decide on the awarding of
scholarships in Germany (see
inset). At the company’s interna-
tional locations, the granting of
scholarships is usually conduct-
ed directly by the company
through its regional organiza-
tions.
The following are a few exam-
ples of how our companies in
various countries approach the
advancement of young scien-
tists, taking care to address the
specific needs of their individual
countries:
China. Since 1996 Bayer has
awarded scholarships to under-
graduate and postgraduate stu-
dents at Beijing University of
Chemical Technology (BUCT) in
recognition of their excellent
academic performance. Bayer
also works with the Chinese
Academy of Science (CAS) to pro-
mote young scientific research-
ers. Together we presented the
“CAS Bayer Research Award” for
the first time in 2002, awarding
prizes in two categories: The
“Start-Up Fund”, endowed with
$25,000, is aimed at scientists
trying to establish their own
research groups, while the
“Young Chinese Scientist
Award,” endowed with $10,000,
is presented to young scientists
at the CAS institutes. Through
2005 we will provide the Chinese
Academy of Sciences with a total
of $500,000 for this purpose. 
Japan. To promote the interest
of young people in science, Bayer
Japan since 2000 has organized
the annual “Bayer Student
Reporters” program in coopera-
tion with the Japanese daily
newspaper Mainichi Shimbum.
High school students selected
during a science essay competi-
tion visit Bayer sites in Germany
and the United States as young
“journalists” and become familiar
with scientific themes such 
as pharmaceutical research, ge-
nomics and environmental pro-
tection. Afterwards the students
report on their trip in the news-
paper.
Australia. Bayer finances a
university research scholarship
that is awarded every two years
by an independent institution,
the Research & Education Foun-
dation of the Royal Australasian
College of Physicians. Receiving
support in particular are re-
search projects that deal with
cardiovascular, anti-infective and
metabolic medicine.
Education and research
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Bayer scholarships
Dr. Carl Duisberg Foundation for German 
students studying abroad
The foundation makes a variable contribution to
the living expenses of German students studying
abroad. 
Dr. Carl Duisberg Foundation for German med-
ical students
Travel grants are awarded to young German 
medical students wishing to intensify or supple-
ment their studies by undergoing clinical training
abroad. 
Kurt Hansen Foundation for the training of 
science teachers
The scholarship takes the form of a grant of €800
paid each semester from the fifth up to and
including the ninth semester. 
You can find information on other Bayer and
Bayer-administered scholarships on the internet
at:
www.bayer.com/about_bayer/social_responsibili
ty/foundations
Mexico. Students at the
National Autonomous University
of Mexico do not learn solely from
their professors, but also from
Bayer HealthCare AG’s Animal
Health experts, who inform the
prospective veterinarians about
the company’s biological safety
programs. In addition to the up-
to-date scientific materials the
company provides free-of-charge
to the students, Bayer also match-
es the volume of products
ordered by the Department of
Veterinary Medicine for treating
animals at no charge. Other divi-
sions, too – such as Pharmaceuti-
cals – promote similar activities to
support student training and the
continuing education of academ-
ics.
France. Via a special button
(“Site étudiants”) at its corporate
website, Bayer France provides
students with information about
important scientific events and
gives them an opportunity to
pose a wide range of science-
related questions to the compa-
ny’s experts. 
Diverse curriculum for 
teachers and students
We aim to promote and support
chemistry teaching at German
schools, both in the scope of our
corporate social responsibility
and in our own interest as a com-
pany. For this reason, we foster
regular contact with teachers
and students in the communities
around our sites. Our goal is to
promote an understanding for
chemistry and other sciences,
increase the acceptance of this
important economic sector and
present attractive career oppor-
tunities. To achieve this, we offer
target-group and demand-ori-
ented programs for teachers and
students of all ages and school
types. A 164-page brochure helps
teachers to choose the right
options out of the various pro-
grams offered (at www.schule.
bayer.de), which range from tours
of the Bayer sites and open house
events in the company’s training
centers through school project
weeks and student internships to
continuing education for teach-
ers and Bayer-supported student
contests. Teachers can also order
Bayer Sustainable Development Report 2004 Responsibility to society 43
➔ Table of Contents
children and young people from
less socially established families
and from orphanages the oppor-
tunity to experience science,
technology and art in an enter-
taining setting. 
In recent years, Bayer has been
participating in an environmen-
tal education program for stu-
dents in Poland. The company
worked together with education
experts to develop a new high
school learning program entitled
“Eco-Class” that is designed to
teach students about environ-
mental protection. So far, four
schools have participated in proj-
ects dealing with recycling and
environmentally friendly trans-
portation and energy. With this
initiative, Bayer supported the
“Green Certificate” program of
the Polish Environment and Edu-
cation Ministry. Bayer has since
been awarded an environmental
prize for its Eco-Class project by
the well-known Polish travel
magazine Poznaj Swiat (“Intro-
duction to the world”).
manuscripts for experimental
presentations and experiments
for schools, as well as lecture
notes on macromolecules and
dyestuffs. Bayer provides the
chemicals necessary for the
selected experiments free of
charge.
“Bay-Labs” established at various
sites are intended to supplement
science classes in schools and
strengthen the interest in science
that undoubtedly exists among
the young participants of various
ages. However, safeguarding the
flow of young talent into the
company is not the only goal
here. Another aim is to stimulate
dialog between the public and
the research community. One
example of this is the “Observa-
tional Laboratory for Molecular
Biology,” which can also be visit-
ed by adults at the Fuhlrott
Museum in Wuppertal.
Further examples:
In Germany, Bayer for several
decades has sponsored the
“Jugend forscht” (Youth per-
forms research) competition for
students. The goal of this com-
petition is to introduce young
people to science and recruit
them into the industry as scien-
tists and researchers. In April
2004 the annual state competi-
tion for North Rhine-Westphalia
was held for the 39th time, 
taking place for the 12th time at
BayKomm, the Bayer Communi-
cation Center in Leverkusen.
Bayer also supports a five-day
state seminar as part of the
Chemistry Olympics.
In the United States, the
“Making Science Make Sense” 
initiative established by Bayer in
1992 is aimed at improving sci-
ence teaching in U.S. schools. We
have already described these
activities in detail in earlier Sus-
tainable Development Reports.
The program has since also been
introduced in Japan, where
Bayer employees demonstrate
experiments at elementary
schools as part of this initiative.
In this way, Bayer aims to revive
the interest of Japanese children
in science, which according to
studies has been sharply declin-
ing in recent years.
In September 2001 the Educa-
tion Business Partnership joined
with Bayer to launch “Science for
Life”, a science competition for
students in the United King-
dom and Ireland. The competi-
tion recognized by Science Year,
an initiative of the British gov-
ernment, is open to teams of up
to four students from the age of
16 in the U.K. and Ireland who
study science. At the center 
of the project is the Science for
Life website (www.sciencefor
life.uk.com), which contains a
tremendous volume of reference
materials that are relevant to
curricula for teachers and stu-
dents.
In Mexico, Bayer for years has
supported a program of the
Papalote Museo del Niño in Mex-
ico City to benefit state schools.
This children’s museum is one of
the most important of its kind in
the world. The program gives
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Awards and prizes as an incentive
In order to promote scientific research and support up-and-com-
ing scientists, Bayer presents awards and prizes in various fields.
These range from the Otto Bayer Prize and the International
Aspirin Award to the “Endowed Prize of the German Diabetes
Society” and the “Ludwig Heilmeyer Prize.” The company also
supports the environmental medicine society “via medica”
through collaboration and financial assistance. Furthermore,
Bayer has provided considerable organizational and financial sup-
port to the Robert Koch Foundation for more than 40 years.
Another important prize, the “Bayer Hemophilia Awards
Program,” was established by the company in September 2002.
The goal of this research initiative is to promote the development
of the next generation of treatment and therapy options for
hemophiliacs. The company provides $2.75 million each year to
finance scholarships for up-and-coming researchers, assistant
university professors and other hemophilia specialists. The pro-
gram is aimed at supporting basic and clinical research and edu-
cation in the field of hemophilia therapy. As part of the awards
program, between five and 15 prizes are awarded each year in four
categories. 
Internships for high school
and university students
A further important activity for
the promotion of young
researchers involves offering
internships to high school stu-
dents so that they can get a
taste of what might await them
in a scientific career. The compa-
ny also offers internships in
many fields that students need
to cover to satisfy the require-
ments of their studies. These
internships are primarily avail-
able in the areas of natural sci-
ence, technology and business,
and can be completed at all
Bayer sites in Germany as well as
a number of foreign locations in
countries such as Argentina, the
United States, China/Hong
Kong, Mexico, Singapore and
Spain.
Since 1993, Bayer Australia has
offered high school graduates a
training program called the
Bayer Youth Traineeship Scheme,
which provides them with
insight into the working world
and helps them find the career
best suited for them. Over a peri-
od of 18 months, the trainees
receive and complete practical
assignments in all parts of the
country. They also study at a col-
lege for higher learning and con-
tinuing education to develop
management expertise.
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Social 
commitment
Like all other corporate policy objectives of the Bayer Group, our corporate social responsibility
objectives are derived from the company’s self-image. Our goal is to grow the value of our Group
over the long term and generate a high value added in the interest of our stockholders, 
employees and society at large in all the countries in which we operate. At Bayer, we believe our
technical and business expertise involves a responsibility to work for the benefit of mankind
and contribute to sustained and environmentally friendly development. 
Since the end of the 19th century, social responsibility has been an integral part of Bayer’s 
corporate culture. That commitment has never been an end in itself, since it involves working
not only for the good of society but also for the attainment of corporate goals, such as the
advancement of our corporate image.
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As a research-based enterprise,
Bayer places great emphasis on
promoting science education for
young people and has therefore
been committed to providing
youth environmental programs
for many years. As partner to the
United Nations Environment
Programme (UNEP), Bayer
organizes and supports a num-
ber of specific projects which
aim to strengthen environmen-
tal awareness and improve
knowledge about the environ-
ment among young people. 
Building on their many years of
cooperation in the Asia-Pacific
region, Bayer and UNEP want to
give their close and successful
partnership a more global basis.
A cooperation agreement, mak-
ing Bayer UNEP’s first private
partner in the area of youth and
the environment, is to be signed
in June 2004. The new commit-
ment focuses on the regions
Asia-Pacific, Central and Eastern
Europe and Latin America.
Bayer and UNEP:
Successful cooperation for youth and the environment 
Young envoys for 
environmental protection
With its Environmental Envoy
project, Bayer provides young
people with opportunities to
gain first-hand experience of
environmental protection, with
a focus on industry, households
and the role of government. A
key goal of the program is to
promote a greater understand-
ing of the interaction between
the different sectors of society
and familiarize young people
with modern industrial product
development and manufacture
based on the concept of sustain-
able development.
Originally established in 1995 in
Thailand, the program has since
been expanded to India, Singa-
pore, the Philippines and China.
Bayer has been the program’s
main sponsor since 1998, with
support also coming from gov-
ernments and authorities of the
countries involved. 
It is planned for the program to
include Indonesia and Korea in
2004. In Latin America, Brazil,
Colombia, Venezuela and Ecua-
dor will join the Bayer Young
Environmental Envoy Program,
as should Poland and possibly
some other Central and Eastern
European countries from this
year on. 
Practical ecological ex-
perience for young people
The Bayer Eco-Camp is an impor-
tant local component of the
youth environmental program.
As well as serving as a tool 
for enhancing basic knowledge 
of sustainable development
among young people, it also
facilitates the selection of Bayer
Young Environmental Envoys
in each country. The students
selected in each country expe-
rience nature, study the science
of environment and engage in
dialog with experts.  Such camps
are currently held in Thailand,
the Philippines, Indonesia and
China.
Discussing and 
implementing new ideas
With the regional youth environ-
mental forum Eco-Innovate 03,
UNEP and Bayer have started a
project, which offers young peo-
ple from Asia-Pacific a unique
platform for discussing innova-
tive project ideas for sustainable
development and environmen-
tal protection. The pilot project
was launched in July 2003 at the
University of New South Wales
in Sydney under the patronage
of Dr. Klaus Töpfer, the Executive
Director of UNEP.
An important objective of the
“Capacity Building” forum was to
provide the participating youth
with an opportunity to interact
with leaders of governmental
and non-governmental organi-
zations, academia, media and
industry through the establish-
ment of a network.
The 100 delegates of Eco-Inno-
vate 03 were chosen from some
1,000 applicants who participat-
ed in national selection process-
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es. By involving young people
from Australia, New Zealand,
Singapore, Thailand, Indonesia,
the Philippines, China and India,
the forum was unique in recog-
nizing the importance of diverse
worldviews in sharing expertise
and developing best practice
across borders.
As part of their partnership in
youth and the environment,
UNEP and Bayer are intending to
further develop the concept of a
“Capacity Building” forum. 
Environmental award for
young journalists
In cooperation with UNEP, Bayer
awards an Environmental Award
for Media, a media prize for
young journalists in Asia Pacific.
It acknowledges outstanding re-
ports that have helped to 
raise awareness of sustainable
development among a wider
public. 
The prize was first awarded in
July 2003 during the Eco-Inno-
vate 03 youth environmental
forum with participation from
seven countries: Australia,
China, Indonesia, New Zealand,
the Philippines, Singapore and
Thailand.    
Children’s art and 
writing competition
To commemorate the World
Environment Day, a children’s
art and writing competition is
organized for the Asia-Pacific
region every year. The World
Environment Day is one of the
principal vehicles through which
the United Nations stimulates
worldwide awareness of the
environment. It therefore pro-
motes activities which serve 
this aim. Bayer supports this
effort in Asia-Pacific as part of 
its partnership with UNEP in 
the region. The topic for the
2004 competition is “Wanted!
Seas and Oceans – Dead or
Alive?.”
Bayer Young
Environmental
Envoy Program
Regional Youth Forum 
Asia-Pacific
Youth Environmental Program
Bayer Young
Environmental Envoy Regional Forum
National SelectionBayer Eco-Camp
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Bayer’s commitment in the area of 
youth and the environment ranges 
from activities for children and young 
people to projects for students and 
young journalists.
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The Global Compact initiative set
up by the United Nations (U.N.) is
a unique project backed by the
world organization and world
business leaders. Under the lead-
ership of U.N. Secretary-General
Kofi Annan, the Global Compact
initiative aims to make principles
for human rights, labor standards
and environmental protection as
adopted by international conven-
tions the basis for corporate
actions, and thus contribute to a
more balanced globalization
process. Bayer expressly supports
the goals and principles of the
Global Compact and rejects
human rights abuses, child and
forced labor, and discrimination.
We described this initiative 
of U.N. Secretary-General Kofi
Annan in detail in our 2001 Sus-
tainable Development Report.
Following the biggest reorganiza-
tion process in Bayer’s more than
140 year history, the company’s
existing management systems in
the areas of health, safety, envi-
ronmental protection and quality
(HSEQ) are now being improved
in terms of content and structure
– partly to ensure and promote
the enactment worldwide of the
Global Compact principles. One
example of the implementation
of these principles in related
areas is the “Supplier Relation-
ship Management; SUPREME”
system, which was introduced in
the spring of 2003.
The management of a sustain-
ability-oriented supply chain is
also a major challenge for Bayer,
considering that our supply chain
comprises more than 25,000 sup-
pliers and half a million raw
materials, products and services.
Suppliers are regularly evaluated
with the help of this system, the
establishment of which is among
the performance targets set by
employees in purchasing. The
system assesses, for example, the
observance of human rights,
working conditions and environ-
mental standards. The goal is to
evaluate 80 percent of all supply
and delivery activities with this
system in the future.
Bayer is not only committed to
the principles of the Global Com-
pact, but was one of just eight
German companies and approxi-
mately 50 enterprises in the
world which were founding
members of the initiative. The
company has also initiated a
number of projects in line with
the objectives of the Global Com-
pact. Below is a selection:
Cooperation to eliminate
child labor in Brazil
Child labor is still widespread in
countries such as Brazil.
Nonetheless, it has declined by
roughly 30 percent in that coun-
try since 1995 – thanks in part to
the Abrinq Foundation for Chil-
dren’s Rights, with which Bayer
cooperates. The goal of the ini-
tiative is to push for children’s
human rights and their rights to
receive health care and educa-
tion on the one hand, and to
support social programs for chil-
dren on the other. As a “child-
friendly” company, Bayer is
authorized to use the Abrinq
logo, which is only awarded to
companies who observe the
principles laid down in the U.N.’s
1989 Convention on the Rights
of the Child. At the recommen-
dation of the Abrinq Foundation,
Bayer supports a home for street
children dependent on drugs
and a care facility for 370 needy
children between four and 14
years of age.
New malaria drug being 
developed
In May 2002 Bayer and “Medi-
cines for Malaria Venture”
(MMV), a WHO initiative fi-
nanced by the World Bank and
private foundations, signed an
agreement on the development
of a new malaria drug based on
artemisone. This new active in-
gredient, for which Bayer holds
the patent rights, is the result of
our research alliance with Hong
Kong University of Science and
Technology. The first registration
is planned for 2006.
Participation in the U.N. Global Compact initiative
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Under the terms of the coope-
ration agreement, Bayer will
assume product development
and supply the finished product,
while WHO/MMV will be respon-
sible for monitored distribution
in the developing countries’
health systems. The price in this
market is to be set at a level that
would allow all segments of the
population in the developing
countries who suffer from
malaria to receive treatment. For
its part, Bayer will market the
product in the industrialized
countries. The demand for new
forms of malaria treatment
remains high. About 2.5 billion
people live in regions where
there is a risk of contracting
malaria, which is transmitted by
the Anopheles mosquito.
Between 300 and 500 million
people are newly infected with
malaria each year, primarily in
tropical developing countries. Of
the one to three million people
who die of malaria each year,
most are children. 
In a number of African countries
– Uganda, Zambia, Mali and
Malawi – Bayer was actively par-
ticipating in the fight against
malaria even before its joint ini-
tiative with the WHO and MMV.
In cooperation with rotating
partners such as the German
Society for Technical Coopera-
tion or the Christian relief orga-
nization World Vision, as well as
with the relevant authorities in
those countries, the company
sponsored the distribution of
mosquito nets treated with
Bayer insecticides that are effec-
tive against the Anopheles mos-
quito but harmless to humans.
This is the only effective way to
prevent insects from stinging
through the fabric of the nets.
Bayer joints the fight 
against AIDS
In 2002 there were more than
45 million HIV-infected people
around the world, mainly in
African countries. Approximate-
ly four million people died of
AIDS in that year alone. In order
to intensify the global fight
against AIDS, Bayer has joined
the Global Business Coalition on
HIV/AIDS, which now includes
more than 100 companies.
HIV/AIDS is a major focus 
of Bayer’s pharmaceutical re-
search. We regard our participa-
tion in this global initiative as 
a further element of our exten-
sive social commitment and a
contribution to fulfilling the
obligations we have assumed
through our support of the
United Nations Global Compact
initiative.
Bayer received good marks from
the Munich-based Oekom Insti-
tute for its social activities in the
communities surrounding its
sites worldwide, for its policy
with regard to social and ethical
problems, and in the manage-
ment and reporting of these
issues (see inset above). The
selection procedure was based
not only on information provid-
ed by the companies them-
selves, but also on details sup-
plied by independent institutes.
Non-governmental organiza-
tions (NGOs) were also used as
a source of information for eval-
uating Bayer’s performance.
Based on the study results,
Oekom recommended Bayer’s
inclusion in the portfolios of
ethically oriented investors and
funds.
Bayer places third in study
A study carried out in 2002 by the Oekom Institute in Munich, Germany, found that Bayer is among
the world’s leading companies in terms of commitment to society and the environment. The study
rated the 22 biggest pharmaceutical companies worldwide according to 200 ecological and social
criteria. Bayer placed third.
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Most of our social policy activi-
ties are decentralized. Our for-
eign subsidiaries and individual
sites can decide for themselves
which projects they support.
These decisions are based on
local needs, as well as on region-
al corporate policy interests and
circumstances. In many coun-
tries we cooperate with social
organizations that are prepared
to work to solve specific prob-
lems. At a number of sites, Bayer
also maintains public private
partnerships, which are coopera-
tion projects with local and gov-
ernment organizations. Here are
a few examples:
Malaysia. Poultry production
is one of the most highly devel-
oped industries in Malaysia. One
of the biggest risks faced by this
industry sector is the threat
posed to stocks by rats. That's
why Bayer Malaysia joined with
the Malaysian Department of
Veterinary Services in 2002 to
inform, in a workshop, more than
200 poultry farmers, dealers and
executives from the Department
of Veterinary Services about vari-
ous rodent control options –
marking the first time in
Malaysia’s history that a multi-
national company has joined
with the local authorities in a
public private partnership of this
kind.
Indonesia. As part of a public
private partnership project, the
German Society for Technical
Cooperation (GTZ), the district
government of Sumba Timur
and Bayer Indonesia worked
together in 2002 to save 80 per-
cent of the harvest in Sumba
Timur from a locust infestation.
By providing an insecticide and
coordinating its use, Bayer safe-
guarded the livelihood of hun-
dreds of farmers. The affected
farmers also received training in
how to use the products, while a
specially constructed early warn-
ing system now detects breed-
ing grounds and the forming of
swarms in plenty of time – giv-
ing the farmers the opportunity
to fight the swarms at an early
stage.
Cuba. The dangerous tropical
disease dengue fever is wide-
spread in Cuba. It is transmitted
by mosquitoes (Aedes aegypti)
and can be fatal in a worst-case
scenario. As part of a special pub-
lic private partnership program
funded by the Cuban Ministry
for Public Health, the German
Federation of Samaritan Workers
and Bayer, 2,270 hermetically
sealed plastic water tanks were
distributed free-of-charge in the
eastern Cuban city of Guantá-
namo in 2002 to reduce the
spread of mosquitoes. Female
mosquitoes like to lay their eggs
on the edges of open water
tanks. If these breeding grounds
are removed or covered, the
mosquitoes can no longer multi-
ply. The city does not have suffi-
cient drinking water available for
the local inhabitants, so the
water needs to be stored in suit-
able containers. In a number of
other Central and South Ameri-
can countries in which dengue
fever is also widespread – such
as Guatemala, the Dominican
Republic, El Salvador and Brazil –
the company has been conduct-
ing regular campaigns for sever-
al years in cooperation with the
national health authorities.
Bayer volunteers have been tak-
ing action in urban locations
where the risk of transmission is
high and in areas where the
Aedes aegypti mosquito species
is common. As part of this proj-
ect, the insecticides and the
spraying equipment and instru-
ments are made available by
Bayer free-of-charge.
In addition to these individual
activities at the sites themselves,
Bayer either participates in, or
has itself launched, a number of
international, non-site-related
initiatives that are managed cen-
trally from Group headquarters
in Leverkusen. Bayer is also a
member of numerous interna-
tional associations, and partici-
pates in projects and collabora-
tions with international organi-
zations such as the United
Nations and the World Health
Organization (WHO).
Cooperation with numerous groups:
Public private partnerships
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Objectives of our social commitment:
Our corporate social responsibility commitment has eight main
objectives:
1. It helps increase the company's value by ensuring our accep-
tance into the portfolios of investment and pension funds that
are oriented around ethical principles and sustainability criteria.
2. It contributes to a positive evaluation from rating agencies
that specialize in assessing the commitment of companies to
social, ecological and sustainable development principles.
3. It is designed to enhance customer loyalty. This applies to
industrial customers who are increasingly examining their sup-
plier chains with respect to the observation of ethical and social
standards. It also applies to consumers for whom the social com-
mitment of a company and its suppliers is an increasingly impor-
tant factor in purchase decisions.
4. The social commitment of the company is intended to con-
tribute to a stable business environment, safeguarding the legit-
imacy and justification for the company's operations while at the
same time strengthening the confidence of a broad cross-section
of society in the company's social responsibility.
5. Behavior as a good corporate citizen is also aimed at making us
an attractive employer for high-skilled personnel.
6. Bayer aims to demonstrate that we respond to social develop-
ment in a responsible manner. We seek to ensure that politicians,
industry leaders, scientists and society at large understand and
appreciate our opinions and positions.
7. We also regard our commitment as an instrument of preven-
tative risk management. In addressing social problems, we aim to
identify issues that could adversely affect business conditions.
8. Bayer’s goal is to boost our company's self-image and sense of
community together with its perception and standing in the
community at large by ensuring that Bayer is seen as different
and distinct from competitors and other companies.
Thailand/South Korea. The
outbreak of the “chicken flu” in
2003 posed a threat to both peo-
ple and animals. To prevent the
further spread of the disease in
Thailand and South Korea, Bayer
has donated the disinfectant
VirKon® S. In Thailand, where the
disease has raged particularly
rampant and the consequences
are most serious, the company
has donated 5,000 kilograms of
the product to the government
and offered unrestricted assis-
tance in combating the disease.
In South Korea the company has
donated the product to the city
of Yangsan in Kyungsang
Province.
Mozambique. Bayer has
signed a two-year agreement
with the Roman Catholic Com-
munity of Sant’Egidio, a charita-
ble organization, concerning the
supply of diagnostic systems
and services. The project aims to
enable targeted therapy for HIV-
infected patients in Mozam-
bique and other African coun-
tries. The shipments will first be
made to Mozambique, where
local authorities and volunteers
are working to establish nation-
wide care and therapy programs
for HIV patients. In addition to
the diagnostic systems, Bayer
HealthCare will offer scientific
and technical cooperation, as
well as training courses and
workshops for specialist person-
nel.
Bayer Sustainable Development Report 2004 Responsibility to society 52
➔ Table of Contents
In all countries in which we are
active we feel a responsibility
towards the local society. This
involves active community work
in and around our sites all over
the world. Instruments of our
social commitment include
donations which we make in
special cases to help overcome
difficult circumstances.
Donations are generally made in
kind, particularly in the context
of international disaster aid.
Bayer adopts a cautious
approach to direct monetary
donations, generally confining
them to specific projects in the
immediate vicinities of our sites. 
The following recent examples
show how Bayer’s donations are
distributed. Further examples
were already mentioned in the
previous chapters. 
Aid in the event 
of disasters
Germany. In August 2002,
Bayer and many of its employees
spontaneously demonstrated
their willingness to help those
affected by flooding along the
Elbe and Mulde rivers that rav-
aged the region surrounding
Bayer’s youngest German site in
Bitterfeld.
In a donation campaign lasting
several weeks, more than 3,600
employees of Bayer AG voluntar-
ily paid €413,630 into a relief
fund set up for the flood victims.
The company made good on its
pledge to match any employee
donation and rounded up the
figure to €828,000, thus in-
creasing total donations and
relief initiatives from Bayer to
€3.3 million. Just a few days after
the flooding began, the compa-
ny made a cash donation of 
€1 million and contributed a 
further amount in excess of 
€1 million in material donations
and relief initiatives.
A charity soccer match between
Bayer 04 Leverkusen and Dyna-
mo Dresden raised an additional
€350,000. In addition, the em-
ployees of Bayer subsidiary Wolff
Walsrode made a donation of
€80,000 and Bayer Vital GmbH
donated €25,000 to a children’s
hospital in Dresden.
Bayer’s activities and donations
for victims of this natural disas-
ter focused on the Bitterfeld
region, where the company
operates an important produc-
tion site. From the onset of the
flooding until the relief activities
were wrapped up, Bayer Bitter-
feld supplied catering for more
than 500 helpers at the dikes
round the clock and transported
an additional 35,000 bottles of
the insect repellent Autan®,
15,000 bottles of sunblock and
urgently needed medicines to
the areas affected by the flood-
ing, where aid workers had to
deal with scorching sunshine
and swarms of mosquitoes for
days on end. 150 Bayer Bitterfeld
employees were on duty the
whole time while the flooding
lasted. A further 220 volunteers
from Bayer AG’s Lower Rhine
Specific help for the community
Flood Medal awarded
As a gesture of thanks for the
company’s active and com-
mitted help during the flood
disaster in Bitterfeld, Saxony-
Anhalt’s Premier Professor Dr.
Wolfgang Böhmer presented
Bayer Bitterfeld GmbH with
the “Flood Medal” in May
2003 on behalf of all Bayer
employees in eastern and
western Germany who had
helped in the relief effort.
Many of these employees
worked to the point of ex-
haustion for several weeks at
the site of the flooding. 
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Bayer Bitterfeld Award 
for outstanding social 
commitment
In October 2002, Bayer cele-
brated the tenth anniversary
of the founding of its site in
Bitterfeld, eastern Germany, by
presenting the €2,500 “Bayer
Bitterfeld Award” for the first
time. This newly established
prize is meant to honor out-
standing commitment to the
Bitterfeld region. Eligible for
nomination were examples of
social commitment, commit-
ment to nature, work on behalf
of young people and resolute
action to promote democracy
and tolerance. The “Society for
the Promotion of the Dessau
School for the Disabled” took
top honors out of a field of 34
nominees.
sites were granted leave of
absence from work to help with
the cleanup and maintenance
efforts, while a group of skilled
laborers from the Leverkusen
site and a firefighting unit
addressed oil spillage and water
and electrical supply problems.
Bayer also provided special
equipment, vehicles and a large
number of sandbags for the
flood relief effort. 
Indonesia. After a flood dis-
aster hit the Indonesian capital
Jakarta in 2002, many Bayer
employees were among those
who came to the aid of flood vic-
tims. Employees at Bayer’s head
office and staff from the Cibubur
and Pulogadung production
sites acted of their own volition
to collect money and clothes to
benefit the victims. The compa-
ny donated medicines and par-
ticipated in a campaign by the
SCTV television station, which
delivered the donations directly
to those affected. Bayer’s contri-
butions included financial assis-
tance, clothing and hygiene arti-
cles. A relief fund was quickly set
up for Bayer employees who
were among the hundreds of
thousands of people affected by
the flood.
Peru. Following a severe cold
spell in July 2002, the population
in many parts of Peru experi-
enced an acute crisis. After the
government asked for Bayer’s
help, the company’s subsidiary
in Lima quickly made available
urgently needed medicines to
save Peru’s threatened livestock,
the means of subsistence for
much of the country’s popula-
tion. Bayer’s employees in Peru
also set up a relief fund to collect
food, clothing and other sup-
plies.
South Korea. Bayer donated
both money and medicines to
aid victims of a typhoon that
destroyed the homes of many
people living near Bayer’s South
Korean subsidiary in September
2002. Bayer also gave assistance
to its employees who had been
affected by the flooding. 
China. In February 2003 the
first cases of SARS (severe acute
respiratory syndrome) were
reported, especially in China. In
response Bayer set up a crisis
management unit in Hong Kong.
Monetary and material 
donations
Brazil. Bayer is one of the first
major foreign sponsors of
Brazil’s “Zero Hunger Program”
aimed at combating poverty in
South America’s largest country.
The program aims to provide not
just food, however, but also
assists in other ways to make life
more bearable for the poor in
many regions of Brazil. As part of
the initiative, Bayer employees
recently undertook a three-week
journey to parts of the state of
Minas Gerais in north-eastern
Brazil at the request of the gov-
ernment to distribute a total of
3.2 million Aspirin® tablets and
nearly 190,000 tablets to purify
water. In some of the areas
where Bayer distributed the
tablets, it has hardly rained in
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more than 18 years. Not surpris-
ingly, the quality of the water is
poor, and the people there can-
not drink it unless it is treated.
Bayer’s aquatabs can make more
than nine million liters of water
potable, a big help for the region.
The Aspirin® tablets were also
distributed at the request of the
Brazilian government. This ship-
ment of aid supplies – the first in
a cooperation agreement sched-
uled to last for an initial period of
four years – will provide assis-
tance to 700,000 people in all.
Bayer was the first company
whose employees personally dis-
tributed supplies in the hardest-
hit areas, as monetary and mate-
rial donations usually go to the
ministry in charge of the “Zero
Hunger Program.” 
Bayer will continue to support
the Brazilian government’s anti-
hunger program in 2004. The
concept involves a collaboration
between Bayer CropScience and
the NGO Agência Mandala,
which has developed efficient
models for irrigation projects to
benefit small farmers (families
with between two and eight
hectares of land) in the drought
region Sertão. The collaboration
will provide the farmers with 
a suitable infrastructure, train-
ing and the necessary water to 
successfully cultivate their land.
With its assistance for the social
policy efforts of the government
in Brasilia, Bayer is once again
expanding its already extensive
social commitment in Brazil.
Since 1992 several hundred thou-
sand Brazilians have taken part
in social programs initiated by
the German company. The proj-
ects cover a variety of topics,
such as education about AIDS or
dengue fever, prevention of child
labor, vocational training and
internships for street children, as
well as the safe use of crop pro-
tection products. 
Venezuela. Bayer Venezuela
supports the rural outpatient
project “La Milagrosa” in the
state of Bolívar by donating
money and medicine. The doc-
tors and caregivers of this facility
provide dental care to about
5,000 people, many of whom are
native Venezuelans belonging to
the Panare tribe.
Thousands of needy people live
in the dock area of La Guaira in
the Venezuelan state of Vargas,
including approximately 2,000
children, most of whom suffer
from deficiencies, infections and
parasite infestation. Bayer
donates medicines for these
people, thus ensuring basic
medical care in the neighbor-
hood. 
Canada. In 2002 Bayer’s
Canadian subsidiary, headquar-
tered in Toronto, supported five
cardiac hospitals with donations
of CAD 10,000 each. Hospitals in
the cities of Vancouver, Calgary,
Toronto, Montreal and Halifax
benefited from the money. Bayer
declared February 2002 to be
“Heart Month.” A portion of the
company’s sales of Aspirin®
between February 1 and 14
(Valentine’s Day) was set aside
for the donation. In this way,
Bayer contributed to the recov-
ery of patients with heart prob-
lems.
Spontaneous assistance
following the terrorist
attack on Bali
Following the terrorist bomb-
ing on the Indonesian island
of Bali in October 2002 – in
which nearly 200 people were
killed and more than 300
injured, some seriously –
Bayer donated tablets of its
anti-infective drug Ciprobay®
to reduce the threat of infec-
tion in those that survived.
The product was made avail-
able to Sanglah Hospital on
Bali, as well as eight Aus-
tralian hospitals where more
than 100 bombing victims
were treated.
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Funding for employee
sponsorships in Australia
At many Bayer sites around
the world, employees partici-
pate in community activities
or do voluntary work for char-
ities, schools and clubs. Bayer
Australia has decided to make
funding available to such
projects on an application
basis. Up to AUD 1,000
(approximately €540) is avail-
able for individual projects.
Bayer’s staff sponsorship pro-
gram will aim to achieve a bal-
ance between environment,
education, science, research
and technology. Bayer also
recognizes that sports and
the arts are an important part
of cultural life. 
Belgium. Bayer Benelux cele-
brated the 100th anniversary of
its founding by donating
€125,000 to the Belgian Cystic
Fibrosis Organization. The
money went to a foundation
that supports adults suffering
from cystic fibrosis by offering
education projects that help
them to integrate into society. 
Bulgaria. Many state-run
hospitals in Bulgaria suffer from
a shortage of all medicines
required for basic patient care,
especially antibiotics. Bayer has
had a long-standing commit-
ment that safeguards the supply
of vital drugs to many hospitals
in Bulgaria. These donations are
so important to Bulgaria that
President Georgi Parvanov has
personally assumed patronage
of the program. All told, drugs
valued at more than €2 million
have been donated in Bulgaria
since the program was launched
in 1997.
Scandinavia/Baltic states.
Since the mid 1990s, Bayer’s
Scandinavian subsidiary has
been supporting annual sum-
mer camps for children from
Latvia, Lithuania, Denmark and
Sweden who suffer from hemo-
philia. At the camps – which
have taken place, for example, at
the Lithuanian seaside resort of
Palanga and on Roslagen, a small
island off the coast of Stockholm
– the children are treated with
Bayer’s Koate DVI and Kogenate®
hemophilia drugs under medical
supervision. This allows them to
play without fear of dangerous
injuries and take part in the
many activities offered at the
camps.
U.S.A./Canada. At many sites
of Bayer’s U.S. subsidiary Bayer
Corporation and Canadian sub-
sidiary Bayer Canada, the compa-
ny’s employees support the
United Way of America and the
United Way of Canada in these
organizations’ efforts to help
solve the most urgent problems
facing cities and communities in
the two countries. Once a year,
the “United Way Day of Caring”
takes place, which is part of
Bayer’s “United Way Campaign”
in which employees solicit and
make donations, as well as vol-
unteer their labor, for example to
renovate a home for abused chil-
dren. The volume of donations is
impressive. In 2003, a total of
$2.4 million was raised at the
company’s North American sites.
The money ultimately goes to
the local United Way chapters. 
South Africa. In August 2002
Bayer South Africa donated a
large volume of vitamin prod-
ucts to various aid organizations
in socially disadvantaged areas
of the country, such as Soweto.
These medications are intended
to improve the quality of life of
critically ill patients. 
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Ecuador. Bayer in Ecuador
supports the efforts of the
National Institute for Children
and Families (INFA) – one of this
South American country’s best-
known charity organizations –
with an annual donation of med-
ications. The medications are
distributed by INFA to needy
families throughout the country.  
Congo. A devastating volcanic
eruption in the eastern part of
the Democratic Republic of
Congo in January 2002 seriously
disrupted the work of the world-
famous Dian Fossey Gorilla Fund
(DFGF). This organization not
only focuses on nature preserva-
tion matters such as protecting
the gorillas in the region, but
also maintains a number of
humanitarian projects that ben-
efit the local population. To
ensure that these activities so
important to the region’s popu-
lation and natural habitat would
not come to a standstill, Bayer
subsidiary H.C. Starck immedi-
ately donated €10,000 to the
fund to finance reconstruction
efforts following the natural dis-
aster. (See also “Support for the
Dian Fossey Gorilla Fund” on the
next page.)
Indonesia. Thousands of In-
donesians suffer from cataracts,
glaucoma and diabetic eye prob-
lems. For diabetics in particular,
treatment of eye problems is
complicated by an Indonesian
law, which forbids eye surgery
for individuals with higher than
normal blood sugar levels. For
this reason, Bayer Indonesia has
donated products to the Rotary
Humanitarian Projects organiza-
tion to help combat diabetic
symptoms and thus enable
vision-impaired Indonesians to
undergo operations to restore
their sight. 
Bayer supports benefit 
for the International Year
of Freshwater
As a member of the Asso-
ciation of Plastics Manufac-
turers in Europe (APME), Bayer
MaterialScience took part in a
global campaign to benefit
the International Year of
Freshwater 2003. The initia-
tive raised €150,000, which
will be used to help finance
urgent water projects of the
international organization
WaterAid in Africa. Through
June 22, 2003, anyone visiting
the campaign’s website could
contribute to the initiative
with just a click of the mouse:
For every mouse click on a spe-
cial button at the site, APME
donated ten cents toward
WaterAid’s goal of improving
water supply and hygiene for
roughly one billion people,
mostly in Africa, who current-
ly do not have access to clean
drinking water.
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Protecting biodiversity
At many sites around the world,
our companies participate in
environmental and nature
preservation projects aimed, for
example, at protecting endan-
gered species from extinction.
Asia: Donating medicines 
for bears
Asiatic black bears, which are
also known as moon or sun
bears due to the crescent-moon-
shaped patch of white fur on
their chest, often suffer a cruel
and tragic fate. In many Asian
countries, thousands of these
animals are confined in tiny
cages on special farms. There the
animals’ bile is extracted directly
from their gallbladder several
times a day in a painful proce-
dure involving a catheter. This
bile is one of the most expensive
substances used in traditional
oriental medicine – although the
ursodeoxycholic acid contained
in it has already long been syn-
thetically produced. The opera-
tion in which the catheter is
implanted is painful and unhy-
gienic and many bears do not
survive the procedure. Thanks to
the efforts of the Animals Asia
Foundation (AAF), captured
bears can often be ransomed.
The catheters in their gallblad-
ders are then surgically removed,
which means they require
urgent medical attention. Bayer
has supported the activities of
the AAF by donating lifesaving
veterinary pharmaceuticals. 
New Zealand: Protecting 
genetic heritage
Bayer makes a special contribu-
tion to biodiversity in New
Zealand. On fallow land in the
neighborhood of a chemical
storage site in East Tamaki, the
company has set up a biotope
that enables 150 rare or endan-
gered plants from New Zealand
to grow in a protected environ-
ment. Protecting the genetic
heritage of fauna and flora is an
issue of great national impor-
tance in New Zealand. Many
species can only be found in New
Zealand, and even there only in
certain regions. This means
there is always a risk that natu-
ral disasters such as forest fires
could forever extinguish certain
rare species.
United States: Award for
Bayer employees
Employees of Bayer Corporation
in Pittsburgh belong to a volun-
teer-based nature protection
team dedicated to the preserva-
tion of natural habitat for flora
and fauna. The company’s site in
Pittsburgh lies between the city
and the airport. Of the 120
hectares of land at the site, more
than 80 hectares serve as a habi-
tat for flora and fauna. The Bayer
employees’ efforts include
implementing programs and
workshops involving the local
community. These activities
focus primarily on pond studies
and research into bird species
native to western Pennsylvania.
The Corporate Lands for Learn-
ingSM award, which was estab-
lished in 2001, is presented to
sites of companies that have
rendered outstanding services 
to environmental education 
and environmental protection
through volunteer work by
employees.
Congo: Support for the 
Dian Fossey Gorilla Fund
In the Democratic Republic of
Congo, Bayer subsidiary H.C.
Starck supports the Dian Fossey
Gorilla Fund (DFGF) in a project
aimed at helping people in the
eastern part of the central
African country to practice envi-
ronmentally friendly extraction
of natural resources. The world-
famous animal rights organiza-
tion wants to create incentives
to encourage miners who in the
past searched for raw materials
such as coltan in national parks
like Kahuzie-Biega – and in the
process threatened rare and pro-
tected animal species that live
there – to leave the parks. By
sponsoring agricultural coopera-
tives outside of the parks, Bayer
is helping to establish a concept
headed by the DFGF and sup-
ported by numerous govern-
mental agencies and non-gov-
ernmental organizations (NGOs)
that is aimed at a sustained
improvement in living condi-
tions in eastern Congo.
The raw material coltan, which is
found in certain African coun-
tries, is used in electronic com-
ponents, cellular phones, com-
puters and cars.
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United Kingdom: Creating 
natural habitat
Bayer CropScience U.K. has set
up a biodiversity project aimed
at better protecting water
resources and enhancing species
variety on the company’s own
farms. For example, wild flowers
have been planted on bordering
strips, areas of land left fallow,
new hedgerows planted and old
woodland and ponds properly
managed. The project is
designed to increase the variety
of flora and fauna on the farms,
while at the same time educat-
ing farmers about the benefits of
natural habitats.
Bayer CropScience supports sim-
ilar projects to protect biodiver-
sity in other countries. In
Guatemala the company works
together with the German Soci-
ety for Technical Cooperation to
teach farmers how to increase
their agricultural yields. They
According to various animal
rights organizations, the miners
had reduced the gorilla popula-
tion in Kahuzie-Biega National
Park from 8,000 to 1,000 ani-
mals within just a few years.
Some environmental organiza-
tions have called for a general
moratorium on exports from the
entire region in order to halt ille-
gal activities such as mining in
national parks. Yet other organi-
zations, including the Dian Fos-
sey Gorilla Fund, consider such
measures to be unsuitable, par-
ticularly for humanitarian rea-
sons, as they would eliminate an
important source of income for
the local population. In this case,
the organizations fear that the
population would be forced to
seek food in the national parks to
an even greater extent than is
currently the case. This would
most likely result in the perma-
nent extinction of severely
endangered species.
Australia: Help 
for butterflies
To help a rare species of butter-
fly, Bayer sponsored a project in
New South Wales, Australia:
More than 280 schools partic-
ipated in the “Richmond Bird-
wing Conservation Project” to
help the endangered Richmond
Birdwing, Australia’s biggest and
best-known butterfly. The com-
pany’s financial support has
allowed many students to be
trained in the development of
concepts to save the butterfly.
Through the productive cooper-
ation between Bayer and the
schools, the butterflies’ situation
has improved considerably. For
its efforts in this area, Bayer
received the “Financial Review
2000 Sponsorship Award” in the
categories Environment, Health
and Education.
learn to protect land and water
resources and maintain species
diversity by optimizing pest con-
trol. In Brazil, Bayer sponsors a
pilot program called “Regenera-
tion through new planting”
together with the University of
São Paolo and the owner of a cit-
rus plantation. This program is
aimed at the renewal of native
plants near sources of water.
Due to the high level of interest
in the program, similar projects
are planned. The aim is to estab-
lish networks of biodiversity
across farms in Brazil.
Bayer Sustainable Development Report 2004 Responsibility to society 59
➔ Table of Contents
Bayer regards assistance for
minority groups – for example in
providing medical care – as a fur-
ther element of its corporate
social responsibility commit-
ment. This is demonstrated by
the following examples from
Mexico, Australia and the United
States:
Mexico: Help for the 
disadvantaged
Bayer Mexico uses the services of
the charitable organization
“Industrias de Buena Voluntad”
(“Industry of Good Will”) for the
shipment of all its printed mate-
rials. One of the organization’s
eight centers in Mexico employs
physically and mentally handi-
capped people who pack and
ship the Bayer publications.
Industrias de Buena Voluntad
provides the disabled workers
with practical training through
special courses and workshops.
Australia: Diabetes 
monitoring for Aborigines
The average life expectancy in
the Aboriginal community of
Australia is nearly 20 years less
than that of the country’s popu-
lation as a whole. One reason for
this is the high rate of type 2 dia-
betes mellitus. Caring for the
health of Australia’s Aboriginal
population has become a little
easier, however – thanks to a
diagnostic system from Bayer
that allows the blood glucose lev-
els of diabetic patients to be
tracked over a period of three
months. As part of a government
project to improve diabetes ther-
apy for Aboriginal people, Bayer is
sponsoring the introduction of its
diagnostic system at 47 Aborigi-
nal health centers in urban and
rural Australia. The program
allows more tests to be conduct-
ed and better monitoring of
patients’ health.
A report published by the Aborig-
inal Community Controlled
Health Organization came to the
conclusion that Bayer’s efforts
offer a good opportunity to
improve diabetes treatment and
help patients better understand
the significance of their health
care.
United States: New home 
for children’s charity
In October 2003, Bayer Health-
Care sold a 90,000 square meter
laboratory, production, office
and storage building in Elkhart,
Indiana, to “Feed the Children”
for the symbolic price of $1. The
children’s charity organization
plans to move its international
headquarters to northern Indi-
ana and will use the laboratory
facilities as an R&D center at
which the nutritional needs of
children around the world will be
researched.
Thanks to Bayer’s offer, “Feed the
Children” can more quickly real-
ize its strategic goal of further
expanding its international
activities. With the building in
Elkhart, the organization will
now be in closer geographical
proximity to – and be able to bet-
ter support – the nearly two mil-
lion families within a 500 kilo-
meter radius of Elkhart who live
at or below the poverty level.
Support for minorities
Bayer Sustainable Development Report 2004 Responsibility to society 60
➔ Table of Contents
Bayer also means clubs 
As a manifestation of a compa-
ny’s corporate social responsibili-
ty commitment, Bayer’s clubs are
probably unique in Europe,
maybe in the world. The compa-
ny maintains 67 of its own clubs
at its German sites alone. 29 of
these clubs are active in recre-
ational, youth or disabled sports,
while 17 involve cultural activities
and groups and 21 are for people
pursuing a variety of hobbies. The
clubs have a total membership of
over 61,000, with sports clubs
accounting for more than 50,000
of these members. All the clubs
share close links with the compa-
ny – a relationship that is illus-
trated by the incorporation of the
Bayer name into their own
names and use of the Bayer Cross
in their logos.
Support for sports has a long tra-
dition at Bayer. The idea of estab-
lishing a company sports club
came from the employees them-
selves at the beginning of the
20th century and arose simply
from their desire to use their
leisure time constructively. Thus,
it was on July 1, 1904 that the TuS
04 Leverkusen company sports
club was founded – the first
works club of any kind to be
established in Germany. TuS 04
Leverkusen underwent a rapid
transformation into a club open
to all members of the communi-
ty. Probably no one could have
guessed in the beginning that
this company sports club would
later evolve into an institution
represented by 195 Olympic ath-
letes who would go on to win a
total of 15 gold, 20 silver and 20
bronze medals between 1952 and
2000.
Bayer provides all clubs with an
infrastructure to make them
attractive to a wide range of
interested social groups. About
30,000 club members are not
employed by Bayer.
At many sites outside Germany,
Bayer clubs organize sporting
and cultural events for employ-
ees and neighbors and provide
training or rehearsal facilities.
At the same time, the company
maintains or supports public
facilities both in Germany and at
many of its non-German sites for
such diverse purposes as recuper-
ation, sports, culture, stakeholder
dialog and much more. These
facilities are an example of
Bayer’s long-term relationship
with the communities around its
sites.
Bayer also means sports
Bayer is closely involved with
sports – and for good reason.
Sports activities strongly pro-
mote social integration, and that
is as much in the company’s
interests as the fostering of
teamwork, social skills and dedi-
cation to tasks. Sports also
encourage our employees to
identify with their company. For
these reasons, sports are an
important element of Bayer’s
social commitment around the
world. This applies to recreation-
al, disabled and professional
sports.
In Germany, Bayer supports
sports primarily through its own
infrastructure consisting of 29
company sports clubs in the
neighborhoods of its sites. These
clubs have a combined member-
ship of more than 50,000 in 50
different sports. The company
also supports major sporting
events. During the 2006 Soccer
World Cup in Germany, the Ger-
man national youth team will
train at the BayArena in Lev-
erkusen, with sessions open to
the fans and media.
Support for leisure, sports and culture
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To support disabled sports in
Germany, Bayer established the
Herbert Grünewald Foundation.
The company is also a main
sponsor of the German Disabled
Sports Association. The Disabled
Sports Section of TSV Bayer 04
was founded in 1950 and is
among the oldest, largest and
most successful sports clubs for
the disabled in Germany. Since
the beginning of the 1990s, the
disabled sports activities in Lev-
erkusen have shifted more and
more to track and field events.
The athletes have managed to
win numerous World Champi-
onship titles and Paralympic
medals.
Outside of Germany, Bayer’s sup-
port for sports usually involves
individual projects or the organi-
zation of events. Yet here too, the
company also maintains perma-
nent institutions such as the
Bayer clubs at a number of sites
or the youth soccer schools in
Brazil and South Korea.
Bayer also means culture
“Cultural events are educational
events.” This philosophy has
characterized our corporate
social responsibility commit-
ment for more than 100 years. In
1901 the “Education Depart-
ment” and an “Orchestral Soci-
ety of the Farbenfabriken Bayer”
were founded. In 1907 the Cul-
tural Affairs Department was
established to define, promote
and bundle such activities.
Today, cultural activities form an
important part of Bayer’s corpo-
rate social responsibility com-
mitment. Cultural events
enhance Bayer’s image both
internally and externally, boost
employee motivation and
improve the company’s accept-
ance by society. We believe that
close involvement with cultural
activities – whether as an active
participant or an audience mem-
ber – encourages open-minded-
ness and the willingness to criti-
cally address themes that are rel-
evant both to Bayer’s commer-
cial success and to the individual
well-being of its employees.
In Germany, Bayer promotes cul-
tural activity mainly through its
own infrastructure consisting of
17 different ensembles and clubs.
In addition, Bayer AG’s Cultural
Affairs Department in Lever-
kusen, Wuppertal, Krefeld-
Uerdingen and Dormagen en-
riches the cultural life of the
local community by organizing
high-caliber and original events
and seasonal programs.
Cultural activity has an interna-
tional focus at Bayer. It repre-
sents a conscious decision on
the company’s part to partici-
pate actively and over the long-
term in the social and cultural
life of all the countries where we
have business operations. Thus
Bayer is building a bridge be-
tween industry and society.
Outside of Germany, Bayer’s cul-
tural activities are usually deter-
mined by the national and
regional subsidiaries. These
activities are often conducted in
close cooperation with the com-
pany’s Cultural Affairs Depart-
ment. Over the past 15 years,
Bayer has organized cultural
activities in western and eastern
Europe, Asia, the United States,
Latin America, South Africa and
Australia.
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The facts and figures given on the following
pages document our achievements in HSE (health, safety and environmen-
tal protection) for the period 2001 to 2002 and in 2003 and relate these to
the achievements of the last ten years (1992 to 2002). Also included is an 
assessment of our achievements in relation to the targets for 2001 and
2002 that we set ourselves in the 2001 Sustainable Development Report.
Due to the far-reaching reorganization that has taken place, this was quite
a demanding task, as the company can no longer be compared with the
Bayer Group as it was in 2001. Following a series of significant divestments
and acquisitions, the company has completely changed its profile. Never-
theless, the figures have been presented in such a way that enables com-
parisons to be made between the targets set and the results achieved and
developments to be evaluated. The facts and figures are oriented to the
structure of subgroups (Bayer HealthCare, Bayer CropScience, Bayer Material-
Science and Bayer Chemicals) and service companies (Bayer Business 
Services, Bayer Technology Services and Bayer Industry Services) that was
set up in the period under review and also include the business activities
that will in future be handled by the new company Lanxess.
Julian Okfen, Germany, aged 7 
“My wish is that plants
remain healthy – and 
that is something that
everybody has to help
achieve.”
➔ More on the children´s pictures
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Dr. Wolfgang Große Entrup,
Head of Governmental and
Product Affairs at Bayer AG
Dr. Wolfgang Große Entrup
Our objectives remain as ambitious as ever
Global competition, changing
customer expectations, the
presence of many very different
stakeholders – these are just a
few characteristics of a world
that is changing at an ever faster
rate. We firmly believe that we
can only overcome these chal-
lenges if we adhere to the princi-
ples of sustainability in all three
dimensions in our everyday
work. This is the only way in
which we can achieve a sustain-
able increase in the value of our
company. But to do this we need
a foundation on which to build –
political and regulatory parame-
ters that must be reliable and
fair if we are to remain competi-
tive.
Dialog with  policymakers
and society
This is why we actively seek dia-
log with policymakers and socie-
ty, enabling us to input our ex-
pertise and make our contribu-
tion to legislation that will have
an impact on our operations.
Current examples include the
European Chemicals Policy, con-
sumer protection, the Integrat-
ed Product Policy and climate
policy. This commitment is
something we view as a major
part of our social responsibility,
and just as important as dialog
with our stakeholders on our
own actions. This is why, for
more than a decade now, we
have been recording and pub-
lishing our key worldwide data
in the fields of health, safety 
and environmental protection.
Nowadays, this activity has 
become second nature to us
throughout the Group as a
whole.
During the period under review,
the Bayer Group has undergone
the furthest-reaching reorgani-
zation of its entire 140-year his-
tory, a dynamic process which
has not yet been concluded. Di-
vestments and site closures
have resulted in the loss of more
than three dozen production
bases while just as many have
been added in the form of acqui-
sitions. Despite all of these
changes, however, our goal re-
mains unchanged: In the future,
as before, we want to set bench-
marks and to be one of the
world’s best companies in the
areas of health, safety and envi-
ronmental protection.
Since the beginning of the
decade, we have been continu-
ously improving and enhancing
our data recording process, in-
cluding in the wake of the Group
restructuring in the past year.
We have recognized that dialog
with our stakeholders will be a
major factor in future when it
comes to prioritizing our specific
sustainable development tar-
gets. This is why we are using
key performance indicators to
provide a clear picture of our
focus. We will be setting our-
selves quantitative targets in
these areas, which will be the
subject of regular reviews, with
progress being communicated
both internally and externally. In
addition, we have actively com-
mitted ourselves to the Global
Reporting Initiative (GRI), and
took part in corresponding activ-
ities in 2003. Indeed, we already
adhere to the GRI recommenda-
tions as far as possible.
Acknowledgement of 
our policy
Bayer will continue in future to
demonstrate its responsibility to
society and the environment, in
keeping with its long tradition!
We will therefore again be ask-
ing independent third parties to
take a critical look at our data
and to voice their opinions. And
as in past reports we will be pub-
lishing our objectives and pro-
viding information on what we
have achieved. This is a policy
that has not gone unnoticed. For
the fifth time in a row we were
included in the renowned Dow
Jones Sustainability Group in-
dices in 2003. This is a success
story that will encourage us to
go on and achieve even greater
things in future.
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Objective, scope and process of validation
The objective was to evaluate how com-
pletely and accurately HSE impacts of
Bayer’s operations are reported and to what
degree improvement targets have been met.
The verification of HSE performance data for
the reporting years 2001 and 2002 was limit-
ed to production sites, nine of which were
selected for a review. The sites were selected
to represent 
all relevant production activities
all regions in which Bayer is operating
production units 
the different size of  production sites. 
The verification is based on an evaluation of
the data reported and on interviews which
included a review of the HSE organization.
Two sites were visited and telephone inter-
views were conducted with seven sites. 
In 2002–2003 Bayer implemented a signifi-
cant organizational restructuring by estab-
lishing four subgroups and three service
companies as legal entities. These entities
are reporting individual sets of data for this
report rather than Bayer reporting one over-
all set of data.  
The effect of this reorganization on the reli-
ability of the data was checked in a second
validation cycle by  comparing the data of
three multi-subgroup sites before and after
the reorganization.
Summary
The number of reporting units increased
from 168 to 444 as a result of the fundamen-
tal restructuring of the corporate organiza-
tion and the inclusion of warehouses, R&D
facilities and administration and sales of-
fices. All production sites and >90 % of the
total reporting units provided an HSE report. 
Compared to previous reports the data qual-
ity has improved which seems to be attribut-
able to limiting the questionnaire to relevant
HSE performance data and the introduction
of key performance indicators (KPIs). In ad-
dition the ongoing introduction of certifi-
able HSE management systems at several
sites supported the improvement of the
data quality. 
Another important element for improving
the data quality is the involvement of the
subgroups and service companies in the
data collection and consolidation process.  
Several of the targets described in the previ-
ous report have already been met or are like-
ly to be met in the target year 2004. 
In particular the conversion from chlor-alkali
electrolysis to membrane technology for 
the manufacture of chlorine is showing its
effect in the reduced mercury load in the
wastewater and in reduced energy con-
sumption. 
Bayer reports engagement in many social ac-
tivities and working with non-profit organi-
zations. We did not, however, verify any of
this information.
Areas for improvement
Safety performance
Extra efforts will be required to meet the
safety performance goal for own and con-
tracted personnel for the year 2004.
Also the reporting of information on con-
tractor work should be checked to ensure
completeness.
In addition the reporting of occupational ill-
nesses needs additional attention to ensure
reporting of all relevant cases.
Environmental reporting
The introduction of new reporting criteria
for environmental incidents is obviously the
reason for a reduction of the number of
cases reported for 2003. It is recommended
to change the criteria for the reporting of in-
cidents as a KPI to ensure the inclusion of
minor incidents. This will improve the basis
for successful risk management and risk
control.
The responsibility for the reporting of trans-
portation accidents needs to be clearly de-
fined to ensure all accidents are included in
this report.
In addition to the energy consumption the
KPIs cover also CO2 emissions. This informa-
tion, however, is of limited relevance since it
does not include the external energy supply
and the reported reductions are partly re-
sulting from the increased outsourcing of
energy production.
It is understood that activities have begun to
ensure achievement of all targets that have
been set for 2004.
Product stewardship
The report contains a number of case stud-
ies and articles on improving the application
and reducing the environmental impact of
products. However, the HSE aspects and
goals of these activities are not always iden-
tified nor is the progress on improving HSE
performance.
Format and contents of report
The involvement of the subgroups and ser-
vice companies in revising the former ques-
tionnaire was key for the successful data col-
lection process for 2003. 
The inclusion of information as per the GRI
guidelines e.g. on material use should be
considered for future reports.
Development of targets
The availability of key performance indica-
tors provides the opportunity for the devel-
opment of specific HSE targets for each re-
porting unit. One subgroup has already
started to develop a five-year rolling HSE im-
provement plan based on this report. 
It is recommended that the other subgroups
and service companies consider following
this example. 
This report should also be used to compare
the development of the HSE performance of
the subgroups and service companies to
identify opportunities for introducing best
practices for all and also to ensure a high
level of performance standards in all parts of
the Bayer Organization.
Wolfgang Baldauf         Simon Berkeley
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The HSE performance indicators of all Bayer production sites in which
the Bayer Group maintains at least a 50 percent holding are surveyed
on an annual basis in the form of an electronic questionnaire. For the
period 2001–2002 we have compiled data according to the principle of
“continuing operations,” including all production sites that were con-
tinuously owned by Bayer throughout the period under review. Sites
that, as a result of divestments, ceased to be owned by Bayer during
this period are generally excluded. New sites are included in the data
recording process as soon as this is possible from a technical and orga-
nizational point of view.
We used the restructuring process in 2003 as an opportunity to extend
the data recording process so that in future it will encompass all sites,
i.e. including offices and warehouses, and we have introduced HSE key
performance indicators. These will be used in future to depict the main
focuses of our continuous improvement process. They will be en-
hanced by quantitative targets against which we will measure our
achievements. Additionally, we are currently working on extending the
social parameters. 
To highlight the development mentioned above as clearly as possible
and enable comparison, we have decided to depict the two periods
under review, 2001–2002 and 2003, separately.
The targets that were set for the periods under review can be
found on pages 92 – 93 of our 2001 Sustainable Development 
Report, as well as on our website www.sd2001.bayer.com
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Validation of the Bayer HSE data
For the purposes of assessing data quality and of the continuous
improvement of HSE management at our sites across the world,
the independent environmental auditing company Arthur D. Little
undertook a validation of the data (see p. 65). 
Site Country / Region    Subgroup       
H.C. Starck, Goslar Germany BCH
Baytown USA BPO/BCH
Thane India BHC/BCS/BPO
Cervantes Mexico BHC/BCS
San Salvador El Salvador BHC
Wuxi China BCH
Filago Italy BHC/BCS/BPO
Rustenburg South Africa BCH
Camacari * Brazil BPO
Site Country / Region    Subgroup       
Dormagen Germany BCS/BPO/BIS/BCH/BTS
Thane India BPO/BCS/BHC
Filago Italy BCS/BPO/BCH
* This site had already taken part in the previous validation cycle. In 2002, the aim was
to ascertain whether improvements had been achieved.
For the year 2003, spot checks were carried out at the following sites:
Abbreviations
BHC Bayer HealthCare
BCS Bayer CropScience
BPO Bayer Polymers*
BCH Bayer Chemicals
BTS Bayer Technology Services
BIS Bayer Industry Services
* since January 1, 2004 
Bayer MaterialScience (BMS)A core feature of this for the period 2001–2002 took the form of spot-
checks of the data relating to nine sites on four continents:  
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Principal changes 2001–2002
The most significant changes that have taken place since the 2001
Sustainable Development Report and which affect our reporting 
include: 
The incorporation of the BASF textile dyestuffs business into DyStar
textile dyestuffs. Bayer’s share in this company fell as a result to 35 per-
cent at the end of 2000, which means that the DyStar sites are no
longer considered for the purposes of this report. 
The sale of the 50 percent holding in EC Erdölchemie GmbH,
Cologne on May 1, 2001.
The sale of Haarmann & Reimer on September 30, 2002. 
The divestment of the Bayer-Degussa joint venture PolymerLatex
on March 4, 2003. This company’s sites are no longer included in the
data due to the fact that there was already in 2002 a specific intention
to sell. 
The acquisition of Aventis CropScience AG (ACS) on June 3, 2002 with
the addition of 38 production sites.  In 2002, ACS still maintained its
own HSE indicators, which, insofar as these are available and compara-
ble, have been included in the information presented here.  
The acquisitions made by Bayer Chemicals such as the acquisition
of Sybron Chemicals and the newly acquired sites of the subsidiary
H.C. Starck.  
2001–2002
Bayer Sustainable Development Report 2004 Worldwide data recording 2001-2002 69
➔ Table of Contents
80 69
These changes, together with further relocations or divestments of
business areas, increases in capacity and plant closures, had a consid-
erable effect on the indicators in some cases during 2002.
The considerable decrease in production volumes after 2000 is mainly
the result of the sale of our share in EC Erdölchemie GmbH which,
with its 3.6 million metric tons, had contributed as much as one quar-
ter of Bayer’s overall production volume (23 percent). 
The production volume of our continuing operations once again rose
slightly, up 6.8 percent during the period under review. Overall, the
production volume of the Bayer Group fell when compared with 2000
by 17.4 percent. This should be taken into account when interpreting
and comparing the environmental parameters of 2000 and 2002.
To enable us nevertheless to make a comparative statement as to the
development in the HSE data of the Bayer Group during the past two
years, we have compiled a number of graphs and tables that portray
the development within the continuing operations. This data takes ac-
count of divestments and site closures. The former ACS sites are treat-
ed separately. These newly acquired sites had a production volume in
2002 of 0.3 million metric tons.
Developments in production volumes in million t
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Our management system in the health, safety and environmental pro-
tection areas forms the basis of our company policy relating to sustain-
able development as an overall concept. We are currently in the process
of reviewing and updating our HSE management system, in such a way
that in future, operational responsibility will lie with the subgroups and
service companies. While Group management lays down the basic 
principles in this regard, in the form of policy guidelines, framework
regulations and coordination measures, it is the responsibility of the
subgroups to construct their own corporate and management systems
for HSE(Q), encompassing the following areas, among others:
Environmental management
Product safety
Measures relating to occupational health and safety
Investigation into causes, follow-up work and learning from 
incidents.
HSE audits
Of the 38 former ACS production sites, 17 (45 percent) were certified to
ISO 14001. In total, 41 percent of all production sites within the Bayer
Group have been certified to this standard. 
Additionally, Bayer has continued its internal audit program – the HSE
management systems at 59 sites have now been audited in accor-
dance with in-house processes, compared with a figure of only 14 by
2000.
By 2002, all sites had additionally undertaken a second self-assess-
ment of their HSE management systems, based upon a predeter-
mined checklist. A catalog of continuous improvement measures has
been drawn up and adopted. The evaluations are complete and the re-
sults have been passed to the subgroups for further processing. From
there, they will be incorporated into the relevant HSE management
systems. 
By 2004, all key Bayer production sites worldwide will be audited by
qualified auditors that do not belong to that particular site. 
Over 40 percent
of all Bayer sites
have achieved
ISO 14001 
certification
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Environmental incidents and 
incidents causing damage
The number of reportable environmental incidents at Bayer fell 
from 69 in 2000 to 53 in 2002, which is equivalent to a reduction of 23
percent. The number of incidents causing damage was almost halved
during the period under review, from seven to four. By continuing and
improving our systematic safety management, we intend to achieve a
further significant reduction in the number of reportable incidents by
2004. Our aim of avoiding environmental incidents or incidents that
cause damage is an expression of our sense of responsibility to society
and the environment. 
Reportable 
environmental
incidents down
by 23 percent
Environmental incidents and incidents causing damage (Bayer Group)
1999 2000 2001 2002
Reportable environmental  incidents 68 69 47 53
Incidents causing damage 6 7 1 4
Given that reporting obligations differ from one site to another, the
individual figures can only be compared against each other to a limit-
ed extent. Our aim in our future reporting is to introduce even stricter,
Group-wide criteria for recording environmental incidents and inci-
dents causing damage. Having worked on and implemented the 
principle of key performance indicators we further optimized the
recording process and performance in this area for 2003 (see p. 105).
We regard as an incident causing damage all events such as chemical
releases, fires or explosions, the direct costs of which, both internally
and to third parties, exceed the damage threshold of €500,000 (inter-
nal) or €100,000 (third-party) or which give rise to health and envi-
ronmental damage beyond the limits of the facility where the 
incident occured. This includes damage that results from incidents 
involving force majeure.
Experts regard as a reportable environmental incident any incident
that occurs as a result of activities undertaken at a production facility
and constitutes a hazard to human health and/or the environment,
either within the site or off-site, and which, by virtue of local or nation-
al regulations, is required to be reported to the local authorities. An
example of this would be fires, explosions or emissions into the
groundwater or the atmosphere that are higher than the legal limits.
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HSE employees
Qualified employees who undergo continuous staff development, a
clear distribution of roles within the various company divisions and
clarity with regard to responsibilities are the basic requirements of an
efficient HSE management system. During the period under review,
approximately every second employee at the 168 sites to which this
report relates attended a safety and environment seminar and ap-
proximately one in ten took a First Aid course.
Almost four percent of Bayer employees at the 168 production sites to
which this report relates carry out functions relating to health, safety
and environmental protection – either within central HSE manage-
ment or in operational HSE units, such as the waste management fa-
cilities, the site fire departments or the environmental analytics units. 
HSE expenditure
Between 1990 and 2002, the Bayer Group invested worldwide approx-
imately €16 billion in environmental protection, of which 83 percent
was spent on financing the operation of the waste management facil-
ities such as wastewater treatment and incineration plants and on
meeting personnel-based expenses relating to environmental protec-
tion. The remaining 17 percent was spent on the construction of new
environmental protection facilities. Across the world as a whole, Bayer
invests around €3 million every day in protecting the environment –
this amounts to approximately €1 billion each year. 
Environmental protection on an industrial scale includes the building
and operation of waste management facilities, which, though just as
necessary as they always were, are now becoming less and less signifi-
cant thanks to the groundbreaking principle of “in-process environ-
mental protection” that Bayer has consistently and successfully pur-
sued since the beginning of the 1980s. Thanks to newly developed
processes and products, emissions have decreased so dramatically
that in some areas, further treatment of waste air and wastewater
and disposal of waste or residues at the end of the production chain is 
either no longer necessary, or has been reduced to a minimum. The
construction of new disposal facilities is therefore only required in a
small number of cases.
€3 million a 
day spent on 
environmental
protection
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Though financial expenditure has decreased significantly as a result
of the principle of in-process environmental protection, the achieve-
ments and advances in relation to health, safety and environmental
protection as before remain at a very high level. In other words: On the
one hand, the costs associated with environmental protection provide
an economically relevant indicator for the ecological commitment of a
company; on the other hand, they are not a direct or comprehensive
reflection of the success of any such commitment. In future, it is,
therefore, our intention to document only our direct achievements
with regard to the environment and to do so using suitable indicators.  
A successful 
principle: 
In-process 
environmental
protection
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Our new corporate structure, changes to our portfolio and other
measures that were taken in order to safeguard our international
competitive position all affected the number of people employed at
the sites of the Bayer Group. Headcounts decreased in Europe, Latin
America and North America, while in Africa, Asia and Australia, Bayer
now employs more people than it did in 2000.
In total, the headcount of the Bayer Group was 2.3 percent lower in
2002 than it had been in 2000.  
Total number of employees at production sites
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Employees at the production sites as of the end of the year, according to region
Africa Asia, Europe Latin North Total
Australia America America
2000 Group 1,205 6,553 64,337 6,479 21,867 100,441
2002 Group – – – – – 98,171
2000 continuing operations 1,205 5,419 56,218 5,899 20,335 89,076
2002 continuing operations 1,249 6,027 50,989 4,957 19,482 82,704
Change in % Group – – – – – –2.3
Change in % continuing operations 3.7 11.2 –9.3 –16.0 –4.2 –7.2
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Health
We work to design and nurture a good working environment for Bayer
employees in order to ensure that at all sites around the world, 
the highest possible degree of health and safety is achieved at all 
times. This is something we have long regarded as our company's so-
cial obligation. We regard the early recognition of occupational and
work-related diseases as being a particularly important task and, for
this reason, we carry out regular and specific preventive healthchecks.  
There is no binding international definition for occupational diseases
and it is therefore difficult to compare the number of occupational
diseases that occur in a corporate organization with worldwide opera-
tions. The processes by means of which cases of occupational disease
are acknowledged also differ from country to country. The acknowl-
edgement process for an occupational disease may take some time,
which means that the data does not necessarily reflect the current sit-
uation. 
If we were to apply rules as stringent to all Bayer sites as those that
currently apply in Germany, then the number of newly acknowledged
cases across the Bayer Group as a whole would come to approximate-
ly 100 per year. 
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Industrial injuries to Bayer staff at production sites (without ex-ACS sites)
1998 1999 2000 2001 2002
Industrial injuries (>= 1 day of absence) 1,285 1,227 888 711 667
Industrial injuries per million hours worked (MAQ) 6.4 6.6 4.8 4.3 4.4
Days of absence due to industrial injuries 15,557 13,728 14,458 9,953 9,470
Days of absence per million hours worked (USQ) 78 74 79 60 62
The number of industrial injuries in the Bayer Group in 2002 was 667,
which was the lowest number ever recorded. This is the result of train-
ing courses, investment and regular dialog and discussion with em-
ployees. It is our objective to continue to considerably reduce the
number of injuries. This will only succeed, however, if considerable ef-
fort is devoted to the issue of safety. The Bayer Chemicals subgroup
has already devised measures and targets in this regard. In order to
enable the development of best practice in reducing the number of in-
juries across the Bayer Group as a whole, subgroups and service com-
panies will be sharing their experiences in seeking to reduce the injury
figures. 
In accordance with internal Group statistics (Bayer Recordable Inci-
dent), an industrial injury is deemed to have taken place if any report-
ed incident gives rise to at least one day’s absence from work. The day
of the accident itself does not count. Injuries are recorded irrespective
of whether there is a legal obligation to notify the authorities. Trends
in injury statistics are evaluated by means of the MAQ (Million Work-
ing Hour Quota), which comprises the number of industrial injuries
for every million hours worked. Trends in the severity of injuries are
tracked by means of the USQ (Injury Severity Quota), which denotes
the number of days of absence for every million hours worked. 
The table contains the absolute figures relating to injuries to Bayer
staff, along with the applicable quotas for previous years. During the
period from 2000 to 2002, the number of injuries per million hours
worked fell by approximately eight percent.
Occupational 
safety
Decline
in the number
of industrial
injuries
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The graph shows the corresponding MAQ value for all the Bayer sites
(production, warehouses, administration, research laboratories). The
ex-ACS sites have already been incorporated into the 2002 figures.
Our aim across the subgroups and service companies is to learn from
one another’s experience to achieve best practice in reducing our in-
jury statistics.
Our commitment to accident prevention and health applies in equal
measure to all who work at Bayer’s sites. This includes employees of
contractors, who are also required to comply with our Group-wide
safety rules. In selecting contractors, we pay particular attention 
to the reputation of contractor companies for ensuring that safety
standards are adhered to. 
Industrial injuries in the Bayer Group (production, 
warehouses, administration, research laboratories)
(MAQ values 2002, incl. ex-ACS sites)
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During the period under review, a reduction of almost 32 percent was
achieved in the number of injuries to contractor staff at our pro-
duction sites. Our aim is intensify even further our efforts to record
and reduce such injuries in future.   
The years under review, 2001 and 2002, unfortunately saw the deaths
of two Bayer employees and two contractor employees.    
Industrial injuries to contractor staff at Bayer production sites
2000 2001 2002 2002
Bayer including 
ex-ACS sites
Industrial injuries (>= 1 day of absence) 349 276 206 214
Industrial injuries per million hours worked (MAQ) 10.4 8.9 7.1 6.0
Fatal accidents
1998 1999 2000 2001 2002 2002
Bayer including 
ex-ACS sites
Bayer employees 3 3 3 2 0 0
Contractor employees 2 0 1 1 1 0
Number of 
injuries to 
contractor 
staff reduced 
by almost 
32 percent
In 2001, the driver of a dump truck suffered fatal injuries at our site in
Rustenburg, South Africa: While using his truck to pick up large stones,
a pipeline was breached which then hit him. As a result, he was
caught between the seat and the steering column of the dump truck
and suffered fatal injuries. Another Bayer employee was killed in a
traffic accident at the Bayer China Company Ltd. A third fatal incident
occurred at our site in Brunsbüttel and involved an employee of a con-
tractor, who was electrocuted while carrying out installation work. 
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In 2002, a fatal accident occurred at La Wantzenau in the Alsace region
of France, in which a single-person work platform fell to the ground
during installation work, probably as a result of supports that were in-
sufficiently secured. The contractor employee using the platform fell
three meters and landed so badly that he later died of his injuries.
All four incidents are somewhat atypical of the type of incidents that
occur in the chemical industry.
Transportation incidents  
A decrease of around 51 percent in the number of transportation  inci-
dents has been recorded since 1998. While a total of 41 such incidents
were recorded in 1998, the equivalent figure for 2002 came to only 20.
As the vast majority of our products are transported by road, any inci-
dents are most likely to occur while using this mode of transport and
this is reflected in the statistics. It is gratifying to note that the num-
ber of incidents involving chemical leakage decreased in 2002 by over
69 percent when compared with the previous two years. 
Transportation incidents are defined as incidents that occur during
the distribution of our raw materials, intermediates and products, in-
sofar as we are directly responsible for the transportation or insofar as
it was commissioned by us. Incidents that were the responsibility of
our suppliers and customers are therefore not included in the incident
statistics. The table contains information relating to the transporta-
tion incidents that occurred from 1998 onwards, according to the type
of transportation used. Transportation incidents are another area in
which we will be further improving our recording systems in future.
Transportation 
of Bayer 
chemicals 
safer than ever
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Total number of transportation incidents 
Number of transportation incidents according to CEFIC* guidelines
1998 1999 2000 2001 2002 2002
Ex- ACS sites
Road 38 25 26 16 18 5
Rail 1 1 2 0 1 1
Internal waterways 1 0 2 1 0 0
Sea 0 0 2 0 0 0
Air 0 0 1 0 0 0
Pipeline 1 0 0 1 1 0
Total number 41 26 33 18 20 6
Transportation incidents involving chemical leakage (Bayer Group)*
1998 1999 2000 2001 2002
Road 15 5 21 16 7
Rail 0 1 2 0 0
Internal waterways 1 0 2 1 0
Sea 0 0 0 0 0
Air 0 0 1 0 0
Pipeline 0 0 0 1 1
Total number 16 6 26 18 8
* CEFIC = European Chemical Industry Council
* Transportation incidents involving chemical leakage were not record-
ed separately at ex-ACS sites.
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In recognition of the fact that chemical production processes involv-
ing a high turnover of materials and energy can impact on the ecosys-
tem, Bayer supports the principles of sustainable, future-proof pro-
duction and designs its processes in such a way that the environment
is not affected any more than necessary. 
Use of raw materials 
Main raw materials for the production process
In 2002, acetone, acrylonitrile, benzene, butadiene, cyclohexane, eth-
ylene oxide, phenol, propylene oxide, styrene and toluene were the
most commonly used basic organic chemicals in terms of volume.
This “top ten” alone accounted for a total of 3.8 million metric tons,
with a value of €2.1 billion.  
In terms of inorganic raw materials, the Bayer sites’ requirements in
2002 were as follows:
1.3 million metric tons of common salt for chlor-alkali electrolysis to
recover chlorine, sodium hydroxide solution and hydrogen chloride.
Excess hydrogen from this process is sold.
400,000 metric tons of nitric acid, most of which is used in MDI/TDI
(methylene diisocyanate/toluene diisocyanate) production.
310,000 metric tons of ammonia, large quantities of which are fed
into caprolactam production (a preliminary stage in the production of
polyamide 6.6).
250,000 metric tons of sulfur, of which 50,000 tons is used for
Bayer’s own production of sulfuric acid.
Sustainable raw materials in the production process
Wherever possible, technically feasible and economically viable, Bayer
makes use of sustainable raw materials, although these do not play a
major role in the overall substance balance sheet.  
The following sustainable raw materials are used:  
Balsam resins, cellulose and its derivatives, fatty acids and alcohols
Substitute fuels from municipal, non-industrial waste, wax and
other stearates
Lignin sulfonates, oils and fats, castor oil
Thickening agents, fragrances, aromas and flavorings
Casein, sugar and its derivatives, starches, citric acid.
Environment
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We also work with our customers to develop products designed to
promote the use of sustainable raw materials, including
polyurethane/natural fiber mat composites with flax and sisal for car
door trims and roof liners. 
Raw materials for energy generation
Energy generation is an area in which we have undergone fundamen-
tal changes since the early 1990s. While in 1992 Bayer was still produc-
ing some 83 percent of its own energy requirement in the form of
electricity and steam, the level of in-house generation had fallen to
just 58 percent by 2002, with the remaining 42 percent being pro-
cured externally. 
The statistics for the energy actually being generated internally are
equally striking. Back in 1992 we produced 120 petajoules (1 petajoule
= 1015 joules) of energy from fossil fuels, compared with only 67 peta-
joules in 2002.
In 2002, only 49 percent of the total energy generated internally by
Bayer was obtained through the consumption of fuels, namely ap-
proximately 1.5 billion cubic meters of natural gas, 500,000 metric
tons of coal and 100,000 metric tons of liquid fuel. The remaining 
energy was generated through the recovery of heat from industrial
processes or from waste incineration at Bayer’s own sites. 
Renewable energies
To ensure future generations have an environment worth living in, our
use of energy in the long term will need to be more efficient.  Sustain-
able energy forms such as water power, biomass, biogas, wind and
solar energy can only make a small contribution. Wherever the use of
renewable energies is technically and economically viable, we support
this commitment insofar as we are able to do so. 
Our Brazilian site in Porto Feliz is contributing to the use of renewable
forms of energy. In 2002, 247 terajoules (1 terajoule = 1012 joules) of en-
ergy were recovered from chippings from the local timber processing
industry.
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Energy consumption 
The energy balance sheet for the 168 Bayer sites analyzed for this re-
port remains positive. Despite a rise in production, energy consump-
tion for continuing operations has fallen by 7.5 percent since 2000 to
136 petajoules per year, with energy efficiency (energy requirement
per production volume) improving by 13 percent.
Energy 
consumption
down a further
7.5 percent 
since 2000
Energy consumption in the Bayer Group in petajoules
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The Bayer sites’ primary energy requirement for continuing opera-
tions has also fallen significantly since 2000 – down 22 percent in the
case of natural gas and 12 percent in the case of coal. This reduction is
partly attributable to the external procurement of energy. Use of
waste heat has also been improved by 25 percent. 
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The shifts in the use of individual types of energy can also be attrib-
uted to fluctuations in the respective raw material prices.
If the former Aventis CropScience sites are included in the energy bal-
ance sheet, the Bayer Group’s total annual energy requirement is 146
petajoules per year. Due to the relatively low production volume in
ACS business (0.3 million metric tons per year), energy efficiency falls
to 11.4 with the inclusion of ex-ACS sites, which corresponds to the
Group figure for the year 2000.
Energy consumption in the Bayer Group according to type of energy
(1 petajoule = 1 thousand trillion joules = 1015 joules)
Energy source Unit 1992 1994 1996 1998 2000 2000 2002 Change 2002
continuing in ex-ACS
operations % sites
Natural gas petajoule/a 81 75 81 74 71 62 48 -22.0 *
Liquid fuels petajoule/a 15 15 9 9 5 4 4 0.5 *
Coal petajoule/a 24 18 20 21 17 17 15 -12.0 *
Externally procured
electricity petajoule/a 25 28 31 35 39 33 35 5.5 *
Waste heat utilization 
e.g. from waste incineration petajoule/a 20 21 22 23 21 10 12 25.0 *
Steam production
(external supplier) petajoule/a 3 3 11 14 24 22 22 1.8 *
Total petajoule/a 168 160 175 176 178 147 136 -7.5 10
Production volume million met. 
tons/a 10.3 10.9 11.8 13.1 15.5 11.7 12.5 6.2 0.3
Energy efficiency petajoule/ 16.3 14.7 14.7 13.4 11.4 12.5 10.9 -13.0 33.3
million met. tons
* These data were not recorded at the ex-ACS sites.
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Water balance
Far-reaching measures have been taken over the past few years to en-
sure that valuable water resources are used carefully and water pollu-
tion avoided. 
Water consumption at the Bayer sites, for example, fell by more than
16 percent to 2.0 million cubic meters per day between 1992 and 2002
despite a rise in production. Most of this water (85 percent) is used as
cooling water. A mere 15 percent of the water used is fed into produc-
tion processes and sanitary installations. Polluted process effluent and
sanitary wastewater are treated in our treatment plants before being
fed back into the environment. In fact, the water taken from the Rhine
by Bayer AG’s Lower Rhine sites is in some parameters less polluted
when discharged after treatment than when it was originally drawn
from the river. 
Water con-
sumption
reduced by 
more than 
16 percent 
since 1992
Water consumption and use in the Bayer Group in millions of cubic meters/day
1992 1994 1996 1998 2000 2000 2002 2002
continuing ex-ACS
operations sites
Total 2.4 2.2 2.3 2.2 2.1 2.0 2.0 0.6
water consumption
Cooling water 2.0 1.9 1.9 1.8 1.7 1.7 1.7 .– *
Process effluent and 0.33 0.32 0.35 0.35 0.32 0.27 0.29 .– *
sanitary wastewater
Major Bayer sites that require a lot of water – such as those in the
Lower Rhine region – generally meet their needs from naturally occur-
ring sources such as rivers, harbor waters or the sites’ own wells. The
four sites that consumed the most water in 2002 were Leverkusen
and Krefeld-Uerdingen in Germany, Antwerp in Belgium and Sarnia in
Canada. Leverkusen and Krefeld-Uerdingen rely on the Rhine to fulfil
their water requirements, while Sarnia is supplied with water from
the St. Clair river and Antwerp uses the brackish water from its harbor.
Throughout the whole of the Bayer Group, less than four percent of
water requirements are met from the public drinking water supply.
* These data were not recorded at the ex-ACS sites.
Bayer Sustainable Development Report 2004 Worldwide data recording 2001-2002 86
➔ Table of Contents
It is frequently the case that the surrounding area can also be sup-
plied with drinking water from our sites. Our subsidiary Wolff Wals-
rode, for example, supplies drinking water to the local community
from its Industrial Park in Bomlitz in Lower Saxony, Germany.    
Water pollution control  
Bayer is also making further advances in the area of water pollution
control, as evidenced, for example, by the chemical oxygen demand
(COD) sum parameter, which has fallen by approximately one quarter
in continuing operations since 2000 and by as much as 77 percent
compared with 1992. This fall also encompasses changes that arose as
a result of divestments.  Taking into account the former Aventis 
CropScience sites, the COD pollutant load per year is only one metric
ton higher.
With regard to the proportion of adsorbable organic halogen com-
pounds (AOX), the sum parameter in this case for continuing opera-
tions fell from 40 to 38 metric tons per year between 2000 and 2002.
Our aim, over and above adhering to the statutory requirements as a
matter of course, is to ensure that the quality of the water that we re-
turn to the environment is at least as high as that of the water we
have drawn from it. The remaining pollutant loads at the Bayer sites
fell again during the period under review – partially due to the sale or
closure of sites but also, in part, due to improved production and
treatment processes.
Chemical 
oxygen demand
of Bayer waste-
water down a
further 25 per-
cent since 2000
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Many of the substances that have generated criticism over past
decades are organic chlorine-containing compounds. AOX as a sum
parameter reveals nothing about the potential actual toxicity of the
substances that are discharged. Individual documentation is required,
which we provide at our sites in accordance with the local regulations.
For this reason we will no longer be documenting the AOX sum 
parameter in future.
COD, AOX and salt loads
Unit 1992 1994 1996 1998 2000 2000 2002 2002
continuing ex-ACS
operations sites
COD 1,000 t/a 74 66 57 48 32 23 17 1
AOX t/a 150 130 128 112 73 40 38 – *
Dissolved million t/a 1.3 1.3 1.2 1.4 2.0 1.6 1.5 – *
inorganic salts
COD, AOX and dissolved organic salts
The chemical oxygen demand (COD) is a measurement of the total
organic substances contained in water, including those substances
that are difficult to break down. The COD reading gives the amount
of oxygen required to oxidize all of the organic substances con-
tained in the water. In the form of a sum parameter, the COD read-
ing can be used to assess the degradation performance of a waste-
water treatment plant. COD degradation rates of between 90 and
95 percent can be achieved. 
An excessively high level of organic substances in natural waters is
not desirable as organic substances in water are generally decom-
posed by organisms, using up oxygen in the process. Depending on
the level of pollution the oxygen present in the water is used up.
AOX stands for adsorbable organic halogen compounds (X = chlo-
rine, fluorine, bromine, iodine), in other words compounds that are
toxic or have poor biodegradability.
The wastewater parameter “dissolved inorganic salts” refers to all
chloride and sulfate salts discharged into receiving waters. 
* These data were not recorded at the ex-ACS sites.
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Heavy metals
As part of our work to record HSE data we monitor the concentration
of heavy metals in our wastewater in accordance with the recommen-
dations of the European chemical association CEFIC. We have been
able to record further reductions in this area. At those sites where op-
erations are being continued, all emissions of heavy metals fell further
during the period under review. Overall, we discharged approximately
50 percent less heavy metal in 2002 than in 1992.
Wastewater parameter: COD in 1,000 t/a
80
70
60
50
40
30
20
10
0
1992 1994 1996 1998 2000 2002
74
66
57
48
32
18
23
17
1
Group total
Continuing operations
Ex-ACS sites
Bayer Sustainable Development Report 2004 Worldwide data recording 2001-2002 89
➔ Table of Contents
The proportion of the Bayer Group’s emissions of heavy metals (Cd, Cr,
Cu, Hg, Ni, Pb, As, Zn) attributable to the former Aventis CropScience
sites was, at 0.64 metric tons in 2002, approximately two percent of
the Bayer Group’s total emissions.  
The Group has also significantly reduced (by 53 percent) its discharge
of mercury into its wastewater, one of the contributing factors being
the refitting of the chlor-alkali electrolysis plant at Bayer’s Dormagen
site which now operates on the basis of state-of-the-art membrane
technology. The Group target for 2004 of discharging less than 30
kilograms of mercury per year into wastewater was almost achieved
in 2002, with a discharge of just 33 kilograms of mercury.  
Heavy metal discharges into receiving waters  in t/a
1992 1994 1996 1998 2000 2000 2002
continuing
operations
Cd (cadmium) 0.3 0.1 0.2 0.2 0.2 0.16 0.08
Cr (chromium) 25 10 9 9 6.2 6.2 5.0
Cu (copper) 17 12 13 11 12 8.2 6.4
Hg (mercury) 0.07 0.04 0.05 0.05 0.08 0.07 0.03
Ni (nickel) 13 9 10 9 7 6.8 5.0
Pb (lead) 4 4 3 3 2 1.5 1.0
As (arsenic) – * – * – * – * 0.7 0.5 0.45
Zn (zinc) – * – * – * – * 14 12.9 11.4
Total (heavy metals) 59 35 35 32 42 36.33 29.36
Contribution of ex-ACS sites 0.64
Sum total 30.00
Clear fall in 
mercury 
emissions
* These values were not recorded in the period under review.
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Wastewater parameter: Total phosphorus (Bayer Group) in 1,000 t/a
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Wastewater parameters: Phosphorus and nitrogen (Bayer Group) in 1,000 t/a
1992 1994 1996 1998 2000 2002
Ptot (total phosphorus) 1.9 1.6 1.6 0.8 0.8 0.6
Ntot (total nitrogen) 9.8 9.4 11.2 6.1 3.4 3.4
Sum of Ptot and Ntot 11.7 11.0 12.8 6.9 4.2 4.0
Nutrients 
Surplus amounts of nutrients such as nitrates, ammonium nitrogen
or phosphates can cause overfertilization (eutrophication) when dis-
charged into receiving waters.  It is therefore one of Bayer’s aims to re-
duce nutrient discharges as far as possible. The table below shows our
results in this area during the period under review. Phosphorus dis-
charges fell by one quarter compared with 2000. Overall, Bayer has
cut nutrient discharges by approximately 66 percent since 1992.
Nutrient discharges of the recently acquired Aventis CropScience sites
scarcely affect our Group’s overall figures, accounting for between
three and four percent of the total amount.
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Gases of relevance to the climate  
Bayer has been committed to climate protection for many years now.
Despite a rise in production output of around seven percent, the
Group’s direct carbon dioxide emissions from continuing operations
fell by around 12 percent between 2000 and 2002. Direct emissions 
of all greenhouse gases, grouped together as “carbon dioxide equiva-
lents,” fell eleven percent over the same period. In 2002, the specific
carbon dioxide equivalent, which expresses these direct emissions in
relation to production output, was 16 percent lower for continuing op-
erations than in 2000.
This means that in 2002 the Bayer Group already exceeded its target
of a 50 percent reduction in direct greenhouse gas emissions by the
year 2010 (compared with 1990). The Group-wide figure for the reduc-
tion in direct emissions of greenhouse gases was 59 percent. Along-
side the sale of affiliated companies and subsidiaries and plant clo-
sures, the transfer of a power station to a utility company and its si-
multaneous conversion from being coal-fired to being fired by highly
efficient gas turbines also contributed to this result. As well as being
more economic, this transfer was also responsible for greater energy
efficiency and, correspondingly, reduced consumption of resources
and lower emission levels. Meanwhile, our energy efficiency improve-
ment measures, such as the switch from mercury-cell to membrane
processes in our chlor-alkali electrolysis operations, have played a
major part in the reduction of indirect climate-relevant emissions. At
Bayer AG in Germany an even more ambitious target of a 53 percent
reduction was set. Direct greenhouse emissions at the sites of Bayer
AG have been reduced by a total of 66 percent.
“Greenhouse gas” is the term used by experts to refer to gases
thought to influence the warming up of the Earth’s climate. Carbon
dioxide – the “basic gas” – has been assigned a warming potential of
GWP 1 (GWP = Greenhouse Warming Potential). Other greenhouse
gases are deemed to be carbon dioxide equivalents and the GWP indi-
cator is used to describe the level of the assumed impact on the cli-
mate compared with carbon dioxide. As far as the Bayer Group is con-
cerned, the only greenhouse gas of major significance is carbon diox-
ide itself.
The table below shows the amounts of greenhouse gases that we our-
selves have released directly during our energy generation and pro-
duction processes.
Air pollution control
Carbon dioxide
emissions from
Bayer sites 
down 12 percent 
since 2000
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Emissions of climate-relevant gases in accordance with the Kyoto Protocol 
CO2 equivalent and specific CO2 equivalent
Unit 1990 1992 1994 1996 1998 2000 2000 2002
continuing
operations
Carbon dioxide mill. t/a 10.1 10.5 9.4 9.6 9.6 9.2 5.9 5.2
Methane t/a – – – – – – 60 60
Dinitrogen monoxide 1,000 t/a 15.9 16.0 14.7 5.7 2.7 1.5 1.5 1.5
Partially halogenated 
hydrofluorocarbons (HFC) t/a – – – 45 45 33 33 33
CO2 equivalent mill. t/a 15.0 15.5 14.0 11.4 10.5 9.7 6.4 5.7 (6.1*)
Production volume mill. t/a 10.1 10.3 10.9 11.8 13.1 15.5 11.7 12.5
Specific CO2 equivalent 1.49 1.50 1.28 0.97 0.80 0.63 0.55 0.47
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The ex-ACS sites accounted for 0.4 million metric tons of carbon diox-
ide emissions in 2002. Overall, the Bayer Group was responsible for a
total of 6.1 million metric tons of direct greenhouse gas emissions in
2002.  
Ozone-depleting emissions 
Bayer has made a commitment to monitor its use of substances that
have a damaging effect on the Earth’s ozone layer. Emissions of these
substances have been dramatically reduced over the past few years.
By recording comprehensive data for substances with the potential to
destroy the ozone layer (see table on page 94), we are ensuring that
our action goes beyond that required under the Protocol introduced at
the CFC Conference held in Montreal in 1987. 
Ozone is a natural gaseous component of the Earth’s atmosphere oc-
curring in varying concentrations in the different layers of air. In the
stratosphere, ozone forms a protective barrier against the sun’s dam-
aging ultraviolet rays. As a result of complex chemical reactions in the
atmosphere, chlorofluorocarbons (CFCs), brominated halon gases and
various different chlorinated hydrocarbons (solvents, carbon tetra-
chloride, methyl chloride and others) with varying potential to cause
damage can all contribute to the depletion of the ozone layer.  
To compare the damaging effect of substances on the ozone layer, a
specific ODP or ozone depletion potential is assigned to these sub-
stances, using a method that is similar in nature to the carbon dioxide
equivalent method.  The reference substance in this case is trichloro-
fluoromethane (CFC-11) which is given the ODP value of 1. On this basis
the CFC-11 equivalent for direct emissions from the Bayer sites is 38
metric tons.
With a CFC-11 equivalent of 22 metric tons, it is chloromethane that
makes up the largest share of emissions of substances with ozone de-
pletion potential.
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We will be continuing within the Group to monitor ozone depletion
potential in future on the basis of the GRI indicator list (EN-9) so as to
work towards a reduction in the pollutants released into the atmos-
phere. 
Further significant air emissions
Volatile organic compounds
Emissions of volatile organic compounds – summarized in the VOC
sum parameter – fell by 13 percent at Bayer between 2000 and 2002
based on the Group’s continuing operations.
In addition to the VOC sum parameter, we have also listed some sub-
stances separately in the table.
The company has achieved a clear improvement in ABS emissions
(acrylonitrile, 1,3-butadiene, styrene). Our target in this area was to cut
emissions by 2004 to less than 250 metric tons per year. During the
period under review we already achieved a reduction from 443 to 272
tons per year, ensuring that we can reach our target by the end of
2004. 
Emissions with ozone depletion potential (Bayer Group in 2002) in t/a
Quantity OPD value CFC-11 equivalent
Trichlorofluoromethane  2 1.00 2.00
Dichlorodifluoromethane  11 0.82 9.02
Chlorodifluoromethane  32 0.03 1.09
Methyl chloride (chloromethane) 1,100 0.02 22.00
Bromomethane  2.5 0.37 0.93
Tetrachloromethane 0.2 1.20 0.24
Chlorodifluoroethane 35 0.086 3.01
CFC-11 equivalent 38.29
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We are not satisfied with the development recorded with regard to or-
ganic chlorine solvents. This rise in emissions is due to the use of
chloromethane in rubber production at Bayer’s sites in Sarnia and 
Zwijndrecht. However, reduction measures are planned. 
The 38 newly integrated Aventis CropScience sites add some 4,000
metric tons per year to the Group-wide figures for VOC emissions. 
Waste air parameter: Total VOC in 1,000 t/a
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* These data were not recorded at the ex-ACS sites.
Emissions of volatile organic compounds
Unit 1992 1994 1996 1998 2000 2000 2002 2002
continuing ex-ACS
operations sites
VOC 1,000 20.6 17.4 14.0 14.0 9.1 8.5 7.4 4.0
t/a
BTXE (benzene, toluene, 
xylenes, ethylbenzene) t/a 780 748 266 215 170 160 152 *
ABS 
(acrylonitrile, 1,3-butadiene, styrene) t/a 685 540 373 440 443 395 272 *
Important organic chlorine solvents 
(chloromethane, dichloromethane, 
trichloromethane, tetrachloro- 
methane, 1,2-dichloroethane) t/a 1,742 1,606 2,167 1,391 628 626 1,140 *
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Volatile inorganic compounds
As with the volatile organic compounds (VOC), volatile inorganic com-
pounds (VIC) also contain air pollutants, emissions of which we are
endeavoring to reduce too.  Sulfur dioxide emissions have already
been greatly reduced: The 2004 target of 5,000 metric tons of sulfur
dioxide was achieved and actually undershot as early as 2002. The
considerable expansion of Bayer CropScience’s activities that occurred
with the acquisition of Aventis CropScience did, however, increase sul-
fur dioxide emissions again, to a total of 7,400 metric tons per year in
2002, with the result that we must now review our 2004 target in
light of the Aventis acquisition.
We continue to devote a great deal of attention to nitrogen oxide
emissions and are aiming to achieve a further reduction (7,500 metric
tons in 2004) by modernizing our production operations. The Group
balance sheet for 2002 shows an annual nitrogen oxide output of
8,100 metric tons, increasing to 9,400 tons per year if the ex-ACS sites
are also included. 
The key individual substances included in VICs – sulfur dioxide, nitro-
gen oxides and carbon monoxide – are mainly produced from energy
generation using fossil fuels. Sulfur dioxide emissions depend to a
large extent on the sulfur content of the fuels used. Coal and oil con-
tain varying concentrations of sulfur, which can result in fluctuations
due to the source of energy selected. Natural gas is actually inherently
sulfur-free but the addition of odorants to give the product a smell for
safety reasons results in the presence of sulfur-containing com-
pounds (mercaptans). Some of our production processes also release
sulfur dioxide and nitrogen oxides.
All direct VIC emissions associated with energy generation have been
cut thanks to the legal transfer of our steam and electricity power sta-
tions to a utility company outside the Group (outsourcing, divest-
ment). However, the targets stipulated in 2001 were also based on
specific reduction projects to improve processes at our headquarters
in Leverkusen and at our site in Antwerp, Belgium.
Sulfur dioxide
target for 2004
already 
undershot at
Bayer sites in
2002
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Major inorganic emissions in 1,000 t/a
1992 1994 1996 1998 2000 2000 2002 2002
continuing ex-ACS
operations sites
Sulfur dioxide (SO2) 21.6 14.3 9.9 7.7 6.6 5.7 4.7 2.7
Nitrogen oxides                                   
(NOx, excluding N2O, calculated as NO2) 17.6 15.1 12.1 12.2 11.2 9.0 8.1 1.3
Carbon monoxide (CO) 10.9 9.2 11.4 9.3 3.8 3.6 3.0 *
VICs 
(excluding CO2, SO2, NOx, CO) 1.4 1.3 1.4 1.3 1.1 1.0 1.2 *
Sum of above parameters 51.5 39.9 34.8 30.5 22.7 19.3 17.0 *
Waste air parameter: SO2 in 1,000 t/a
25
20
15
10
5
0
1992 1994 1996 1998 2000 2002
21.6
14.3
9.9 7.7
6.6 7.45.7 4.7
2.7
Group total
Continuing operations
Ex-ACS sites
* These data were not recorded at the ex-ACS sites.
Waste air parameter: NOx in 1,000 t/a
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Particulates
The target set for 2004 of reducing particulate emissions to at most
1,500 metric tons per year was achieved by the Bayer Group in 2002
and actually improved on to the tune of 700 metric tons. The major
contribution to this trend came from the Brazilian site in Camacari,
where particulate emissions were practically eliminated as a result of
the closure of the polymerization plant in 2002. While the acquisition
of Aventis CropScience did lead to a renewed increase in particulate
emissions of 14 percent, Bayer will nevertheless still achieve its self-
imposed target by the end of 2004.
Particulates are emitted by the combustion installations used for 
energy generation as well as in production processes when, for 
example, pneumatic conveyors are used to transport solid granules. 
Waste air parameter: Particulates (Bayer Group) in 1,000 t/a
2.5
2.0
1.5
1.0
0.5
0
1992 1994 1996 1998 2000 2002
2.3
1.8 1.7
1.3
1.9
0.8
Bayer has made a commitment to make its emissions data directly ac-
cessible to the responsible State Environmental Office (StUA) by elec-
tronic data transfer from 2005 onwards. This will affect several haz-
ardous waste incinerators and power stations at the Bayer Chemical
Parks in Leverkusen, Dormagen and Krefeld-Uerdingen. In future, all rel-
evant parameters – half-hour values and average daily values – will be
transmitted electronically to the StUA every day. In addition, an annual
report will be compiled and the emissions situation will be published
once a year in the media.
Through this ruling Bayer complies with a framework agreement be-
tween the German Chemical Industry Association and the government
of North Rhine-Westphalia. This agreement allows companies to decide
whether they want to publish the data on the internet or automatically
via electronic data transfer.
Bayer Sustainable Development Report 2004 Worldwide data recording 2001-2002 99
➔ Table of Contents
110 99
Waste volumes
Most of the solid waste produced is generated in the production areas
of the Bayer Chemicals and Bayer Polymers subgroups. Over the past
ten years, we have succeeded in greatly reducing waste levels in these
areas, success that is particularly well illustrated by the amount of
waste produced in relation to product volumes. While only 48 kilo-
grams of waste (4.8 percent) needed to be disposed of for each metric
ton of product produced in 2002, the equivalent figure in 1992 had
been almost three times as high, at 123 kilograms. Overall, Bayer has
achieved a 61 percent reduction. The downward trend is also clearly
evident when continuing operations for the years 2000 and 2002 are
considered .
The ongoing principle in terms of waste management is the maxi-
mum reduction or recycling of production residue. The methods used
to achieve this include the ongoing development of our production
processes, the targeted selection of raw materials and, quite generally,
the choice to opt for high-quality products with a long service life.
In addition to our production waste we also register all other types of
waste such as household waste, sewage sludge and construction
waste products (building site waste, rubble, excavated earth, broken-
up road surface materials). Construction waste was included as a dis-
tinct category in its own right for the first time in our 2002 data com-
pilation. Due to restructuring measures we had a relatively high pro-
portion of construction waste in 2002 for the Group as a whole at ap-
proximately 400,000 metric tons. Our Camacari site in Brazil alone ac-
counted for some 100,000 tons of rubble and excavated soil due to
closures and renovation of the polymerization operations. 
Waste products that we take over from outside the Group for disposal
purposes are also included in the figures. These include municipal
waste and, to an increasing extent, waste produced by the companies
operating from within our chemical and industrial park sites. The rise
Waste management
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in the volume of this waste is also partly due to the sale of operations
to other companies that make use of our central waste management
facilities. Once such example is EC Erdölchemie GmbH, where Bayer
divested its 50 percent stake. Waste from this company – in the region
of 100,000 metric tons per year – is now recorded as external waste.
Total waste in million t/a
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Continuing operations
The annual figures for the newly acquired ACS sites, at approx. two
percent, scarcely affected waste levels in 2002.  
Waste data 1992 – 2002 (Group totals in millions of metric tons/year)
1992 1994 1996 1998 2000 2000 2002
continuing 
operations
Waste from (chemical) production 1.27 1.10 1.05 1.10 0.76 0.72 0.60
Other waste 1.02 0.98 0.86 0.86 0.86 0.64 0.30
Construction waste – – – – – – 0.40
External waste (taken on by 
Bayer sites for disposal) 0.02 0.04 0.14 0.11 0.15 0.24 0.31
Total waste including waste  
from third parties (total)* 2.3 2.1 2.1 2.1 1.8 1.6 1.6
Waste from production process/
Production volume in % 12.3 10.1 8.9 8.4 4.9 6.1 4.8
* Value includes recycled waste and waste from third parties.
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Final fate of waste as a percentage of solid waste disposed of
1996 1998 2000 2002
Landfilled 47 50 47 60
Incinerated 17 14 19 26
Recycled 36 36 34 14
Disposed of externally 23 31 26 19
Types of disposal
Some 60 percent of our waste was landfilled during the period under
review, with 26 percent being incinerated and 14 percent recycled. In
other words, compared with 2000, a greater proportion of waste was
landfilled and incinerated while recycling levels dropped. More than
half of the waste that is incinerated (53 percent) is used for thermal re-
covery. 
One reason for the decrease in recycling lies in the larger volume of
construction waste. This could no longer be put to the same use as a
replacement construction material, in the construction of landfill
sites, for example, as there was no longer any need for the building
materials in question and some of the waste products were contami-
nated and unsuitable for reuse.
Approximately four-fifths of the waste for disposal is disposed of by
Bayer internally using its own landfill facilities. The remainder (19 per-
cent) is sent to external disposal companies. This figure has been con-
sistently reduced between 1998 and 2002, which is testimony to the
performance and capacity of our own disposal facilities, which are in-
creasingly also being used by our contractual partners, particularly in
the chemical parks.
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Data recording 2003
The main changes regarding reporting for 2003 compared with the
previous year relate to the improved data collection based on sub-
group structure at the respective sites and the additional inclusion of
sites other than production bases which have warehouse facilities, of-
fices and research laboratories. Previous data compilation encom-
passed 168 production sites across the world, grouped geographically.
Using the new method, 444 sites grouped according to geographical
location and also according to subgroup have been included in the
survey.
The result is a revised set of HSE performance data including defini-
tions, known as HSE key performance indicators. Particular attention
has been paid to ensuring that these definitions are internationally
comprehensible and unambiguous.
Our 12 key indicators relating to social issues, transport safety, envi-
ronmental emissions and use of raw materials describe those areas to
which we attach particular importance. We will be setting ourselves
targets in these areas and providing regular progress reports and will
allow ourselves to be measured against these targets. The HSE key
performance indicators will be used to manage our achievements in
this area.
Focus on 12 HSE key performance indicators from the areas of
Social issues
Transport safety
Environmental emissions
Use of raw materials
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Accident statistics
Reducing the number of accidents is one of our key goals. We report
the injury rate of our employees resulting in at least one day’s ab-
sence from work in the form of the MAQ, which represents the num-
ber of industrial injuries resulting in absence from work for every mil-
lion hours worked. We have, however, extended the group of employ-
ees included in this calculation. While in the past contractors, part-
time employees and employees on fixed-term contracts were exclud-
ed, it is now the case that all contractors who report directly to Bayer
line managers, part-time employees and employees with fixed-term
contracts are included in the figures. Yet despite this extension of the
group of employees covered, we have succeeded in achieving a slight
reduction in the injury rate for the Group as a whole compared with
the previous year, down from 3.5 to 3.4. Targeted campaigns on the
part of the subgroups and service companies, such as Bayer Chemi-
cals’ 1000-Day Program, have made a major contribution to this result.
Bayer Sustainable Development Report 2004 Worldwide data recording 2003 104
➔ Table of Contents
Additionally, for the first time, we are reporting on injuries to Bayer
employees that may not result in absence from work but do result, for
example, in the employee being assigned light duties or requiring
medical treatment. The combined parameter is known as the 
reportable injury rate of Bayer employees. Only when we succeed in
reducing this statistic too, will we be able to reduce the number of in-
juries resulting in absence from work in the long term. The first value
calculated per million working hours is 7.2, which is 2.1 times as high
as the rate for lost time injuries.
For the first time in 2003 we have prepared these figures on a world-
wide basis based on data compilation at site level through the sub-
groups and service companies.
Industrial injuries suffered by Bayer employees in the Group
(production, warehouses, administration and research laboratories)
(MAQ = million working hour quota, injuries per 1 million hours worked)
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Environmental incidents and 
incidents causing damage
To date, only those incidents have been recorded that have required a
report to be submitted to the authorities in accordance with local reg-
ulations. For this reason only limited comparison of individual results
across the Group as a whole was possible.
For 2003, however, we have classified environmental incidents and in-
cidents causing damage into three levels according to three Group-
wide uniform definitions. Incidents that can be allocated to the first
two levels are then reported in the form of the key performance indi-
cator “major environmental incident.” By doing so, we demonstrate
that our sense of responsibility goes beyond the statutory re-
quirements. At the same time, this parameter is not only recorded at
our production sites but at all 444 Bayer Group sites, since environ-
mental incidents and incidents causing damage can also occur in
warehouses or research laboratories, for example. In total, there were
21 major environmental incidents in the Group in 2003, plus 117 inci-
dents classed as belonging to level three i.e. with a lower environmen-
tal or damage impact.
Environmental incidents and incidents causing damage in the Bayer Group 
1999 2000 2001 2002 2003
Reportable environmental incidents 68 69 47 53
Incidents causing damage 6 7 1 4
Major environmental incidents (levels 1 + 2) 21
Environmental incidents (level 3) 117
The figures for environmental and damage-causing incidents from
previous years can only be compared to the 2003 figures to a limited
extent. The higher figures for 2003 do not indicate an increase in the
number of incidents but are the result of the new definition and
recording structure.
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This parameter has been recorded using the definition provided by
the European Chemical Industry Council (CEFIC) as in previous years,
but, for the first time, the 2003 figures encompass all of the Group's
sites and not just production facilities. Overall, the number of trans-
portation incidents rose slightly from 26 to 28. However, all of the in-
cidents related to road accidents.
Transport safety
Number of transportation incidents according to CEFIC* guidelines
1998 1999 2000 2001 2002 2003
Road 38 25 26 16 23 28
Rail 1 1 2 0 2 0
Internal waterways 1 0 2 1 0 0
Sea 0 0 2 0 0 0
Air 0 0 1 0 0 0
Pipeline 1 0 0 1 1 –
Total number 41 26 33 18 26 28
* CEFIC: European Chemical Industry Council
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emissions
The manufacture of our products causes emissions to be released into
the air and waterways and creates waste materials that cannot cur-
rently be recycled. Our aim is to continually work to minimize these
emissions and to responsibly handle hazardous waste whose produc-
tion is unavoidable. It is therefore important to our company that we
pursue an active management approach in this area using key per-
formance indicators. These environmental KPIs are recorded only at
our production sites as these are the only sites with a significant im-
pact in this area.
Emissions into the air
Emission of greenhouse gases
Climate protection requirements and the terms of the Kyoto Protocol
are something to which we adhere to well in excess of the statutory
requirements. This is why we are striving to reduce direct emissions
of greenhouse gases further. During 2003, we again achieved an
eleven percent reduction in these emissions compared with the previ-
ous year, expressed as CO2 equivalents. Both at the sites of Bayer AG
and at those of the Group as a whole direct emissions of gases of rele-
vance to the climate have fallen by over 60 percent.
Direct greenhouse gas emissions as CO2 equivalents  in million t/a
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This means that the Bayer Group had already exceeded its target of a 50
percent reduction in direct greenhouse gas emissions by the year 2010
(compared with 1990) by the end of 2002. Alongside the sale of affiliat-
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ed companies and subsidiaries and plant closures, the transfer of a
power station to a utility company and its simultaneous conversion
from being coal-fired to being fired by highly efficient gas turbines also
contributed to this result. As well as being more economic, this transfer
was also responsible for greater energy efficiency and, correspondingly,
reduced consumption of resources and lower emission levels. Mean-
while, our energy efficiency improvement measures, such as the switch
from mercury-cell to membrane processes in our chlor-alkali electrol-
ysis operations, have played a major part in the reduction of indirect 
climate-relevant emissions. 
This results in the following picture: Despite an increase in production
since 1990 of 16 percent, emissions of greenhouse gases relevant to the
climate fell by over 60 percent, as a consequence of the measures de-
scribed.
Emissions of volatile organic carbons (VOC)
In addition to the ongoing reduction of greenhouse gas emissions, we
strongly believe in the need to reduce emissions of volatile organic
compounds (VOC), which impact ozone levels. As a result of the acqui-
sition of Aventis Crop Science and the related expansion of our activi-
ties, the VOC emissions figure rose between 2000 and 2002 from
9,100 t/a to 11,400 t/a. During 2003 a reduction of six percent to
10,700 t/a was achieved.
Emissions of volatile organic carbons (VOC)
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Emissions into water
The emission of nutrients (nitrates, ammonium nitrogen or phos-
phates) can cause overfertilization of receiving waters. This is why we
are working to make ongoing reductions to discharge levels. During
2003, there was no measurable change compared with the previous
year in terms of the discharge of nutrients.
Wastewater parameter: Total phosphorus (Bayer Group) in 1,000 t/a
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Wastewater parameter: Total nitrogen (Bayer Group)      in 1,000 t/a
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Wastewater parameters: Phosphorus and nitrogen (Bayer Group) in 1,000 t/a
1992 1994 1996 1998 2000 2002 2003
Ptot (total phosphorus) 1.9 1.6 1.6 0.8 0.8 0.6 0.6
Ntot (total nitrogen) 9.8 9.4 11.2 6.1 3.4 3.4 3.4
Sum of Ptot and Ntot 11.7 11.0 12.8 6.9 4.2 4.0 4.0
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Waste management
Total volume of hazardous waste production
Our reporting with regard to waste has been developed greatly.
Crucially important in this regard is the volume of hazardous waste
that is produced. It is important to us that we reduce the level of haz-
ardous waste to a minimum and that we handle and dispose of this
waste responsibly so that no risk is posed to humankind or the envi-
ronment. This is why we are reporting the volume of hazardous waste
produced for the first time. During 2003 hazardous waste accounted
for 50 percent of total waste produced in the Group. The total level of
waste produced by the Bayer Group fell by 23 percent. 
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Total volume of hazardous waste disposed of at landfill sites
To date we have only reported the total volume of waste disposed of
at landfill sites. For the first time, we are reporting the volume of haz-
ardous waste disposed of via landfill facilities. Our aim is to reduce 
the total volume of hazardous waste requiring disposal via landfill,
thereby taking on board our long-term responsibility for the environ-
ment. The volume of hazardous waste disposed of in this way in 2003
was 20 percent of the total waste produced.
Total waste produced by the Bayer Group in million t/a
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Conserving water and energy is a key priority at Bayer, which is why
we are permanently striving to reduce our water and energy con-
sumption levels.
Water consumption
Only one percent of the Earth’s total water supply is fresh water. In a
bid to draw attention to the scarcity of this resource, the UN declared
2003 to be the International Year of Freshwater. Compared with the
previous year, the Bayer Group succeeded in reducing its water con-
sumption by 19 percent in 2003. The greatest contribution to this re-
duction was made by the BCS subgroup.
Water consumption in million m3/day
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Bayer Sustainable Development Report 2004 Worldwide data recording 2003 113
➔ Table of Contents
Energy consumption
Energy consumption always involves the use of a natural resource. This
is why we are striving to cut our energy consumption levels further. 
During the year under review we were able to achieve a  three percent
reduction in our energy use. 
Through this worldwide improvement the total energy consumption in
the Bayer Group has fallen since 1992 by some 15 percent. At the same
time, emissions of greenhouse gases have been reduced worldwide by
60 percent. Alongside the sale of affiliated companies and subsidiaries
and plant closures, the transfer of a power station to a utility company and
its simultaneous conversion from being coal-fired to being fired by highly
efficient gas turbines also contributed to this result as did numerous mea-
sures to improve energy efficiency (see also p. 107).
Energy consumption in the Bayer Group in petajoule/a
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Sustainable development objectives
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For many years already, Bayer has set itself
objectives against which it allows itself to be measured. In the 2001 Sus-
tainable Development Report we documented the objectives, that we had
set in all areas of the company. In the following pages you will read
whether we have achieved the targets we set ourselves and you will be
able to find out which objectives we have set ourselves for the future. The
sustainable development objectives of the subgroups and service compa-
nies make up the sum of our Group objectives. As explained in the section
on data recording for 2003 we shall continue to develop these objectives on
the basis of our key performance indicators for environmental emissions, use
of raw materials, safety and social issues. No new objectives were set 
for Bayer Chemicals since this subgroup will be combined with some 
businesses of Bayer MaterialScience to form the independent company
Lanxess. This will be floated on the stock exchange in 2005 and will then be
responsible for developing and pursuing its own corporate policy.
In-Sung Cho, Korea, aged 6 
➔ More on the children´s pictures
“The birds in the air and
the animals in the fields
should always be able 
to live well.”
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Objectives from 2001
A (second) self-evaluation of HSE management systems is to be
implemented at all sites by 2002, that evaluation to include an
action plan for continuous improvement until the next self-
evaluation/audit 
All relevant Bayer production sites are to be evaluated by
qualified outside auditors by 2004
To reduce direct emissions of climate-relevant gases, Bayer
AG is committed to a 53 percent cut in emissions by 2010
(compared with the base year 1990): additionally, efforts are in
place to identify further potential for reductions throughout the
Group
By continuing to pursue a systematic safety management
program, the aim is to reduce work-related injuries by 50 per-
cent by 2004
By continuing/further developing cooperation with contractors
in the area of occupational safety at Group sites, the aim is to
improve accident levels for these external companies 
Status at end of 2003
The evaluation has been completed and the results have been
passed to the subgroups for further action. 
Each subgroup is currently establishing its own integrated,
cross-site HSE(Q) management system based on the present
system’s components. 
This objective is still being pursued. As part of the reorganiza-
tion of the Bayer Group into independent subgroups, further
development of the HSE(Q) systems falls initially within the
scope of the subgroups (see above). 
The objective for 2010 has already been achieved at the German
sites. At the German sites and across the Group as a whole,
direct emissions of climate-relevant gases have been reduced
by considerably more than 60 percent compared with 1990. 
By the end of 2003 work-related injuries had declined consid-
erably. A variety of tools and activities are being applied to
achieve this goal e.g. Bayer Chemicals’ 1,000-Day Program to
become accident-free within 1,000 days and Bayer Industry
Services’ program for improved safety and health protection
targeting all its employees.
In 2003 improvement of workplace safety for contractors was
achieved at quite a number of sites. Here, too, a variety of
tools and activities continue to be applied to reduce the 
number of accidents and injuries to a minimum, e.g. at the 
Lower Rhine sites and Brunsbüttel through:
 Inspections of construction sites and bases together with
the responsible employers’ accident liability insurance
association (e.g. for metal industry, construction industry
etc.)
 Exchange of experience with the responsible representa-
tives of contractors on causes and necessary action follow-
ing accidents.
The Bayer Group
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By continuing to pursue a systematic safety management
program, the aim is to achieve further major reductions in
reportable incidents by 2004
As part of an International Council of Chemical Associations
(ICCA) program, Bayer is establishing harmonized, interna-
tionally recognized data records with tests and assessments
(published on the internet as part of the OECD Existing
Chemicals Program) for about 70 HPV products
The Eco-Check is to be further developed as an instrument for
quality-based portfolio management as part of sustainable
corporate development and open dialog both internally and
with the public
The strategic orientation of the business groups regarding
sales products with critical toxicological and ecotoxicological
properties should be subjected to systematic debate
The development of sustainable products is to be promoted sys-
tematically
The Group-wide system to identify and record transportation
incidents is to be expanded in order to ensure continuous
improvement in the safe transport of our products
A variety of tools and activities are being applied to this end e.g.
continuous improvement of the safety concept for produc-
tion units, the installation of suitable safety barriers and the
implementation of safety audits and discussions.
Between the years 2000 and 2002 the number of reportable
incidents fell by 25 percent. With the introduction of key per-
formance indicators in 2003 the Bayer-internal definition for
reportable incidents was modified and harmonized across
the whole Group (see p. 105). A direct comparison between
the figures for 2003 and those for 2002 is therefore only pos-
sible to a limited extent.
By the end of 2003, reports on 20 substances, for which Bayer
was the lead company, had been completed under the
OECD’s ICCA program. Another nine substance reports were
compiled by consortia in which Bayer participated. 
The Eco-Check method has been and is being successfully
applied in the subgroups to assess a variety of products and
technologies. In addition, it has been presented, and dis-
cussed, both internally at Bayer and externally at a variety of
venues (e.g. econsense, the 2nd German-Japanese Expert
Seminar about Product and Production Integrated Environ-
mental Protection in Osaka (PIUS), the Sustainable Product
Design Forum). With the reorganization of the Group and the
associated changes to the portfolio we have further devel-
oped our methodology and adapted it to the new require-
ments.
A cross-business-area committee regularly discusses this
issue. Where necessary, project groups are formed to look
into specific subjects and products in greater detail.
The results are given in detail on pages 23 – 28.
A new management system for the evaluation of transport
incidents (TUMAS) was introduced on a trial basis in 2002, ini-
tially at Bayer AG only. In 2003, it was taken over as a standard
system.
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Consistent Responsible Care target management, the intensive
exchange of best practices and support of Responsible Care
coordinators at affiliate companies are to be applied to support
the continuous improvement process
Conversion of chlor-alkali electrolysis from a mercury-cell
process to a membrane process should result in a clear reduc-
tion in mercury loads in wastewater from 75 kg/a (2000) to 
< 30 kg/a (equates to a 60 percent reduction). Mercury levels
should be significantly cut as early as 2004 
By means of a second nitrification/denitrification stage at the
wastewater treatment plant in Leverkusen, the aim is to
achieve a 20 percent reduction in the nitrogen loads recorded
at the plant outlet by 2004
Using various technical measures (especially at Antwerp and
Leverkusen) and by means of outsourcing and relocating pro-
duction to modern plants, emissions of acid gases are to be
reduced further by 2004: 
Sulfur dioxide 6,600 –> 5,000  t/a 
Nitrogen oxides 11,200 –> 7,500  t/a
Acrylonitrile, butadiene and styrene emissions are to be cut
from 443 t/a (2000) to 250 t/a (2004), equating to a 44 percent
reduction
Appropriate process improvements and production reloca-
tion measures at various Group sites will be used to reduce par-
ticulate emissions from 1,900 t/a (2000) to 1,500 t/a (2004)
Within the new Bayer structure Responsible Care (RC) has
been given a firm basis through RC Commitments by the sub-
groups and service companies and through the appointment
of RC coordinators. There is a company-wide exchange of
experience among RC representatives. A continuous improve-
ment process in the fields of health, safety and environmental
protection is a fundamental objective. The subgroups and
service companies set and track their own separate RC tar-
gets. In addition, at our German chemical and industrial parks
annual agreements are concluded with the partner compa-
nies located there on RC site objectives.
The switch to the membrane process is taking place gradual-
ly. The goal was almost achieved in 2002 when the mercury load
was 33 kg. In 2003, the target was unfortunately not achieved
by some margin as a result of an individual incident at one site
during the cleaning of a wastewater sewer. We expect to
achieve our target of < 30 kg in 2004 as we have already
reached an advanced stage in the conversion of the electroly-
sis plants.
This goal was achieved when the second nitrification/denitri-
fication stage came on stream in 2002.
At the Bayer sites the 2002 target of a maximum 5,000 met-
ric tons sulfuric acid was easily achieved in 2002. Through the
considerable expansion of Bayer CropScience’s activities with
the acquisition of Aventis CropScience total sulfur dioxide
emissions increased again to 7,400 metric tons in 2002, how-
ever. Through targeted measures we were able to cut back
sulfur dioxide emissions in 2003 to 5,900 metric tons. The
target for nitrogen oxide emissions was already achieved in
2003. 
Since 2000, emissions have fallen to 279 t/a, a considerable
decrease.
Emissions have been reduced substantially since 2000; the
goal was already achieved in 2002 by a considerable degree. In
2003 the value was 900 t/a.
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New objectives for 2003/2004
Improve product safety in regard to environmental aspects
Increase drug safety
Strengthen consciousness for prevention 
Strengthen the control mechanisms for drug safety
Development of a new drug to treat malaria
Activities
Investigate and monitor the environmental impact of our
retail products.
Development of software to generate hospital discharge let-
ters with the objective of minimizing the occurrence of
adverse drug reactions and thus supporting safe use of ther-
apeutic drugs. 
 Bayer HealthCare in Argentina is collaborating with the
Argentinean Heart Foundation to conduct a campaign
aimed at increasing awareness of cardiovascular risk.
 BHC’s Biological Products Division is supporting a project
initiated by the World Federation of Hemophilia (WFH), an
international organization for hemophilia patients, with
the objective of establishing improved, uniform global
standards for laboratory tests in hemophilia therapy cen-
ters.
In addition to the existing Critical Action Committees at divi-
sional level, a BHC Critical Action Committee will be estab-
lished for critical issues concerning the product safety of
human pharmaceuticals and medicinal products. 
Bayer and the “Medicines for Malaria Venture” (MMV), a WHO
initiative financed by the World Bank and private founda-
tions, have signed an agreement to develop a new malaria
drug. Under the terms of the cooperation agreement, Bayer
will develop the product and WHO/MMV will be responsible
for monitoring distribution through the public health sys-
tems in developing countries. Bayer will supply the drug dis-
tributed in this way. The price in this market segment will be
set to ensure that all parts of the population in developing
countries that are affected by malaria can receive treatment.
Bayer will market the drug in industrialized countries. Clinical
testing has already started.
Bayer HealthCare
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Continuation of the optimization of an in vitro model to
reduce the number of animal studies
Increase diabetics’ personal responsibility for their manage-
ment by introducing the Ascensia® blood glucose meter and
disseminate the measures derived from the results of STOP-
NIDDM (Study to Prevent Non-Insulin-Dependent Diabetes
Mellitus) 
Work will continue on the development of an apparatus-
based process for the comparative investigation of the ten-
dency of active substances to crystallize in body fluids; the
overall aim is to reduce the number of animal studies that
need to be carried out.
Development of the method has been successfully conclud-
ed. 
In order to support diabetic patients in their efforts to man-
age their condition, Bayer HealthCare launched the easy-to-
use “Ascensia®” blood glucose meter in the third quarter of
2003 as the ideal complement to its range of products for dia-
betics. The meter can take blood from the finger tip or, alter-
natively, from the forearm, abdomen, or thigh, and measure
the level of glucose exactly. STOP-NIDDM (Study to Prevent
Non-Insulin-Dependent Diabetes Mellitus) showed that it is
extremely important to measure blood glucose, particularly
after meals. The new study also documents a 49 percent
reduction in the risk of developing cardiovascular disease and
a 91 percent reduction in the risk of suffering a heart attack in
patients who took Glucobay®. In addition, there was a reduc-
tion in the risk of developing high blood pressure, and Glu-
cobay® also improved blood lipid values. The findings confirm
the importance of regularly monitoring the patient’s blood
glucose level. The new meter is a great help in ensuring that
the diabetic patient eats a balanced diet which is optimized
to prevent late complications of the condition.
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Objectives from 2001
Bring to market maturity and launch Bayrepel®, the new Bay-
er active ingredient in the Autan® product family, an active
substance with superior efficacy and a more favorable risk
profile in children
Analysis of the potential environmental impact of pharma-
ceutical active ingredients and their degradation products
during development
Promotion of health care through health education and
improved consumer information concerning the topic of anti-
bacterial resistance
Safeguarding the supply of Bayer’s tropical drugs Germanin®
and Lampit®
Status at end of 2003
Numerous scientific studies have confirmed that the active
ingredient in Autan, Bayrepel®, provides effective protection
against insect bites. Unlike conventional substances, Bay-
repel® does not damage materials and has a neutral odor; its
outstanding tolerability means that it can even be used on
children from the age of two. The product has been launched.
The entire Autan® product family was divested in 2002/2003.
All development substances are investigated systematically
by Pharma for biodegradability and ecotoxicity and the find-
ings documented. As part of a collaboration project with the
Swiss Federal Institute of Technology in Zurich (ETH), for
example, a doctoral candidate co-sponsored by Bayer investi-
gated the effects of drug products on the environment.
In response to the growing global resistance to antibacterial
substances, Bayer AG has started an international scientific
education campaign called LIBRA. The campaign also involves
international experts and opinion leaders. The objective is 
to promote the correct and responsible use of antibiotics all
over the world. There is also an internet site at www.libra
initiative.com featuring constantly updated material.
In November 2002, Bayer and the WHO concluded an agree-
ment on the donation of Bayer’s drug Germanin® (active
ingredient: suramin) to combat African sleeping sickness.
Bayer has agreed to provide the WHO with the drug at no
charge for an initial period of five years.
As a further aspect of Bayer’s social commitment to eliminat-
ing African sleeping sickness, the company is supporting
studies intended to lead to extension of the indication for its
drug Lampit® (active ingredient: nifurtimox). Several studies
featuring various dose strengths for the treatment of sleep-
ing sickness have already been completed.
Availability of Lampit® has been safeguarded by restarting
manufacture of this drug in El Salvador.
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New objectives for 2003/2004
Introduce a knowledge information system for recipes, haz-
ardous goods and safety data for Bayer CropScience’s prod-
ucts to provide globally consistent specifications and materi-
al safety data sheets
Develop and introduce new crop protection products with
reduced application rates 
Continue the gradual replacement of formulations in WHO
(World Health Organization) class I 
Continue developing attractive bait formulations 
Improve application methods for the control of termites
Objectives from 2001
Replacement of crop protection products by new combina-
tions requiring lower application volumes
Development of crop protection products with a favorable
toxicological profile, faster degradation in soil/water and
high selectivity – so called “reduced-risk” products under the
registration system in the United States
Development of active ingredients with a favorable ecotoxi-
cological profile
Early deployment of crop protection products to avoid expen-
sive and time-consuming frequent spraying later in the vege-
tation period
Development of methods (“closed system”) to make handling
safe for the user and thus to reduce the burden on the envi-
ronment
Expansion of the herbicide range by products with targeted
action against weeds combined with selectivity for many
major crops
Activities
Develop and implement a QHSE knowledge information system
for global use by Bayer CropScience and its customers.
Expand the use of sulfonylurea-containing products (MaisTer®‚
Atlantis®‚ etc) in some crops. 
Introduce new products and new formulations.
Launch new bait formulations for insects, which currently are
not managed in this fashion.
Launch Premise® perimeter (band) treatments, which signifi-
cantly reduce the spray volume / active ingredient content
required. 
Status at end of 2003
Akteur® has replaced carbofuran in sugar beet seed pelleting
in Germany already.
Approval of the reduced-risk fungicide trifloxystrobin (FLINT®
etc) has been granted in the United States. Additionally the her-
bicide mesosulfuron has received reduced-risk status for the
registration process in the United States.
Approval of Calypso® has already been granted in more than 
40 countries.
Treatment of cotton seed with small volumes of Gaucho® has
been successfully introduced.
Special drums and Micromatic valves have been introduced
on banana plantations to ensure complete emptying and
rinsing of crop protection drums and to avoid exposure of the
user through the closed system approach.
Tacco® (licensed to Spiess) has been introduced in Germany.
Bayer CropScience
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New objectives for 2003/2004
Work safety: Reduction in accidents/injuries
Environment: Reduction of emissions into the water, air and
soil
Development of a Group-wide integrated HSEQ manage-
ment system
Use of polymers for flexible and economic solar energy appli-
cations
Activities
Reduction in accidents/injuries through a rigorous safety
management system applying various instruments, e.g.
 System-supported accident recording and reporting proce-
dures,
 Systematic development of a safety organization covering
all employees,
 Documentation of ongoing hazard investigations and
assessments,
 Implementation of “near-miss” programs and “blue spot
campaign” (labeling potential danger areas) to improve
identification and across-the-board elimination of sources
of accidents.
Continuous improvement in the reduction of wastewater
emissions (amount and load) from production units and Bay-
er MaterialScience sites, e.g. through targeted process opti-
mization projects.
Further reduction in waste in production units.
Further reduction in gas emissions detailed in Kyoto protocol
– long-term reduction.
Consolidation of the health, safety, environment and quality
management systems, based, among other things, on the
global principles of Responsible Care and sustainable devel-
opment, into a single global management system for Bayer
MaterialScience AG.
Status: By March 2004, more than 90 percent of Bayer
MaterialScience AG’s sites and organizational units in Europe,
the Middle East, Africa and Asia subject to the new integrated
quality management system were certified according to 
DIN EN ISO 9001 (matrix certification). 
The use of thermoplastic polyurethane as the encapsulation
material in the continuous production of flexible solar mod-
ules yields integrated functionality. This, coupled with the
weight reduction achieved by substituting polycarbonate
sheet for glass, allows the use of solar energy devices in new
applications.
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Development of new raw materials for coatings with signifi-
cantly reduced emissions of volatile organic compounds
(VOC)
Further development of Makrolon® polycarbonate as a glaz-
ing material in the automotive industry
Broadening the field of applications for metal-plastics hybrid
technology
Development of new rigid insulating foams to reduce the
energy consumption of domestic appliances (refrigerators
and freezers)
Bayer’s two-component waterborne polyurethane technolo-
gy cuts the amount of volatile organic compounds released
into the atmosphere while achieving durability and aesthetic
standards previously only possible using solventborne coat-
ings. Bayhydrol®/Bayhydur® raw materials for waterborne
coatings are used in a growing range of applications, such as
industrial and wood finishes, floor and automotive coatings,
adhesives and paper applications.
Development of coatings to enable the use of Makrolon®
polycarbonate as a replacement for glass in automotive glaz-
ing. Improved safety behavior and weight reduction are two
of the advantages of Makrolon®. Other positive features of
Makrolon® as a material for automotive glazing are greater
flexibility in design and easier integration of functional parts.
By combining the individual strengths of metal and plastics,
hybrid technology allows the production of lightweight parts
with high static and dynamic stability and the potential to
integrate functions. The technology for front-ends is already
in place with various automotive companies such as AUDI or
Ford. Other applications are set to follow. Compared to all-
metal solutions, hybrid technology means lower weight and
fewer manufacturing steps (e.g. welding), giving clear overall
savings in terms of the energy expended during manufactur-
ing and later use of the parts. Recycling simply involves sepa-
rating the metal from the plastic mechanically. 
Bayer MaterialScience has set up a number of projects with a
view to increasing the insulating efficiency of rigid
polyurethane foams. The intention is to continuously
improve the already good insulating properties and excep-
tionally beneficial processing and final properties of rigid
polyurethane foams. 
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Objectives from 2001
Development of plastics for use in automotive engineering,
sparing use of resources and considerable energy savings
Improved raw materials for environmentally compatible vehi-
cle tires: Development and testing of tire rubbers with opti-
mized polymer structure and of new types of crosslinking
agents
Development of special-purpose elastomers with improved
temperature properties for environment-friendly vehicle
motors
Greater use of high-temperature elastomers with reduced
fire risk
Energy-saving construction using polyurethane rigid foam
insulating boards
Status at end of 2003
Projects for car roof modules featuring a combination of film
and continuous strand reinforced polyurethane or
polyurethane sandwich structures are being pursued with
partners in the industry with the aim of saving on weight and
material. The initial results of prototype testing with a view to
future series production have been encouraging. Bayer Mate-
rialScience is also working on other concepts and technolo-
gies in this area of automotive engineering.
Market trials with Vulcuren® initiated highly positive cus-
tomer response. Market introduction began at the beginning
of 2004.
Two new Therban® grades with improved low-temperature
properties i.e. higher sealing power also at lower tempera-
tures (reduced oil leakage) have been introduced (Therban®
LT grades). Further improvements in aging resistance are
increasing the service life of products in some applications
(Therban® HT technology) and also open up new fields of
application for Therban®. The XT technology is making it 
possible to produce toothed belts with a reduced space
requirement and an improved performance, which is making
itself felt, for example, through lower fuel consumption in
the engine. It is planned to introduce PT (Process Technology)
grades, which save energy in processing.
Levapren® FRNC (fire-resistant non-corrosive grade) is being
used in various vehicle projects. The FRNC concept is still
being tested for automotive engineering applications (fuel
lines).
Bayer MaterialScience is engaged in the ongoing develop-
ment of polyurethane heat insulation in the building sector,
for example composite thermal insulation systems using
rigid polyurethane foam.
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Development of low-solvent paint and coating systems based
on Bayhydrol®/Bayhydur® components and powder coatings
based on Crelan®/Rucote®
Development of sprayable, recyclable, peel-off films for pro-
tecting vehicles during transportation
Development of biocide-free antifouling coatings
Development of thinner packaging films for foodstuffs
Development of high-quality chemical products based on cel-
lulose, a renewable raw material
Waterborne two-component polyurethane coatings have been
introduced into the market for finishing wood and plastics, as
floor and wall coatings and as transportation coatings. 
The target is to develop new applications for these products,
especially in the automotive topcoat segment. This requires
optimization of waterborne two-component polyurethane
coatings in respect to their processing properties, a further
reduction in solvent emissions and extremely high quality
requirements. The development of new Bayhydrol® and Bay-
hydur® components represents a clear step in this direction.
Furthermore, a concept to streamline the mixing and appli-
cation technology has been developed.
Powder coatings are used without the addition of solvents.
The acquisition of Rucote® (binder) enables us to participate
with all crosslinking technologies. This product together with
Crelan® (crosslinker) makes us a systems supplier of PU pow-
der coating technology.
For the first time in the world, the sprayable peel-off film was
introduced on the production line of an automotive manu-
facturer. The technology was established through the opti-
mization of the Bayhydrol® component and the application
technology.
The antifouling effects identified in extensive field trials were
not sufficient to satisfy the technical milestones. The project
was abandoned at the end of 2002 given the lack of short- or
medium-term realizability.
Successful launch of thin packaging films (C20P), substitut-
ing films of 33 percent greater thickness and also possessing
technical advantages.
Market presentation of new high-purity hydroxypropyl-
methylcelluloses (HPMC) as formulation aids for foodstuff,
cosmetic and pharmaceutical products (Walocel® HM).
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Objectives from 2001
Baypure® biodegradable complexing agents
Replacement of nitro and polycyclic musk fragrances with
macrocyclic musk fragrances
Switch from animal to plant-based raw materials for flavor-
ings
Recycling of refractory metals
Felt-free treatment of wool
Waterproofing of leather
Enzyme-based textile processing chemicals
Status at end of 2003
Market introduction has taken place, with further expansion
of production in 2003 owing to high demand for Baypure®
CX.  
The relevant business is no longer part of the Bayer Group.
The relevant business is no longer part of the Bayer Group.
Recycling rate over period 2001–2003 over 50 percent (relative
to raw material use).
Work on the felt-free treatment of plasma-treated wool is
complete. At the moment a production unit for this innova-
tive and virtually wastewater-free processes is being set up at
a wool processor in Germany. 
A new two-component waterproofing system for leather
which can be fixed in the leather without the addition of
heavy metals was introduced in 2002 under the trade names
of XERODERM® P-AF and S-AF, with the market responding
positively.
The market introduction of the BAYLASE® product range was
highly successful and the product range is being steadily
expanded. The ecological benefits (low water consumption,
complete biodegradability) have been achieved in full.  
Bayer Chemicals*
* Bayer Chemicals – with the exception of H.C.Starck
and Wolff Walsrode – is to be combined with some of
Bayer MaterialScience’s operations to form a new inde-
pendent company Lanxess, which is to be floated on the
stock exchange by the beginning of 2005. The company
will be responsible for setting its own sustainable de-
velopment objectives.
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New objectives for 2003/2004
Intensification of technical vehicle controls
Intensification of dialog
Integration of Responsible Care in training and further edu-
cation
Activities
Reduction, through suitable measures, in rejection quota of
vehicles belonging to carriers employed by Bayer on the
grounds of being in a technically unsatisfactory state.
Open house day involving all Chemical Park partners and the
local community.
Increased communication of Responsible Care activities
(measures and projects) and educational offers in the Bayer
media “direkt,” “aktuell” and “Bayer News Channel,” on the
intranet and in the daily press. 
Continuation and optimization of the training and educa-
tional program for Responsible Care, environmental protec-
tion and occupational safety.
Intensive support for the Responsible Care philosophy in
training and further education through:
 Implementation of the Responsible Care training objec-
tives embedded in the restructured training curriculum.
 Strengthening of the personal sense of responsibility
towards Responsible Care of all trainees.
 Continuation of Responsible Care projects in the training
departments.
Bayer Business Services (BBS) 
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New objectives for 2003/2004
Individual responsibility linked to handling of resources –
resource management
Reduction in work-related accidents
Introduction of an HSEQ management system for BTS
Activities
Strengthening of sense of responsibility in handling
resources, energy and BTS property to reduce consumption
and avoid waste.
Targeted staff training and further education in matters of
day-to-day occupational and plant safety through safety dis-
cussions and pertinent safety lectures.
Establishment of a BTS occupational safety committee.
Systematization of occupational safety on construction sites
and statistical recording of accidents in projects.
Drafting of HSEQ guidelines and instructions.
Certification according to ISO 9001/2000 involving further
BTS organizational units.
Bayer Technology Services (BTS) 
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New objectives for 2003/2004
Implementation of an HSEQ management system for BIS
Realization of the 2003 Responsible Care campaign “Individ-
ual Responsibility” and 2004 campaign “Resource Conserva-
tion” at the Bayer sites Leverkusen, Dormagen, Elberfeld,
Brunsbüttel, Krefeld-Uerdingen and Bitterfeld
Further reduction in accident/injury statistics
Get contractors involved in Responsible Care objectives of 
the respective sites. The aim is to cooperate closely with con-
tractors working at Group sites to help them achieve an
improvement in accident/injury figures
Improvement of incident management
Activities
 Establishment of a uniform HSEQ management system for
BIS which incorporates already existing certifications and
accreditations.
 Achievement of certification to ISO 9001/2000 and ISO
14001 in relevant areas.
Publication of (annual) leaflets/posters incl. demonstration of
work/travel accidents and suggestions for improvements;
realization of a Bayer AG wide competition for production
facilities incl. Bayer Chemical Park partners at these sites;
realization of operational measures (e.g. daily 5-minute dis-
cussions, systematic recording of near-misses and obvious
sources of errors, plant-internal training, introduction of Prof-
iteam, an IT-supported reporting system for hazards at the
workplace, RC commitment signed by the employees, bring-
ing the subject of hazards and transport safety home to
employees); intensive information/communication incl. use
of Responsible Care intranet site that is accessible across 
the Group and to Chemical Park partners; RC internet site; 
presentation of RC at open house days.
Reduction in number of accidents at work and on the way
to/from work of BIS employees compared to 2002 through
systematic safety management.
 Inspection of construction sites and bases together with
the responsible employers’ accident liability insurance
association (e.g. engineering and metal association, con-
struction association).
 Exchange of experience with the responsible individuals of
the contract partners following incidents to establish caus-
es and necessary action.
Specific practices with the involved communities and depart-
ments.
Bayer Industry Services (BIS) 
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Dialog at Bayer
Information shapes acceptance
Communication is very important for Bayer because it shapes
the way we are seen by our employees and society as a whole.
The Bayer Group therefore gives equal priority to providing
timely and extensive information for employees, stockholders,
financial analysts, the media and the general public alike. 
Many people only know the
chemical industry from media
reports so they find it hard to
imagine what we actually do at
our sites. The chemical and phar-
maceutical industry and modern
biotechnology are a source of
hope and expectation but they
also provoke fear and concern.
Bayer is aware of the need to
explain to people as clearly as
possible what it does, why it
does it and what implications its
work might have. Personal con-
tact is essential to create trust:
Talking to one another and learn-
ing to understand one another is
essential to reduce misunder-
standings. We pay special atten-
tion to showing the general pub-
lic how seriously we take our
responsibilities in all areas of our
operations. That includes social
as well as economic and ecologi-
cal responsibility. We use a vari-
ety of communication methods
to help us achieve this goal: 
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days held at twelve sites
throughout Germany.
Regular publications such 
as “direkt,” a magazine for em-
ployees and the local commu-
nity, the magazines published by
our subsidiaries for their em-
ployees and customers, our R&D
Through almost daily news
releases and regular news
conferences we keep the media
informed of all major events and
developments in the Bayer
Group. Modern methods of
communication such as the
internet enable us to provide
extensive and up-to-date infor-
mation. In addition, our em-
ployees worldwide are kept in-
formed via our in-house intra-
net. A full overview of the Bayer
Group and its global activities
can be found on the internet at
www.bayer.com
The Bayer Communication
Center (“BayKomm”) in Lever-
kusen, Germany, which was
opened in 1991, is the heart of
our communication activities.
Being open to the wide variety of
opinions about the chemical and
pharmaceutical industry is fun-
damental to our approach. Con-
sequently, BayKomm was specif-
ically designed as a forum for
discussion and encounter. The
1,350 square meter exhibition
area is divided into eight
sections centering on specific
topics: “Sport – Leisure,”
“Building/Construction/Home,”
“Transportation,” “Information
Technology,” Safety and
Environmental Protection,”
“Health Care,” “Nutrition” and
“Bayer: Names – Figures – Facts.”
Every year Bayer welcomes
about 140,000 visitors from Ger-
many and abroad to BayKomm.
The meeting rooms, bistro and,
last but not least, the exhibition
area, provide an ideal platform
for informative discussions,
debates, experimental lectures
and slide shows. 
Many of Bayer’s sites hold
regular open house events so
that local inhabitants can find
out more about issues of
interest to them. In September
2003 Bayer welcomed some
85,000 people to the open house
Bayer has been a member of the global chemical industry’s
Responsible Care initiative from the beginning, is a founder
member of the United Nations’ Global Compact and the econ-
sense Sustainable Development Forum, sponsors the United
Nations Environment Programme (UNEP) and is a member of the
World Business Council for Sustainable Development (WBCSD).
Bayer is included in a variety of ethical investment indices such
as the Dow Jones Sustainability World Index and the Advanced
Sustainable Performance Index (ASPI) for the euro zone and in
the ethical investment funds managed by the Norwegian 
insurer Storebrand. 
magazine “research,” our com-
pany magazine “report,” our
annual report and stockholders’
newsletter and the present 2004
Sustainable Development Report
provide a range of information
for the general public on the
Bayer Group.
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Glossary
AOX
Abbreviation for adsorbable
organic halogen compounds; 
X stands for the halogens fluo-
rine, chlorine, bromine and
iodine. The sum of these organic
halogen compounds, 
determined by a standardized
procedure and calculated as the
chloride content, is an indication
of the degree of pollution of a
water course. Organic halogen
compounds are toxic and/or
have poor biodegradability
Audit
A systematic investigation
designed to establish whether
the relevant activities (e.g. envi-
ronment-related activities in the
case of an environmental audit)
and the resultant effects comply
with the planned requirements.
It also examines whether these
requirements are met and
whether they are appropriate for
achieving the intended goals.
Biological wastewater 
treatment
Process for breaking down
organic substances by microor-
ganisms in special treatment
plants. Microorganisms are
capable of breaking down
organic substances in surface
waters: Wastewater treatment
plants make selective use of this
natural process.
BMBF
Abbreviation for the German
Federal Ministry of Education,
Science, Research and 
Technology.
BTXE
Abbreviation for the aromatic
hydrocarbons benzene, toluene,
xylene and ethylbenzene.
COD value
Abbreviation for chemical oxy-
gen demand.
This value, determined by 
a standardized procedure, 
indicates the degree of 
contamination with organic
compounds in a water course.
Corporate citizenship
The term signifies the role of the
company as a “citizen” of a
country and city, and also as a
“global citizen.” Rules for global
citizenship are given, for exam-
ple, in the Global Compact.
Corporate governance
Responsible corporate manage-
ment and monitoring aimed 
at increasing the value of a 
company.
Corporate social 
responsibility
Umbrella term for the social
dimension of sustainable man-
agement and the readiness to
take on responsibility in the
social sphere. Depending on the
size of the company, degree of
internationalization and range
of products, responsibility can
be on a local, regional or global
scale.
Denitrification
Process in which special bacteria
are used to break down nitrate,
releasing nitrogen (N2) as found
in air. By-products of denitrifica-
tion are laughing gas (N2O) and
nitric oxide (NO).
DIN/ISO 14001
International standard for envi-
ronmental management sys-
tems. Companies formulate
their own, internal environmen-
tal protection objectives, set up
environment programs to attain
these objectives and develop an
appropriate environmental
management system which
should cover all environmental
protection activities and be doc-
umented in an environment
manual. Certification is awarded
following inspection by inde-
pendent auditors.
DIN 33922
German standard which 
prescribes how environmental
reports intended for the public
are to be presented.
Eco-efficiency
In 1992, the World Business
Council of Sustainable Develop-
ment (WBCSD), of which Bayer is
a member, introduced the term
“eco-efficiency” as a strategic
concept for companies. The
term is defined by the WBCSD as
follows: “Eco-efficiency is
reached by the delivery of com-
petitively priced goods and ser-
vices that satisfy human needs
and bring quality of life, while
progressively reducing ecologi-
cal impacts and resource inten-
sity throughout the life cycle, to
a level at least in line with the
Earth's estimated carrying
capacity.”
Ecology
(Greek: oikos = household, logos
= reason)
The science of interactions
between organisms and their
environment.
Emissions
Solid, liquid and gaseous sub-
stances released into the envi-
ronment as a result of chemical,
industrial and even biological
processes. Emissions also
include noise, heat and radia-
tion.
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European Regulation on Eco-
Audits (EMAS = Environmen-
tal Management and Audit
System)
Companies may set up a volun-
tary environmental manage-
ment system and issue environ-
mental statements to the public
detailing their achievements in
the field of environmental pro-
tection. The companies are
inspected by authorized envi-
ronment auditors and, if they
meet the requirements, are enti-
tled to use the EU Eco-Audit
label. Applies only in Europe.
Fair disclosure
Corporate principle according to
which all stockholders and
important target groups are
informed in the same way about
the company.
Global Compact
Joint initiative of the United
Nations and selected major
companies relating to human
rights, working conditions and
environmental protection in
businesses. Bayer was one of the
45 founding companies.
Global Reporting Initiative
(GRI)
An international initiative result-
ing in the drafting of guidelines
for the compilation of environ-
mental and sustainable develop-
ment reports.
HSE
International abbreviation for
health, safety and environmen-
tal protection.
Kyoto Protocol
In 1997, the parties to the United
Nations Framework Convention
on Climate Change agreed,
among other things, on the
reduction of certain gases such
as carbon dioxide which are
thought to have a negative
effect on the Earth's climate.
MAQ
Yardstick for recording the fre-
quency of occupational acci-
dents: The number of injuries
leading to at least one day of
absence for every million work-
ing hours performed.
NGO
Abbreviation for non-govern-
mental organization.
Nitrification
Process in which ammonia is
oxidized with special bacteria
known as “nitrificants” to form
nitrate.
Petajoule
Unit of work, energy and heat 
(1 joule = 1 Watt x seconds =
0.2239 calories; 1 petajoule = 
1015 joules).
Resource productivity
Efficiency of use of raw materi-
als and energy.
Responsible Care
Global initiative launched in
Canada in 1985 by the chemical
industry to promote continuous
improvements in health, safety
and environmental protection.
Bayer committed itself to this
initiative in 1994 together with
the Association of the German
Chemical Industry (VCI).
Stakeholders
The stakeholder principle entails
the consideration of a company
within its full social context and
the attempt to harmonize the
various claims of the different
interest groups. In addition to
stockholders, the main stake-
holders are staff, customers and
the state.
Sustainable development
According to the definition of
the World Commission on Envi-
ronment and Development
(WCED), “sustainable develop-
ment is development that
meets the needs of the present
without compromising the abili-
ty of future generations to meet
their own needs.” (Brundtland
Commission Report 1987).
Toxicity
The poisonousness of a sub-
stance.
UNEP
Abbreviation for the United
Nations Environment Pro-
gramme.
USQ
Yardstick for recording the sever-
ity of accidents which reflects
the number of work days lost for
every million working hours per-
formed.
VIC/VOC
Abbreviation for volatile inor-
ganic compounds/volatile
organic compounds.
The sum of volatile
inorganic/organic compounds in
the air, determined by a stan-
dardized procedure.
WBCSD
Abbreviation for the World Busi-
ness Council for Sustainable
Development.
Bayer Sustainable Development Report 2004 Children’s pictures III
➔ Table of Contents
In our 2001 Sustainable Development Report experts such as Kofi
Annan, Secretary-General of the United Nations and winner of
the Nobel peace prize, Weera Sakultab, Director-General of the
Department of Environmental Quality Promotion in Thailand,
and Prof. Ernst Ulrich von
Weizsäcker, Founding President
of the renowned Wuppertal
Institute for Climate, Environ-
ment and Energy, outlined their
visions for sustainable develop-
ment.
In the 2004 issue we present the
visions of some of the people who are most affected by sustain-
able development because it directly affects their future: 
children and young people around the world. 
As “experts on the future,” we asked
them to show us their visions of 
tomorrow’s world. This report shows
what we consider to be the best of the
hundreds of pictures we received. They
should be an additional incentive for 
us to help create a livable and lovable
world for them and all subsequent 
generations. 
Visions of the future
Mellina Albuquerque Nascimento, Brazil, aged 10
Julia Dobler, Germany, aged 5
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